#GO enrichment for all type A BioProject samples analyzed together,,,,,,
#delta.rank = the difference in the mean rank for the GO term and the mean rank for all other genes. Larger negative values indicate tendency toward downregulation under stress. Positive values indicate tendency toward upregulation.,,,,,,
#pval = the raw p-value for the GO terms enrichment,,,,,,
#nseqs = the number of genes in the dataset annotated with the GO term,,,,,,
#term = the GO term accession,,,,,,
#name = the descriptive name of the GO term,,,,,,
#p.adj =  p-value adjusted for multiple testing (Benjamini–Hochberg procedure),,,,,,
#goDivision = the division the GO term is from (BP=Biological Process; MF = Moleular Function; CC = Cellular Compnent),,,,,,
delta.rank,pval,nseqs,term,name,p.adj,goDivision
-971,8.98E-25,496,GO:0006259,DNA metabolic process,2.01E-21,BP
-1400,7.75E-17,149,GO:0006260,DNA replication,6.38E-14,BP
-1075,8.54E-17,256,GO:0006281,DNA repair,6.38E-14,BP
637,2.59E-15,706,GO:0035556,intracellular signal transduction,1.25E-12,BP
692,2.79E-15,585,GO:1902531,regulation of intracellular signal transduction,1.25E-12,BP
2088,9.97E-15,57,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",3.72E-12,BP
1815,1.27E-14,75,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,4.08E-12,BP
2027,2.14E-14,59,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,5.50E-12,BP
-650,2.36E-14,622,GO:0043436,oxoacid metabolic process,5.50E-12,BP
-1369,2.46E-14,130,GO:0006310,DNA recombination,5.50E-12,BP
-640,4.27E-14,630,GO:0006082,organic acid metabolic process,8.69E-12,BP
1323,7.69E-14,134,GO:0019884,antigen processing and presentation of exogenous antigen,1.37E-11,BP
-667,8.02E-14,560,GO:0019752,carboxylic acid metabolic process,1.37E-11,BP
803,8.54E-14,375,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,1.37E-11,BP
1326,1.00E-13,132,GO:0002478,antigen processing and presentation of exogenous peptide antigen,1.50E-11,BP
1458,1.22E-13,108,GO:0006986,response to unfolded protein,1.71E-11,BP
633,1.36E-13,617,GO:0032270,positive regulation of cellular protein metabolic process,1.74E-11,BP
1268,1.40E-13,143,GO:0019882,antigen processing and presentation,1.74E-11,BP
-689,1.53E-13,510,GO:0051276,chromosome organization,1.74E-11,BP
1287,1.55E-13,138,GO:0090150,establishment of protein localization to membrane,1.74E-11,BP
1270,1.84E-13,141,GO:0048002,antigen processing and presentation of peptide antigen,1.96E-11,BP
945,2.75E-13,255,GO:0050776,regulation of immune response,2.80E-11,BP
609,3.43E-13,646,GO:0051247,positive regulation of protein metabolic process,3.34E-11,BP
623,4.76E-13,606,GO:0043085,positive regulation of catalytic activity,4.45E-11,BP
1311,5.22E-13,127,GO:0035966,response to topologically incorrect protein,4.61E-11,BP
959,5.35E-13,241,GO:0031347,regulation of defense response,4.61E-11,BP
1356,6.02E-13,118,GO:0002764,immune response-regulating signaling pathway,5.00E-11,BP
1302,7.56E-13,127,GO:0034976,response to endoplasmic reticulum stress,6.05E-11,BP
1415,8.14E-13,107,GO:0006612,protein targeting to membrane,6.29E-11,BP
1332,2.28E-12,116,GO:0002757,immune response-activating signal transduction,1.70E-10,BP
-1450,5.80E-12,94,GO:0006261,DNA-dependent DNA replication,4.19E-10,BP
1059,7.08E-12,177,GO:0072657,protein localization to membrane,4.81E-10,BP
1213,7.09E-12,134,GO:0002253,activation of immune response,4.81E-10,BP
1130,8.03E-12,154,GO:0045088,regulation of innate immune response,5.16E-10,BP
545,8.06E-12,723,GO:0044093,positive regulation of molecular function,5.16E-10,BP
1965,8.67E-12,50,GO:0006521,regulation of cellular amino acid metabolic process,5.39E-10,BP
646,1.30E-11,486,GO:0031401,positive regulation of protein modification process,7.86E-10,BP
1954,1.82E-11,49,GO:0006977;GO:0072431;GO:1902400,signal transduction involved in mitotic G1 DNA damage checkpoint,1.08E-09,BP
741,2.24E-11,353,GO:0051347,positive regulation of transferase activity,1.28E-09,BP
635,3.20E-11,483,GO:0080134,regulation of response to stress,1.75E-09,BP
766,3.20E-11,324,GO:0062012,regulation of small molecule metabolic process,1.75E-09,BP
1622,3.87E-11,69,GO:0006613;GO:0006614;GO:0045047,protein targeting to ER,2.06E-09,BP
1390,8.37E-11,91,GO:0002758,innate immune response-activating signal transduction,4.36E-09,BP
1746,9.55E-11,57,GO:0071158,positive regulation of cell cycle arrest,4.86E-09,BP
1830,1.38E-10,51,GO:1902402;GO:0072422;GO:1902403;GO:0072401;GO:0072413;GO:0072395,signal transduction involved in mitotic DNA damage checkpoint,6.87E-09,BP
868,1.45E-10,232,GO:0120035,regulation of plasma membrane bounded cell projection organization,7.07E-09,BP
1377,1.55E-10,90,GO:0002221,pattern recognition receptor signaling pathway,7.28E-09,BP
1276,1.56E-10,105,GO:0002218,activation of innate immune response,7.28E-09,BP
-707,1.78E-10,353,GO:0000280,nuclear division,8.15E-09,BP
849,2.39E-10,237,GO:0031344,regulation of cell projection organization,1.07E-08,BP
1503,2.98E-10,73,GO:0072599,establishment of protein localization to endoplasmic reticulum,1.29E-08,BP
800,3.00E-10,265,GO:0045087,innate immune response,1.29E-08,BP
1360,3.25E-10,89,GO:0034620,cellular response to unfolded protein,1.37E-08,BP
1016,3.78E-10,160,GO:0001817,regulation of cytokine production,1.57E-08,BP
1422,4.54E-10,80,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.85E-08,BP
639,4.73E-10,415,GO:0006955,immune response,1.89E-08,BP
-1718,5.63E-10,54,GO:0000236,mitotic prometaphase,2.21E-08,BP
1379,5.93E-10,84,GO:0030968,endoplasmic reticulum unfolded protein response,2.29E-08,BP
1438,6.14E-10,77,GO:0070972,protein localization to endoplasmic reticulum,2.33E-08,BP
594,7.34E-10,475,GO:0007167,enzyme linked receptor protein signaling pathway,2.74E-08,BP
1632,7.53E-10,59,GO:0031571;GO:0044783;GO:0044819,mitotic G1 DNA damage checkpoint,2.75E-08,BP
-1283,7.61E-10,96,GO:0006302,double-strand break repair,2.75E-08,BP
934,9.60E-10,181,GO:0010769,regulation of cell morphogenesis involved in differentiation,3.41E-08,BP
618,9.82E-10,428,GO:0002682,regulation of immune system process,3.44E-08,BP
1264,1.10E-09,97,GO:0006413,translational initiation,3.80E-08,BP
647,1.25E-09,383,GO:0042327,positive regulation of phosphorylation,4.23E-08,BP
-745,1.28E-09,285,GO:0051321,meiotic cell cycle,4.28E-08,BP
619,2.08E-09,409,GO:0045937;GO:0010562,positive regulation of phosphate metabolic process,6.87E-08,BP
868,2.20E-09,201,GO:0010975,regulation of neuron projection development,7.13E-08,BP
1480,2.77E-09,67,GO:0019058,viral life cycle,8.87E-08,BP
1725,4.32E-09,48,GO:0006415,translational termination,1.36E-07,BP
715,4.44E-09,289,GO:0016567,protein ubiquitination,1.38E-07,BP
472,4.78E-09,703,GO:0031399,regulation of protein modification process,1.47E-07,BP
818,5.42E-09,216,GO:0006511,ubiquitin-dependent protein catabolic process,1.64E-07,BP
1162,5.59E-09,105,GO:0035967,cellular response to topologically incorrect protein,1.67E-07,BP
1119,6.06E-09,113,GO:0048011,neurotrophin TRK receptor signaling pathway,1.79E-07,BP
1180,6.49E-09,101,GO:0010565,regulation of cellular ketone metabolic process,1.89E-07,BP
757,6.84E-09,250,GO:0051603,proteolysis involved in cellular protein catabolic process,1.96E-07,BP
511,6.95E-09,576,GO:0042325,regulation of phosphorylation,1.97E-07,BP
730,7.51E-09,268,GO:0045860,positive regulation of protein kinase activity,2.10E-07,BP
747,7.66E-09,255,GO:0044257,cellular protein catabolic process,2.12E-07,BP
-1833,7.99E-09,41,GO:0022616,DNA strand elongation,2.17E-07,BP
-1006,8.03E-09,138,GO:0033044,regulation of chromosome organization,2.17E-07,BP
529,8.29E-09,528,GO:0048585,negative regulation of response to stimulus,2.19E-07,BP
1104,8.30E-09,114,GO:0038179,neurotrophin signaling pathway,2.19E-07,BP
755,8.45E-09,248,GO:0044764,multi-organism cellular process,2.20E-07,BP
908,8.96E-09,169,GO:0048193,Golgi vesicle transport,2.31E-07,BP
1431,9.18E-09,67,GO:0033238,regulation of cellular amine metabolic process,2.34E-07,BP
629,1.02E-08,359,GO:0070647,protein modification by small protein conjugation or removal,2.56E-07,BP
-1841,1.04E-08,40,GO:0006271,DNA strand elongation involved in DNA replication,2.57E-07,BP
601,1.05E-08,395,GO:0009894,regulation of catabolic process,2.57E-07,BP
-609,1.06E-08,384,GO:0048285,organelle fission,2.57E-07,BP
622,1.17E-08,365,GO:0001934,positive regulation of protein phosphorylation,2.82E-07,BP
-1697,1.54E-08,46,GO:0071897,DNA biosynthetic process,3.66E-07,BP
1475,1.55E-08,61,GO:0006414,translational elongation,3.66E-07,BP
-1839,1.65E-08,39,GO:0007131;GO:0035825,reciprocal meiotic recombination,3.85E-07,BP
699,1.73E-08,279,GO:0033674,positive regulation of kinase activity,4.00E-07,BP
1387,2.02E-08,68,GO:0000022,mitotic spindle elongation,4.61E-07,BP
1199,2.10E-08,91,GO:0006984,ER-nucleus signaling pathway,4.70E-07,BP
823,2.10E-08,196,GO:0050778,positive regulation of immune response,4.70E-07,BP
660,2.13E-08,310,GO:0032446,protein modification by small protein conjugation,4.70E-07,BP
1426,2.14E-08,64,GO:0071156,regulation of cell cycle arrest,4.70E-07,BP
550,2.19E-08,455,GO:0006952,defense response,4.74E-07,BP
510,2.20E-08,537,GO:0001932,regulation of protein phosphorylation,4.74E-07,BP
-1574,2.47E-08,52,GO:0044786,cell cycle DNA replication,5.28E-07,BP
985,2.60E-08,134,GO:0010498;GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,5.50E-07,BP
1037,2.80E-08,120,GO:0045089,positive regulation of innate immune response,5.86E-07,BP
1363,3.47E-08,68,GO:0002224,toll-like receptor signaling pathway,7.20E-07,BP
1193,3.56E-08,89,GO:0050770,regulation of axonogenesis,7.31E-07,BP
761,3.74E-08,222,GO:0019941,modification-dependent protein catabolic process,7.62E-07,BP
601,3.77E-08,363,GO:0031329,regulation of cellular catabolic process,7.62E-07,BP
800,4.45E-08,198,GO:0042303,molting cycle,8.90E-07,BP
-862,4.88E-08,169,GO:0046942;GO:0015849,organic acid transport,9.61E-07,BP
1655,4.89E-08,45,GO:0019080;GO:0019083,viral gene expression,9.61E-07,BP
-873,5.59E-08,163,GO:0046394;GO:0016053,organic acid biosynthetic process,1.09E-06,BP
-1405,5.64E-08,62,GO:0032200,telomere organization,1.09E-06,BP
-857,6.33E-08,168,GO:0140013,meiotic nuclear division,1.21E-06,BP
541,7.02E-08,435,GO:0006886,intracellular protein transport,1.33E-06,BP
-1402,7.73E-08,61,GO:0000723,telomere maintenance,1.45E-06,BP
1357,7.89E-08,65,GO:0034142,toll-like receptor 4 signaling pathway,1.47E-06,BP
737,8.25E-08,225,GO:0043632,modification-dependent macromolecule catabolic process,1.52E-06,BP
648,8.27E-08,294,GO:0022604,regulation of cell morphogenesis,1.52E-06,BP
508,9.61E-08,487,GO:0051338,regulation of transferase activity,1.75E-06,BP
-728,1.16E-07,225,GO:0015711,organic anion transport,2.10E-06,BP
648,1.17E-07,287,GO:0044419,interspecies interaction between organisms,2.11E-06,BP
518,1.23E-07,459,GO:0044265,cellular macromolecule catabolic process,2.18E-06,BP
481,1.32E-07,535,GO:0010259,multicellular organism aging,2.32E-06,BP
-677,1.34E-07,259,GO:0051186,cofactor metabolic process,2.35E-06,BP
984,1.37E-07,120,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,2.38E-06,BP
685,1.39E-07,252,GO:0006412,translation,2.39E-06,BP
1392,1.52E-07,59,GO:0034138,toll-like receptor 3 signaling pathway,2.60E-06,BP
647,1.59E-07,281,GO:0044403,symbiont process,2.70E-06,BP
1266,1.68E-07,71,GO:0051231,spindle elongation,2.84E-06,BP
446,1.86E-07,615,GO:0045184,establishment of protein localization,3.11E-06,BP
480,1.95E-07,522,GO:0008340,determination of adult lifespan,3.24E-06,BP
542,1.98E-07,402,GO:0061024,membrane organization,3.26E-06,BP
-1112,2.04E-07,91,GO:0015718,monocarboxylic acid transport,3.32E-06,BP
562,2.04E-07,371,GO:0009607,response to biotic stimulus,3.32E-06,BP
465,2.31E-07,553,GO:0009967,positive regulation of signal transduction,3.72E-06,BP
-838,2.58E-07,159,GO:0098813,nuclear chromosome segregation,4.13E-06,BP
851,2.82E-07,153,GO:0007264,small GTPase mediated signal transduction,4.48E-06,BP
1306,2.93E-07,64,GO:0030330,"DNA damage response, signal transduction by p53 class mediator",4.62E-06,BP
521,3.06E-07,423,GO:0009968,negative regulation of signal transduction,4.79E-06,BP
1130,3.28E-07,85,GO:0072331,signal transduction by p53 class mediator,5.10E-06,BP
825,3.36E-07,161,GO:0031349,positive regulation of defense response,5.18E-06,BP
564,3.41E-07,354,GO:0030163,protein catabolic process,5.23E-06,BP
685,3.65E-07,235,GO:1903530,regulation of secretion by cell,5.56E-06,BP
864,3.87E-07,145,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,5.85E-06,BP
687,3.96E-07,232,GO:0016032,viral process,5.95E-06,BP
497,4.18E-07,457,GO:0023057,negative regulation of signaling,6.21E-06,BP
1377,4.19E-07,56,GO:0002756,MyD88-independent toll-like receptor signaling pathway,6.21E-06,BP
750,4.73E-07,191,GO:0051056,regulation of small GTPase mediated signal transduction,6.97E-06,BP
955,5.00E-07,116,GO:0031098,stress-activated protein kinase signaling cascade,7.32E-06,BP
650,5.51E-07,253,GO:0043408,regulation of MAPK cascade,8.02E-06,BP
488,5.65E-07,462,GO:0010648,negative regulation of cell communication,8.17E-06,BP
425,5.75E-07,626,GO:0010647,positive regulation of cell communication,8.26E-06,BP
-797,6.03E-07,165,GO:0051052,regulation of DNA metabolic process,8.57E-06,BP
-637,6.04E-07,262,GO:1903046,meiotic cell cycle process,8.57E-06,BP
-584,6.23E-07,314,GO:0006520,cellular amino acid metabolic process,8.77E-06,BP
-1618,6.82E-07,39,GO:0033260,nuclear DNA replication,9.55E-06,BP
606,6.87E-07,288,GO:0002684,positive regulation of immune system process,9.55E-06,BP
1125,6.94E-07,81,GO:0008063,Toll signaling pathway,9.60E-06,BP
429,8.25E-07,594,GO:0015031,protein transport,1.13E-05,BP
480,8.33E-07,465,GO:0044092,negative regulation of molecular function,1.14E-05,BP
859,8.46E-07,138,GO:0031398,positive regulation of protein ubiquitination,1.14E-05,BP
775,8.47E-07,170,GO:0032147,activation of protein kinase activity,1.14E-05,BP
475,8.79E-07,473,GO:0016482,cytosolic transport,1.18E-05,BP
596,8.89E-07,292,GO:0071363,cellular response to growth factor stimulus,1.19E-05,BP
1348,9.20E-07,55,GO:0035666,TRIF-dependent toll-like receptor signaling pathway,1.22E-05,BP
1346,9.43E-07,55,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,1.24E-05,BP
517,9.79E-07,390,GO:0045859,regulation of protein kinase activity,1.28E-05,BP
986,9.81E-07,103,GO:0008286,insulin receptor signaling pathway,1.28E-05,BP
565,9.88E-07,324,GO:1902533,positive regulation of intracellular signal transduction,1.28E-05,BP
862,1.02E-06,135,GO:0000209,protein polyubiquitination,1.31E-05,BP
418,1.09E-06,612,GO:0015833,peptide transport,1.39E-05,BP
536,1.10E-06,359,GO:0043207;GO:0051707,response to other organism,1.40E-05,BP
701,1.16E-06,204,GO:0032535,regulation of cellular component size,1.47E-05,BP
626,1.27E-06,256,GO:0051046,regulation of secretion,1.59E-05,BP
743,1.29E-06,179,GO:0043410,positive regulation of MAPK cascade,1.61E-05,BP
927,1.29E-06,114,GO:0051403,stress-activated MAPK cascade,1.61E-05,BP
-1436,1.31E-06,47,GO:0000724;GO:0000725,double-strand break repair via homologous recombination,1.61E-05,BP
900,1.31E-06,121,GO:0002831,regulation of response to biotic stimulus,1.61E-05,BP
461,1.34E-06,486,GO:0022603,regulation of anatomical structure morphogenesis,1.64E-05,BP
-833,1.38E-06,141,GO:0071103,DNA conformation change,1.67E-05,BP
-618,1.41E-06,260,GO:0006820,anion transport,1.71E-05,BP
411,1.44E-06,621,GO:0023056,positive regulation of signaling,1.73E-05,BP
1346,1.48E-06,53,GO:0031348,negative regulation of defense response,1.77E-05,BP
746,1.53E-06,175,GO:0002697,regulation of immune effector process,1.83E-05,BP
555,1.66E-06,321,GO:0032101,regulation of response to external stimulus,1.96E-05,BP
381,1.79E-06,722,GO:0012501,programmed cell death,2.10E-05,BP
648,1.79E-06,231,GO:0051090,regulation of DNA-binding transcription factor activity,2.10E-05,BP
-614,1.89E-06,257,GO:0032787,monocarboxylic acid metabolic process,2.20E-05,BP
-901,1.91E-06,117,GO:1905039;GO:1903825,carboxylic acid transmembrane transport,2.22E-05,BP
1114,1.92E-06,76,GO:0042593,glucose homeostasis,2.22E-05,BP
404,1.93E-06,628,GO:0007568,aging,2.22E-05,BP
1330,1.98E-06,53,GO:0006900,vesicle budding from membrane,2.27E-05,BP
-1165,2.07E-06,69,GO:0051983,regulation of chromosome segregation,2.35E-05,BP
1223,2.30E-06,62,GO:0043624,cellular protein complex disassembly,2.60E-05,BP
1232,2.33E-06,61,GO:0002755,MyD88-dependent toll-like receptor signaling pathway,2.63E-05,BP
-1261,2.40E-06,58,GO:0033045,regulation of sister chromatid segregation,2.69E-05,BP
-1089,2.42E-06,78,GO:0000070,mitotic sister chromatid segregation,2.70E-05,BP
464,2.46E-06,453,GO:0051336,regulation of hydrolase activity,2.73E-05,BP
1370,2.47E-06,49,GO:0050777,negative regulation of immune response,2.73E-05,BP
-1030,2.51E-06,87,GO:0072330,monocarboxylic acid biosynthetic process,2.75E-05,BP
1086,2.56E-06,78,GO:2000134;GO:1902807,negative regulation of G1/S transition of mitotic cell cycle,2.80E-05,BP
1075,2.81E-06,79,GO:0033500,carbohydrate homeostasis,3.05E-05,BP
-828,2.83E-06,134,GO:0051260,protein homooligomerization,3.06E-05,BP
-1587,2.85E-06,36,GO:0006312,mitotic recombination,3.07E-05,BP
-587,3.01E-06,271,GO:0044848,biological phase,3.23E-05,BP
-967,3.16E-06,97,GO:0061982,meiosis I cell cycle process,3.37E-05,BP
-1557,3.20E-06,37,GO:0000018,regulation of DNA recombination,3.40E-05,BP
-967,3.50E-06,96,GO:0006766,vitamin metabolic process,3.70E-05,BP
-1490,3.63E-06,40,GO:0010833,telomere maintenance via telomere lengthening,3.82E-05,BP
940,3.76E-06,101,GO:0043433,negative regulation of DNA-binding transcription factor activity,3.93E-05,BP
380,3.82E-06,672,GO:0006915,apoptotic process,3.98E-05,BP
783,3.92E-06,146,GO:0018996,"molting cycle, collagen and cuticulin-based cuticle",4.06E-05,BP
-1658,3.97E-06,32,GO:0006284,base-excision repair,4.10E-05,BP
702,4.05E-06,182,GO:0023014,signal transduction by protein phosphorylation,4.16E-05,BP
391,4.13E-06,627,GO:0042886,amide transport,4.22E-05,BP
1655,4.14E-06,32,GO:0030433;GO:0036503,ubiquitin-dependent ERAD pathway,4.22E-05,BP
718,4.29E-06,173,GO:0031396,regulation of protein ubiquitination,4.35E-05,BP
477,4.32E-06,406,GO:0043549,regulation of kinase activity,4.35E-05,BP
-1017,4.33E-06,85,GO:0007127,meiosis I,4.35E-05,BP
541,4.51E-06,309,GO:0070848,response to growth factor,4.51E-05,BP
413,4.84E-06,548,GO:0006508,proteolysis,4.82E-05,BP
582,5.04E-06,263,GO:0043043,peptide biosynthetic process,5.00E-05,BP
-1264,5.07E-06,54,GO:0033047,regulation of mitotic sister chromatid segregation,5.00E-05,BP
565,5.23E-06,278,GO:0006605,protein targeting,5.14E-05,BP
1206,5.47E-06,59,GO:0034134,toll-like receptor 2 signaling pathway,5.35E-05,BP
-578,5.62E-06,264,GO:0022403,cell cycle phase,5.47E-05,BP
-706,6.57E-06,172,GO:0006732,coenzyme metabolic process,6.35E-05,BP
-1549,6.58E-06,35,GO:0031577,spindle checkpoint,6.35E-05,BP
579,6.69E-06,258,GO:0030155,regulation of cell adhesion,6.44E-05,BP
-648,6.90E-06,204,GO:0006790,sulfur compound metabolic process,6.60E-05,BP
-1005,7.15E-06,83,GO:0006323,DNA packaging,6.81E-05,BP
546,8.01E-06,287,GO:1901699,cellular response to nitrogen compound,7.59E-05,BP
678,8.04E-06,183,GO:1903320,regulation of protein modification by small protein conjugation or removal,7.59E-05,BP
-1596,9.01E-06,32,GO:0033046;GO:0051985,negative regulation of chromosome segregation,8.48E-05,BP
1080,9.35E-06,70,GO:0032088,negative regulation of NF-kappaB transcription factor activity,8.70E-05,BP
-1645,9.36E-06,30,GO:0032201,telomere maintenance via semi-conservative replication,8.70E-05,BP
1330,9.38E-06,46,GO:0006901,vesicle coating,8.70E-05,BP
438,9.40E-06,449,GO:0060341,regulation of cellular localization,8.70E-05,BP
-1161,1.01E-05,60,GO:2001251,negative regulation of chromosome organization,9.30E-05,BP
-796,1.02E-05,129,GO:0098656,anion transmembrane transport,9.33E-05,BP
-1609,1.04E-05,31,GO:0071173,spindle assembly checkpoint,9.55E-05,BP
-1224,1.22E-05,53,GO:0010965;GO:1905818,regulation of chromosome separation,1.11E-04,BP
858,1.28E-05,108,GO:0001819,positive regulation of cytokine production,1.16E-04,BP
732,1.58E-05,146,GO:0008361,regulation of cell size,1.43E-04,BP
359,1.65E-05,652,GO:0051049,regulation of transport,1.49E-04,BP
761,1.71E-05,134,GO:0046328,regulation of JNK cascade,1.53E-04,BP
-615,1.88E-05,205,GO:0007059,chromosome segregation,1.68E-04,BP
1376,1.90E-05,40,GO:0033619,membrane protein proteolysis,1.68E-04,BP
1154,1.90E-05,57,GO:0034130,toll-like receptor 1 signaling pathway,1.68E-04,BP
1115,1.90E-05,61,GO:0032675,regulation of interleukin-6 production,1.68E-04,BP
-948,2.08E-05,84,GO:0000819,sister chromatid segregation,1.83E-04,BP
-1506,2.09E-05,33,GO:0000722,telomere maintenance via recombination,1.83E-04,BP
580,2.16E-05,228,GO:0001558,regulation of cell growth,1.88E-04,BP
1012,2.22E-05,73,GO:0002819,regulation of adaptive immune response,1.93E-04,BP
553,2.23E-05,251,GO:1901652,response to peptide,1.93E-04,BP
1047,2.26E-05,68,GO:0051099,positive regulation of binding,1.95E-04,BP
1572,2.27E-05,30,GO:0032092,positive regulation of protein binding,1.95E-04,BP
-729,2.37E-05,141,GO:0015893,drug transport,2.03E-04,BP
875,2.46E-05,97,GO:2000045;GO:1902806,regulation of cell cycle G1/S phase transition,2.09E-04,BP
1334,2.69E-05,41,GO:0035419,activation of MAPK activity involved in innate immune response,2.29E-04,BP
-1557,2.74E-05,30,GO:0007094;GO:0045841;GO:1902100;GO:2000816;GO:0033048;GO:1905819,mitotic spindle assembly checkpoint,2.32E-04,BP
468,2.82E-05,347,GO:0030029,actin filament-based process,2.38E-04,BP
427,2.84E-05,420,GO:0051248,negative regulation of protein metabolic process,2.38E-04,BP
-972,2.88E-05,77,GO:0043648,dicarboxylic acid metabolic process,2.41E-04,BP
747,2.96E-05,131,GO:0000956,nuclear-transcribed mRNA catabolic process,2.46E-04,BP
652,2.99E-05,173,GO:0071375;GO:1901653,cellular response to peptide hormone stimulus,2.48E-04,BP
-895,3.19E-05,90,GO:0003333,amino acid transmembrane transport,2.64E-04,BP
-627,3.21E-05,186,GO:1901605,alpha-amino acid metabolic process,2.64E-04,BP
657,3.22E-05,169,GO:0043405,regulation of MAP kinase activity,2.64E-04,BP
-1074,3.29E-05,62,GO:0006805,xenobiotic metabolic process,2.69E-04,BP
716,3.34E-05,141,GO:0032872;GO:0070302,regulation of stress-activated MAPK cascade,2.72E-04,BP
1100,3.37E-05,59,GO:0071453,cellular response to oxygen levels,2.73E-04,BP
-907,3.40E-05,87,GO:0044839,cell cycle G2/M phase transition,2.75E-04,BP
411,3.45E-05,446,GO:0016071,mRNA metabolic process,2.78E-04,BP
-557,3.51E-05,235,GO:0098763,mitotic cell cycle phase,2.82E-04,BP
1298,3.54E-05,42,GO:0002698,negative regulation of immune effector process,2.83E-04,BP
428,3.58E-05,407,GO:0032269,negative regulation of cellular protein metabolic process,2.85E-04,BP
-1161,3.91E-05,52,GO:0006855,drug transmembrane transport,3.10E-04,BP
574,3.92E-05,218,GO:1900542,regulation of purine nucleotide metabolic process,3.10E-04,BP
711,4.04E-05,140,GO:0006402,mRNA catabolic process,3.19E-04,BP
-811,4.07E-05,107,GO:0006865,amino acid transport,3.20E-04,BP
569,4.26E-05,220,GO:0006140,regulation of nucleotide metabolic process,3.34E-04,BP
-677,4.41E-05,153,GO:0006575,cellular modified amino acid metabolic process,3.44E-04,BP
1281,4.47E-05,42,GO:0007160,cell-matrix adhesion,3.47E-04,BP
719,4.47E-05,135,GO:0043406,positive regulation of MAP kinase activity,3.47E-04,BP
-907,4.66E-05,84,GO:0000086,G2/M transition of mitotic cell cycle,3.60E-04,BP
-815,4.74E-05,104,GO:0007088,regulation of mitotic nuclear division,3.65E-04,BP
1261,4.84E-05,43,GO:0050688,regulation of defense response to virus,3.71E-04,BP
643,4.94E-05,168,GO:0071902,positive regulation of protein serine/threonine kinase activity,3.78E-04,BP
619,5.02E-05,181,GO:0051650,establishment of vesicle localization,3.82E-04,BP
532,5.05E-05,248,GO:0071417,cellular response to organonitrogen compound,3.83E-04,BP
1243,5.09E-05,44,GO:0042035,regulation of cytokine biosynthetic process,3.86E-04,BP
-1390,5.23E-05,35,GO:0045839,negative regulation of mitotic nuclear division,3.94E-04,BP
1153,5.26E-05,51,GO:0001816,cytokine production,3.95E-04,BP
999,5.34E-05,68,GO:0006892,post-Golgi vesicle-mediated transport,4.00E-04,BP
839,5.71E-05,96,GO:0007254,JNK cascade,4.26E-04,BP
1025,5.72E-05,64,GO:0051437,obsolete positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,4.26E-04,BP
-378,5.91E-05,501,GO:0006974,cellular response to DNA damage stimulus,4.37E-04,BP
-1400,5.92E-05,34,GO:0051289,protein homotetramerization,4.37E-04,BP
910,5.98E-05,81,GO:0009746,response to hexose,4.41E-04,BP
560,6.07E-05,218,GO:0045321,leukocyte activation,4.44E-04,BP
1063,6.07E-05,59,GO:0001818,negative regulation of cytokine production,4.44E-04,BP
386,6.13E-05,476,GO:0060284,regulation of cell development,4.47E-04,BP
969,6.18E-05,71,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,4.50E-04,BP
521,6.21E-05,252,GO:0080135,regulation of cellular response to stress,4.50E-04,BP
662,6.23E-05,154,GO:0043087,regulation of GTPase activity,4.50E-04,BP
605,7.11E-05,182,GO:0051348,negative regulation of transferase activity,5.12E-04,BP
1365,7.14E-05,35,GO:0030951,establishment or maintenance of microtubule cytoskeleton polarity,5.12E-04,BP
-1017,7.50E-05,63,GO:0006289,nucleotide-excision repair,5.37E-04,BP
1128,7.58E-05,51,GO:0010771,negative regulation of cell morphogenesis involved in differentiation,5.41E-04,BP
905,7.97E-05,79,GO:0051224;GO:1904950,negative regulation of establishment of protein localization,5.67E-04,BP
645,8.06E-05,157,GO:0000165,MAPK cascade,5.71E-04,BP
637,8.09E-05,161,GO:0022407,regulation of cell-cell adhesion,5.71E-04,BP
484,8.18E-05,284,GO:0045664,regulation of neuron differentiation,5.76E-04,BP
594,8.23E-05,186,GO:0051648,vesicle localization,5.78E-04,BP
634,8.34E-05,162,GO:0046578,regulation of Ras protein signal transduction,5.84E-04,BP
676,8.48E-05,142,GO:0050708,regulation of protein secretion,5.92E-04,BP
-1140,8.83E-05,49,GO:0030261,chromosome condensation,6.14E-04,BP
1066,8.93E-05,56,GO:0051436,obsolete negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,6.19E-04,BP
-1084,9.09E-05,54,GO:0006767,water-soluble vitamin metabolic process,6.29E-04,BP
788,9.14E-05,103,GO:0043901,negative regulation of multi-organism process,6.30E-04,BP
523,9.18E-05,238,GO:0043434,response to peptide hormone,6.31E-04,BP
-1402,9.55E-05,32,GO:0071174,mitotic spindle checkpoint,6.54E-04,BP
429,9.75E-05,358,GO:0007411,axon guidance,6.66E-04,BP
596,9.86E-05,180,GO:0030811,regulation of nucleotide catabolic process,6.71E-04,BP
807,9.93E-05,97,GO:0032874;GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,6.74E-04,BP
665,9.95E-05,144,GO:0016050,vesicle organization,6.74E-04,BP
1067,1.02E-04,55,GO:0036294;GO:0071456,cellular response to hypoxia,6.85E-04,BP
1118,1.02E-04,50,GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",6.88E-04,BP
439,1.03E-04,339,GO:0043086,negative regulation of catalytic activity,6.88E-04,BP
1280,1.05E-04,38,GO:0038061,NIK/NF-kappaB signaling,7.00E-04,BP
462,1.07E-04,302,GO:0070201,regulation of establishment of protein localization,7.14E-04,BP
815,1.09E-04,94,GO:0046330,positive regulation of JNK cascade,7.25E-04,BP
818,1.12E-04,93,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,7.41E-04,BP
657,1.13E-04,145,GO:0002791,regulation of peptide secretion,7.49E-04,BP
1040,1.16E-04,57,GO:0032069,regulation of nuclease activity,7.62E-04,BP
421,1.21E-04,362,GO:0097485,neuron projection guidance,7.93E-04,BP
-1207,1.21E-04,42,GO:0072088,nephron epithelium morphogenesis,7.93E-04,BP
917,1.21E-04,73,GO:0007391,dorsal closure,7.93E-04,BP
-1301,1.23E-04,36,GO:0006027,glycosaminoglycan catabolic process,8.03E-04,BP
630,1.27E-04,156,GO:0033124,obsolete regulation of GTP catabolic process,8.22E-04,BP
1356,1.27E-04,33,GO:0071347,cellular response to interleukin-1,8.22E-04,BP
435,1.29E-04,334,GO:0001775,cell activation,8.31E-04,BP
353,1.30E-04,523,GO:0006468,protein phosphorylation,8.35E-04,BP
-1231,1.30E-04,40,GO:0051784,negative regulation of nuclear division,8.35E-04,BP
1351,1.35E-04,33,GO:0071326;GO:0071331;GO:0071333,cellular response to monosaccharide stimulus,8.64E-04,BP
448,1.35E-04,313,GO:0043604,amide biosynthetic process,8.64E-04,BP
704,1.37E-04,123,GO:0030522,intracellular receptor signaling pathway,8.69E-04,BP
1057,1.37E-04,54,GO:0002768,immune response-regulating cell surface receptor signaling pathway,8.72E-04,BP
963,1.38E-04,65,GO:0031345,negative regulation of cell projection organization,8.76E-04,BP
441,1.39E-04,322,GO:0051345,positive regulation of hydrolase activity,8.77E-04,BP
873,1.43E-04,79,GO:0009749,response to glucose,9.02E-04,BP
-1288,1.45E-04,36,GO:0060675;GO:0072171,ureteric bud morphogenesis,9.09E-04,BP
-792,1.45E-04,96,GO:0045132,meiotic chromosome segregation,9.09E-04,BP
471,1.50E-04,278,GO:0051223,regulation of protein transport,9.35E-04,BP
487,1.50E-04,259,GO:0031400,negative regulation of protein modification process,9.35E-04,BP
328,1.57E-04,597,GO:0009057,macromolecule catabolic process,9.73E-04,BP
872,1.60E-04,78,GO:0042770,signal transduction in response to DNA damage,9.91E-04,BP
-1145,1.61E-04,45,GO:0030071;GO:1902099,regulation of mitotic metaphase/anaphase transition,9.94E-04,BP
536,1.64E-04,210,GO:0045926,negative regulation of growth,0.001011446,BP
389,1.67E-04,410,GO:1901701,cellular response to oxygen-containing compound,0.001023136,BP
502,1.71E-04,239,GO:0007163,establishment or maintenance of cell polarity,0.001048585,BP
1393,1.74E-04,30,GO:0006891,intra-Golgi vesicle-mediated transport,0.001059869,BP
1081,1.74E-04,50,GO:0070555,response to interleukin-1,0.001060047,BP
1003,1.76E-04,58,GO:0051352;GO:0051444,negative regulation of ubiquitin-protein transferase activity,0.001067525,BP
741,1.78E-04,107,GO:0032956,regulation of actin cytoskeleton organization,0.001076711,BP
-644,1.79E-04,142,GO:0090305,nucleic acid phosphodiester bond hydrolysis,0.001081592,BP
1365,1.84E-04,31,GO:0034146;GO:0035681,toll-like receptor 15 signaling pathway,0.00110944,BP
1264,1.93E-04,36,GO:0007250;GO:1901224;GO:1901222,activation of NF-kappaB-inducing kinase activity,0.001157109,BP
422,2.05E-04,334,GO:0043900,regulation of multi-organism process,0.001222231,BP
1276,2.05E-04,35,GO:0045670,regulation of osteoclast differentiation,0.001222231,BP
1293,2.09E-04,34,GO:0045727,positive regulation of translation,0.001244575,BP
445,2.13E-04,297,GO:0090066,regulation of anatomical structure size,0.001266555,BP
814,2.15E-04,86,GO:0034284,response to monosaccharide,0.001276726,BP
-1174,2.21E-04,41,GO:0072078,nephron tubule morphogenesis,0.001303228,BP
580,2.21E-04,171,GO:0009118;GO:0033121,regulation of purine nucleotide catabolic process,0.001303228,BP
701,2.22E-04,116,GO:0032970,regulation of actin filament-based process,0.001303228,BP
454,2.34E-04,282,GO:0090087,regulation of peptide transport,0.001369452,BP
1245,2.38E-04,36,GO:0001678,cellular glucose homeostasis,0.001390425,BP
1154,2.38E-04,42,GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,0.001390425,BP
429,2.45E-04,315,GO:0030036,actin cytoskeleton organization,0.001425977,BP
1278,2.47E-04,34,GO:0071322,cellular response to carbohydrate stimulus,0.001436175,BP
-615,2.49E-04,149,GO:0046395;GO:0016054,carboxylic acid catabolic process,0.001438983,BP
1044,2.50E-04,51,GO:0002429,immune response-activating cell surface receptor signaling pathway,0.001441263,BP
1076,2.50E-04,48,GO:0002709,regulation of T cell mediated immunity,0.001441652,BP
939,2.53E-04,63,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,0.001452948,BP
623,2.65E-04,144,GO:1902532,negative regulation of intracellular signal transduction,0.001519733,BP
-1001,2.68E-04,55,GO:0051053,negative regulation of DNA metabolic process,0.001530775,BP
481,2.69E-04,245,GO:0071900,regulation of protein serine/threonine kinase activity,0.001530896,BP
453,2.72E-04,277,GO:0001667,ameboidal-type cell migration,0.001549064,BP
323,2.79E-04,568,GO:0051241,negative regulation of multicellular organismal process,0.001582908,BP
620,2.83E-04,144,GO:0032869,cellular response to insulin stimulus,0.001599951,BP
-1167,2.85E-04,40,GO:0006026,aminoglycan catabolic process,0.001605694,BP
-994,2.93E-04,55,GO:0065004,protein-DNA complex assembly,0.001651457,BP
-1052,2.97E-04,49,GO:0007478,leg disc morphogenesis,0.001667288,BP
796,2.98E-04,86,GO:0030308,negative regulation of cell growth,0.001669347,BP
753,3.03E-04,96,GO:0007265,Ras protein signal transduction,0.001690361,BP
-1259,3.07E-04,34,GO:0042558,pteridine-containing compound metabolic process,0.001704457,BP
-452,3.07E-04,273,GO:0010948,negative regulation of cell cycle process,0.001704457,BP
1191,3.07E-04,38,GO:0030952,establishment or maintenance of cytoskeleton polarity,0.001704457,BP
-1185,3.28E-04,38,GO:0001504,neurotransmitter uptake,0.001815144,BP
673,3.29E-04,119,GO:0034330,cell junction organization,0.001817499,BP
-1310,3.34E-04,31,GO:2000826,regulation of heart morphogenesis,0.001836243,BP
-1152,3.40E-04,40,GO:0050885,neuromuscular process controlling balance,0.001864261,BP
855,3.40E-04,73,GO:0051443,positive regulation of ubiquitin-protein transferase activity,0.001864261,BP
883,3.53E-04,68,GO:0010506,regulation of autophagy,0.001931253,BP
1121,3.55E-04,42,GO:0050852,T cell receptor signaling pathway,0.001935992,BP
-1120,3.58E-04,42,GO:0070192,chromosome organization involved in meiotic cell cycle,0.001946542,BP
404,3.64E-04,336,GO:0010942,positive regulation of cell death,0.001976282,BP
806,3.75E-04,81,GO:0031397,negative regulation of protein ubiquitination,0.002029181,BP
-346,3.80E-04,464,GO:0010564,regulation of cell cycle process,0.002053262,BP
758,4.01E-04,91,GO:0009743,response to carbohydrate,0.002159675,BP
333,4.04E-04,501,GO:0007409,axonogenesis,0.002167878,BP
417,4.14E-04,309,GO:0006518,peptide metabolic process,0.002216179,BP
386,4.15E-04,363,GO:0032880,regulation of protein localization,0.002217703,BP
842,4.16E-04,73,GO:0002703,regulation of leukocyte mediated immunity,0.002217703,BP
-1133,4.26E-04,40,GO:0072527,pyrimidine-containing compound metabolic process,0.002266091,BP
650,4.27E-04,123,GO:0042594,response to starvation,0.002267142,BP
-846,4.31E-04,72,GO:0071466,cellular response to xenobiotic stimulus,0.002283848,BP
353,4.34E-04,436,GO:0051960,regulation of nervous system development,0.002290327,BP
688,4.41E-04,109,GO:0031669,cellular response to nutrient levels,0.002326928,BP
891,4.69E-04,64,GO:0002274,myeloid leukocyte activation,0.002465107,BP
-306,4.79E-04,585,GO:0017144,drug metabolic process,0.002510566,BP
-672,4.80E-04,113,GO:0015850,organic hydroxy compound transport,0.002511445,BP
567,4.88E-04,159,GO:0008038,neuron recognition,0.002548842,BP
488,4.94E-04,216,GO:0016331,morphogenesis of embryonic epithelium,0.002571246,BP
-798,5.10E-04,79,GO:0071824,protein-DNA complex subunit organization,0.002652902,BP
394,5.13E-04,336,GO:0032940,secretion by cell,0.002661509,BP
292,5.17E-04,640,GO:0016310,phosphorylation,0.002674206,BP
1009,5.21E-04,49,GO:0006987,obsolete activation of signaling protein activity involved in unfolded protein response,0.002690583,BP
390,5.29E-04,341,GO:0050767,regulation of neurogenesis,0.002723339,BP
1158,5.36E-04,37,GO:0002763,positive regulation of myeloid leukocyte differentiation,0.002754656,BP
1099,5.42E-04,41,GO:0002720,positive regulation of cytokine production involved in immune response,0.002775994,BP
872,5.57E-04,65,GO:0007249,I-kappaB kinase/NF-kappaB signaling,0.002847587,BP
767,5.69E-04,84,GO:0007416,synapse assembly,0.002901222,BP
-425,5.93E-04,280,GO:0008610,lipid biosynthetic process,0.003018592,BP
322,6.45E-04,497,GO:0042330,taxis,0.00327646,BP
954,6.47E-04,53,GO:0002761,regulation of myeloid leukocyte differentiation,0.003277907,BP
1110,6.58E-04,39,GO:0042308;GO:1904590,negative regulation of protein import into nucleus,0.003325185,BP
-1205,6.62E-04,33,GO:0001658,branching involved in ureteric bud morphogenesis,0.003340347,BP
284,6.79E-04,648,GO:0034613,cellular protein localization,0.003417492,BP
940,6.89E-04,54,GO:0002821,positive regulation of adaptive immune response,0.003459292,BP
451,6.95E-04,241,GO:0009617,response to bacterium,0.00348124,BP
792,7.10E-04,76,GO:0034250,positive regulation of cellular amide metabolic process,0.003550621,BP
761,7.28E-04,82,GO:0032984,protein-containing complex disassembly,0.003633596,BP
1013,7.39E-04,46,GO:0009620,response to fungus,0.003680734,BP
442,7.47E-04,248,GO:0034097,response to cytokine,0.003711936,BP
682,7.55E-04,102,GO:0045216,cell-cell junction organization,0.003739796,BP
564,7.57E-04,150,GO:0006184,obsolete GTP catabolic process,0.003741698,BP
867,8.05E-04,62,GO:0002706,regulation of lymphocyte mediated immunity,0.003972046,BP
788,8.15E-04,75,GO:0051351,positive regulation of ligase activity,0.004006283,BP
-888,8.17E-04,59,GO:1901607,alpha-amino acid biosynthetic process,0.004006283,BP
336,8.17E-04,434,GO:0071495,cellular response to endogenous stimulus,0.004006283,BP
827,8.20E-04,68,GO:0051439,obsolete regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,0.004012071,BP
-479,8.48E-04,206,GO:0034660,ncRNA metabolic process,0.004132849,BP
863,8.49E-04,62,GO:0031589,cell-substrate adhesion,0.004132849,BP
1000,8.59E-04,46,GO:0050851,antigen receptor-mediated signaling pathway,0.004172577,BP
1034,8.61E-04,43,GO:0045639,positive regulation of myeloid cell differentiation,0.004172577,BP
-1099,8.68E-04,38,GO:0021983,pituitary gland development,0.004198271,BP
929,8.91E-04,53,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.004299878,BP
-1094,9.12E-04,38,GO:0006283,transcription-coupled nucleotide-excision repair,0.004394647,BP
301,9.45E-04,539,GO:0061564,axon development,0.00454331,BP
-1038,9.50E-04,42,GO:0033559,unsaturated fatty acid metabolic process,0.00455552,BP
630,9.64E-04,115,GO:0031668,cellular response to extracellular stimulus,0.004614994,BP
436,9.83E-04,244,GO:0050890,cognition,0.004697117,BP
-1059,9.97E-04,40,GO:0006304,DNA modification,0.004752648,BP
-855,0.001041364,61,GO:0032392,DNA geometric change,0.004952562,BP
1016,0.001064292,43,GO:0006903,vesicle targeting,0.005050875,BP
940,0.00110054,50,GO:0061387,regulation of extent of cell growth,0.005211858,BP
921,0.001105573,52,GO:0034332,adherens junction organization,0.005224648,BP
730,0.001113673,83,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,0.005251848,BP
-540,0.00112377,153,GO:0010639,negative regulation of organelle organization,0.00528833,BP
-853,0.001182415,60,GO:0007143,female meiotic nuclear division,0.005552641,BP
621,0.001191595,114,GO:0002683,negative regulation of immune system process,0.005568126,BP
-569,0.001192869,136,GO:0032259,methylation,0.005568126,BP
536,0.00119317,154,GO:0006401,RNA catabolic process,0.005568126,BP
1069,0.001197296,38,GO:0032943;GO:0070661;GO:0046651,lymphocyte proliferation,0.005575765,BP
-806,0.001204086,67,GO:1902275,regulation of chromatin organization,0.005595751,BP
-831,0.001214464,63,GO:0051225,spindle assembly,0.005630588,BP
293,0.001216609,543,GO:1901698,response to nitrogen compound,0.005630588,BP
322,0.001231975,443,GO:0006935,chemotaxis,0.005689945,BP
-863,0.001259188,58,GO:0032508,DNA duplex unwinding,0.005803666,BP
634,0.001273549,108,GO:0009896,positive regulation of catabolic process,0.005857804,BP
750,0.00133657,76,GO:0051092,positive regulation of NF-kappaB transcription factor activity,0.006135074,BP
571,0.001360563,132,GO:0071496,cellular response to external stimulus,0.006232434,BP
1151,0.001364857,32,GO:0010160,formation of animal organ boundary,0.006234823,BP
-735,0.001366651,79,GO:0008652,cellular amino acid biosynthetic process,0.006234823,BP
1029,0.001371638,40,GO:1900181,negative regulation of protein localization to nucleus,0.006244858,BP
747,0.001406373,76,GO:0002495;GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,0.006390011,BP
601,0.001472424,117,GO:0042110,T cell activation,0.006676578,BP
-371,0.001494655,315,GO:0006325,chromatin organization,0.006763693,BP
524,0.001516143,154,GO:0098542,defense response to other organism,0.006847097,BP
369,0.001528116,318,GO:0043068,positive regulation of programmed cell death,0.006887282,BP
576,0.001532047,127,GO:0007613,memory,0.006891134,BP
970,0.001573693,44,GO:0032663,regulation of interleukin-2 production,0.007064275,BP
1135,0.001587364,32,GO:0050728,negative regulation of inflammatory response,0.007111389,BP
294,0.00160437,510,GO:0007268;GO:0098916;GO:0099537;GO:0099536,chemical synaptic transmission,0.007173232,BP
815,0.001629927,62,GO:0032387,negative regulation of intracellular transport,0.007272979,BP
-478,0.001640133,183,GO:0051783,regulation of nuclear division,0.007303974,BP
741,0.001650565,75,GO:0045637,regulation of myeloid cell differentiation,0.007335846,BP
933,0.001670049,47,GO:0002708,positive regulation of lymphocyte mediated immunity,0.007407744,BP
942,0.0016883,46,GO:0002718,regulation of cytokine production involved in immune response,0.007473897,BP
737,0.001748103,75,GO:0043506,regulation of JUN kinase activity,0.007723373,BP
370,0.001759878,307,GO:0043065,positive regulation of apoptotic process,0.007760092,BP
400,0.001783822,260,GO:0007369,gastrulation,0.007850221,BP
888,0.001845191,51,GO:0032075,positive regulation of nuclease activity,0.00810437,BP
1119,0.001853787,32,GO:0042098,T cell proliferation,0.008111568,BP
393,0.001854073,268,GO:0030334,regulation of cell migration,0.008111568,BP
-1117,0.001878072,32,GO:0006749,glutathione metabolic process,0.008200548,BP
722,0.001886138,77,GO:0035023,regulation of Rho protein signal transduction,0.008219743,BP
-804,0.00189655,62,GO:1903509,liposaccharide metabolic process,0.008249072,BP
-404,0.001922315,252,GO:1901988,negative regulation of cell cycle phase transition,0.008344932,BP
511,0.001927686,155,GO:1901069,guanosine-containing compound catabolic process,0.008352063,BP
1022,0.001946848,38,GO:0031103,axon regeneration,0.008418801,BP
255,0.002027477,666,GO:0048812;GO:0120039,neuron projection morphogenesis,0.008750576,BP
567,0.002050823,124,GO:0051346,negative regulation of hydrolase activity,0.008831058,BP
956,0.002054009,43,GO:0031102,neuron projection regeneration,0.008831058,BP
515,0.002091033,150,GO:0006417,regulation of translation,0.008973016,BP
724,0.002108317,75,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,0.009029887,BP
738,0.002140956,72,GO:0050727,regulation of inflammatory response,0.009152176,BP
575,0.002172846,119,GO:1903706,regulation of hemopoiesis,0.009270812,BP
436,0.002182716,209,GO:0034248,regulation of cellular amide metabolic process,0.009295218,BP
-454,0.002188889,193,GO:0016569,covalent chromatin modification,0.009298167,BP
-786,0.002191711,63,GO:0006399,tRNA metabolic process,0.009298167,BP
249,0.002214006,691,GO:0070727,cellular macromolecule localization,0.009372497,BP
541,0.0022176,134,GO:0043547,positive regulation of GTPase activity,0.009372497,BP
622,0.002320829,100,GO:0000187,activation of MAPK activity,0.009790313,BP
-903,0.002359065,47,GO:0072337,modified amino acid transport,0.009932907,BP
-253,0.002390547,653,GO:0006629,lipid metabolic process,0.010028661,BP
620,0.002390761,100,GO:0007297,ovarian follicle cell migration,0.010028661,BP
756,0.002405928,67,GO:0031145,anaphase-promoting complex-dependent catabolic process,0.010073419,BP
510,0.002485928,148,GO:0045862,positive regulation of proteolysis,0.010388952,BP
-861,0.0025261,51,GO:1901568,fatty acid derivative metabolic process,0.010536472,BP
470,0.002530635,174,GO:0045785,positive regulation of cell adhesion,0.010536472,BP
-632,0.002545171,95,GO:0009308,amine metabolic process,0.010569966,BP
646,0.002548117,91,GO:1902105,regulation of leukocyte differentiation,0.010569966,BP
1022,0.002570276,36,GO:0050832,defense response to fungus,0.010642179,BP
-628,0.002584715,96,GO:0016042,lipid catabolic process,0.010682218,BP
-784,0.002640608,61,GO:0006664,glycolipid metabolic process,0.010893114,BP
522,0.002686493,139,GO:0000302,response to reactive oxygen species,0.011062029,BP
486,0.002715032,160,GO:0046039,GTP metabolic process,0.01115903,BP
725,0.002747859,71,GO:0048814,regulation of dendrite morphogenesis,0.011273268,BP
263,0.002786451,578,GO:0035637,multicellular organismal signaling,0.011410696,BP
649,0.002859813,88,GO:0031331,positive regulation of cellular catabolic process,0.011689745,BP
652,0.00290496,87,GO:0050773,regulation of dendrite development,0.01185266,BP
-769,0.002975524,62,GO:0035218,leg disc development,0.012118499,BP
619,0.002991026,96,GO:0034329,cell junction assembly,0.012159527,BP
-787,0.003000347,59,GO:0051180,vitamin transport,0.01217532,BP
-281,0.00300865,494,GO:0044255,cellular lipid metabolic process,0.012186936,BP
262,0.003027202,574,GO:0019226,transmission of nerve impulse,0.012239951,BP
618,0.003035707,96,GO:0007298,border follicle cell migration,0.012252225,BP
466,0.003066516,170,GO:0032868,response to insulin,0.012354311,BP
772,0.003092048,61,GO:0043507,positive regulation of JUN kinase activity,0.012428953,BP
-439,0.003096141,192,GO:0016570,histone modification,0.012428953,BP
-357,0.003146814,294,GO:1901987,regulation of cell cycle phase transition,0.012601678,BP
-850,0.003150419,50,GO:0015807,L-amino acid transport,0.012601678,BP
841,0.003166252,51,GO:0003382,epithelial cell morphogenesis,0.012642431,BP
866,0.003188771,48,GO:0030516,regulation of axon extension,0.012709691,BP
815,0.003271307,54,GO:0010977,negative regulation of neuron projection development,0.013015504,BP
482,0.003362554,156,GO:0001933,negative regulation of protein phosphorylation,0.013354823,BP
-1036,0.003413602,33,GO:0006690,icosanoid metabolic process,0.013533573,BP
842,0.003442702,50,GO:0002705,positive regulation of leukocyte mediated immunity,0.013624827,BP
-1085,0.003466014,30,GO:0008033,tRNA processing,0.013692893,BP
-976,0.0035116,37,GO:0006633,fatty acid biosynthetic process,0.013848565,BP
-950,0.003535536,39,GO:0042180,cellular ketone metabolic process,0.013898987,BP
590,0.00353841,102,GO:0048640,negative regulation of developmental growth,0.013898987,BP
-395,0.003543001,232,GO:0000075,cell cycle checkpoint,0.013898987,BP
-356,0.003580471,288,GO:0090407,organophosphate biosynthetic process,0.014021423,BP
1079,0.003644792,30,GO:0008587,imaginal disc-derived wing margin morphogenesis,0.014248402,BP
1027,0.003717042,33,GO:0001952,regulation of cell-matrix adhesion,0.01450553,BP
1040,0.003806016,32,GO:0030011,maintenance of cell polarity,0.014826914,BP
395,0.003831652,228,GO:0007611,learning or memory,0.014900867,BP
731,0.003844056,65,GO:0071216,cellular response to biotic stimulus,0.0149232,BP
459,0.003870964,167,GO:1901068,guanosine-containing compound metabolic process,0.01500166,BP
482,0.003879981,151,GO:0051051,negative regulation of transport,0.015010635,BP
235,0.003939166,684,GO:0048598,embryonic morphogenesis,0.01521333,BP
-990,0.003971389,35,GO:0048596,embryonic camera-type eye morphogenesis,0.015311379,BP
-1004,0.003992586,34,GO:0003156,regulation of animal organ formation,0.015354184,BP
446,0.003996201,176,GO:0007186,G protein-coupled receptor signaling pathway,0.015354184,BP
656,0.004009131,80,GO:0051438,regulation of ubiquitin-protein transferase activity,0.015377487,BP
-903,0.004032795,42,GO:0031076,embryonic camera-type eye development,0.015441813,BP
1046,0.004169475,31,GO:0034333,adherens junction assembly,0.015937926,BP
-471,0.004238385,155,GO:0008202,steroid metabolic process,0.016173735,BP
-815,0.004249292,51,GO:0051262,protein tetramerization,0.016187779,BP
608,0.004287644,92,GO:0009267,cellular response to starvation,0.01630615,BP
409,0.004383062,206,GO:0090130,tissue migration,0.016613717,BP
391,0.004383351,226,GO:0045936;GO:0010563,negative regulation of phosphate metabolic process,0.016613717,BP
-819,0.00443555,50,GO:0001657;GO:0072164;GO:0072163,mesonephric epithelium development,0.016783164,BP
990,0.004527965,34,GO:0035567,non-canonical Wnt signaling pathway,0.01710395,BP
-495,0.004546968,138,GO:0006631,fatty acid metabolic process,0.017146816,BP
-870,0.00455911,44,GO:0021545,cranial nerve development,0.017163709,BP
935,0.004617933,38,GO:0070585,protein localization to mitochondrion,0.01735599,BP
436,0.004640312,178,GO:0008037,cell recognition,0.017406735,BP
-858,0.004657605,45,GO:0051785,positive regulation of nuclear division,0.017406735,BP
-662,0.004660524,76,GO:0045931,positive regulation of mitotic cell cycle,0.017406735,BP
490,0.004662518,140,GO:0001700,embryonic development via the syncytial blastoderm,0.017406735,BP
921,0.004697073,39,GO:0050764,regulation of phagocytosis,0.017506561,BP
945,0.004721249,37,GO:0072655,establishment of protein localization to mitochondrion,0.01756744,BP
306,0.004791403,368,GO:0022610,biological adhesion,0.017798911,BP
810,0.004877208,50,GO:0090317,negative regulation of intracellular protein transport,0.018087661,BP
872,0.004960099,43,GO:0002685,regulation of leukocyte migration,0.018341862,BP
-771,0.004969171,55,GO:0033273,response to vitamin,0.018341862,BP
442,0.004970317,170,GO:0042326,negative regulation of phosphorylation,0.018341862,BP
852,0.00499785,45,GO:0032755,positive regulation of interleukin-6 production,0.01841313,BP
614,0.005027021,87,GO:0046883,regulation of hormone secretion,0.018490192,BP
305,0.005036638,367,GO:0007155,cell adhesion,0.018495196,BP
525,0.005141082,119,GO:0022409,positive regulation of cell-cell adhesion,0.018847829,BP
-658,0.005167885,75,GO:0016999,antibiotic metabolic process,0.018886921,BP
263,0.005168608,499,GO:0010243,response to organonitrogen compound,0.018886921,BP
961,0.005187891,35,GO:0090175,regulation of establishment of planar polarity,0.018926509,BP
-828,0.005295903,47,GO:0035222,wing disc pattern formation,0.019289141,BP
1000,0.005401082,32,GO:0048265,response to pain,0.019640298,BP
-792,0.005494479,51,GO:0003407,neural retina development,0.019947542,BP
-927,0.005563129,37,GO:0044273,sulfur compound catabolic process,0.020164092,BP
850,0.005576442,44,GO:0040003,chitin-based cuticle development,0.020179694,BP
-488,0.005649306,135,GO:0060041,retina development in camera-type eye,0.020409009,BP
1010,0.005665414,31,GO:0007029,endoplasmic reticulum organization,0.020409009,BP
694,0.005667145,66,GO:0048660,regulation of smooth muscle cell proliferation,0.020409009,BP
509,0.005761493,123,GO:0032103,positive regulation of response to external stimulus,0.020715482,BP
992,0.005786576,32,GO:0042108,positive regulation of cytokine biosynthetic process,0.020772323,BP
948,0.005831326,35,GO:1900076,regulation of cellular response to insulin stimulus,0.020899472,BP
-960,0.005925628,34,GO:0045840,positive regulation of mitotic nuclear division,0.021203525,BP
418,0.006108134,182,GO:0071345,cellular response to cytokine stimulus,0.021821722,BP
-968,0.006221179,33,GO:0007076,mitotic chromosome condensation,0.022190192,BP
553,0.006287042,102,GO:0002699,positive regulation of immune effector process,0.022359743,BP
-829,0.006288678,45,GO:1901992;GO:1901989,positive regulation of mitotic cell cycle phase transition,0.022359743,BP
530,0.006318173,111,GO:1903532,positive regulation of secretion by cell,0.022429014,BP
-936,0.006471825,35,GO:0046470,phosphatidylcholine metabolic process,0.022938115,BP
609,0.006548801,83,GO:0045765,regulation of angiogenesis,0.023174274,BP
432,0.006598106,167,GO:0022411,cellular component disassembly,0.023311922,BP
-797,0.00665742,48,GO:2001252,positive regulation of chromosome organization,0.023484442,BP
580,0.006695032,91,GO:0008306,associative learning,0.023579986,BP
-794,0.006861029,48,GO:0060840,artery development,0.024126695,BP
-569,0.006883814,94,GO:0045333,cellular respiration,0.024168877,BP
-769,0.007005973,51,GO:0033875;GO:0034032;GO:0033865,purine nucleoside bisphosphate metabolic process,0.024544035,BP
984,0.007019791,31,GO:0019935,cyclic-nucleotide-mediated signaling,0.024544035,BP
827,0.007023539,44,GO:0046823,negative regulation of nucleocytoplasmic transport,0.024544035,BP
816,0.007114915,45,GO:0034612,response to tumor necrosis factor,0.024824627,BP
223,0.007177607,659,GO:0007389,pattern specification process,0.025004418,BP
619,0.007399501,78,GO:0007162,negative regulation of cell adhesion,0.025737396,BP
918,0.007562857,35,GO:0043388,positive regulation of DNA binding,0.026264806,BP
556,0.007656573,96,GO:0032102,negative regulation of response to external stimulus,0.026549107,BP
847,0.007696583,41,GO:1903531,negative regulation of secretion by cell,0.026646594,BP
783,0.007714534,48,GO:0030048,actin filament-based movement,0.026650653,BP
903,0.007721551,36,GO:0010883,regulation of lipid storage,0.026650653,BP
600,0.007739047,82,GO:0051340,regulation of ligase activity,0.026669946,BP
636,0.008085775,72,GO:0017148;GO:0034249,negative regulation of translation,0.027822023,BP
983,0.008102499,30,GO:0034109,homotypic cell-cell adhesion,0.027836806,BP
685,0.008136015,62,GO:0045732,positive regulation of protein catabolic process,0.027909146,BP
752,0.008382029,51,GO:0046425;GO:1904892,regulation of receptor signaling pathway via JAK-STAT,0.028709089,BP
561,0.008421415,92,GO:0001704,formation of primary germ layer,0.028799952,BP
433,0.008529347,155,GO:0006457,protein folding,0.029118143,BP
-789,0.008540455,46,GO:0034728,nucleosome organization,0.029118143,BP
502,0.008704506,114,GO:0046777,protein autophosphorylation,0.029600036,BP
779,0.008708225,47,GO:0048168,regulation of neuronal synaptic plasticity,0.029600036,BP
689,0.00875037,60,GO:0035162,embryonic hemopoiesis,0.029698226,BP
279,0.008774414,384,GO:0046903,secretion,0.029706812,BP
-843,0.008792079,40,GO:0006775,fat-soluble vitamin metabolic process,0.029706812,BP
-469,0.008792686,131,GO:0042445,hormone metabolic process,0.029706812,BP
208,0.008880802,725,GO:0051094,positive regulation of developmental process,0.029959332,BP
484,0.009029714,122,GO:0007269;GO:0099643,signal release from synapse,0.030415879,BP
509,0.009077717,110,GO:0007015,actin filament organization,0.030531661,BP
215,0.009196512,668,GO:0000904,cell morphogenesis involved in differentiation,0.030884837,BP
-727,0.009317933,53,GO:0015749,monosaccharide transmembrane transport,0.031213782,BP
-826,0.00932233,41,GO:0007480;GO:0035127,imaginal disc-derived leg morphogenesis,0.031213782,BP
906,0.009366551,34,GO:0010811,positive regulation of cell-substrate adhesion,0.031315036,BP
481,0.009433445,122,GO:0051091,positive regulation of DNA-binding transcription factor activity,0.031491679,BP
-904,0.00956258,34,GO:0006942,regulation of striated muscle contraction,0.031834042,BP
494,0.009572394,115,GO:0030100,regulation of endocytosis,0.031834042,BP
855,0.009578636,38,GO:0032735,positive regulation of interleukin-12 production,0.031834042,BP
573,0.009606513,85,GO:0007606,sensory perception of chemical stimulus,0.031852979,BP
843,0.009612774,39,GO:0098722,asymmetric stem cell division,0.031852979,BP
-823,0.009628809,41,GO:0048048,embryonic eye morphogenesis,0.031858983,BP
581,0.009887683,82,GO:0001738,morphogenesis of a polarized epithelium,0.032667271,BP
533,0.010141369,97,GO:0042542,response to hydrogen peroxide,0.033456064,BP
-664,0.010248796,62,GO:1901606,alpha-amino acid catabolic process,0.033750141,BP
-762,0.010268314,47,GO:0000279,M phase,0.033750141,BP
-558,0.010275713,88,GO:0006576,cellular biogenic amine metabolic process,0.033750141,BP
-936,0.0103358,31,GO:0044728,DNA methylation or demethylation,0.033857564,BP
-952,0.010342869,30,GO:0008156,negative regulation of DNA replication,0.033857564,BP
213,0.010365546,657,GO:0016477,cell migration,0.033857564,BP
738,0.010368879,50,GO:0008637,apoptotic mitochondrial changes,0.033857564,BP
880,0.010438249,35,GO:0006626,protein targeting to mitochondrion,0.034034466,BP
557,0.010460508,88,GO:0007173;GO:0038127,ERBB signaling pathway,0.034057468,BP
-573,0.010496708,83,GO:0042133,neurotransmitter metabolic process,0.034078505,BP
-776,0.010497397,45,GO:0034605,cellular response to heat,0.034078505,BP
407,0.010668306,166,GO:0002252,immune effector process,0.034583222,BP
-578,0.01083906,81,GO:0050905,neuromuscular process,0.035085975,BP
-505,0.011014644,106,GO:0043414,macromolecule methylation,0.035602891,BP
443,0.011054852,138,GO:0044089,positive regulation of cellular component biogenesis,0.035681366,BP
-943,0.011083145,30,GO:0002526,acute inflammatory response,0.035721215,BP
-824,0.011426738,39,GO:0006282,regulation of DNA repair,0.036775707,BP
486,0.011449227,113,GO:0050863,regulation of T cell activation,0.036795221,BP
743,0.011480592,48,GO:0010675;GO:0006109,regulation of cellular carbohydrate metabolic process,0.036843159,BP
407,0.011683261,162,GO:0046649,lymphocyte activation,0.037439922,BP
406,0.011726278,162,GO:0050808,synapse organization,0.037524088,BP
366,0.011789721,201,GO:0048469,cell maturation,0.037673288,BP
818,0.012025331,39,GO:0042067,establishment of ommatidial planar polarity,0.038371426,BP
567,0.012383874,81,GO:0001764,neuron migration,0.039459284,BP
-719,0.012484837,50,GO:0009064,glutamine family amino acid metabolic process,0.039724482,BP
608,0.012578314,70,GO:2000377,regulation of reactive oxygen species metabolic process,0.03996514,BP
266,0.01261915,383,GO:0051640,organelle localization,0.040038095,BP
522,0.012772043,95,GO:0009615,response to virus,0.04046588,BP
570,0.012982544,79,GO:0048167,regulation of synaptic plasticity,0.041074717,BP
439,0.013078631,134,GO:0008360,regulation of cell shape,0.041237381,BP
531,0.013080693,91,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,0.041237381,BP
231,0.013089187,512,GO:0051093,negative regulation of developmental process,0.041237381,BP
565,0.013176343,80,GO:0030278,regulation of ossification,0.041435153,BP
315,0.01319545,264,GO:0030162,regulation of proteolysis,0.041435153,BP
-473,0.013207455,115,GO:0035108,limb morphogenesis,0.041435153,BP
433,0.013442439,137,GO:0007431,salivary gland development,0.042113376,BP
-454,0.013526462,124,GO:0060173,limb development,0.042317424,BP
463,0.013611135,119,GO:0044773,mitotic DNA damage checkpoint,0.042522931,BP
-623,0.01374357,65,GO:0008643,carbohydrate transport,0.042876877,BP
320,0.013775141,253,GO:0032870,cellular response to hormone stimulus,0.042915599,BP
526,0.014030107,91,GO:1901342,regulation of vasculature development,0.043604882,BP
912,0.014035321,30,GO:2000379,positive regulation of reactive oxygen species metabolic process,0.043604882,BP
621,0.014055228,65,GO:0002833,positive regulation of response to biotic stimulus,0.043606249,BP
476,0.014221975,111,GO:0007030,Golgi organization,0.044059924,BP
202,0.014240797,670,GO:0034655,nucleobase-containing compound catabolic process,0.044059924,BP
304,0.014279135,279,GO:0055082,cellular chemical homeostasis,0.044117604,BP
797,0.014390845,39,GO:2000060;GO:1903052;GO:1903364,positive regulation of proteolysis involved in cellular protein catabolic process,0.044401505,BP
-543,0.01468294,84,GO:0006997,nucleus organization,0.04524042,BP
-774,0.014806927,41,GO:0035214,eye-antennal disc development,0.045559775,BP
-552,0.014873386,81,GO:0044242,cellular lipid catabolic process,0.045701488,BP
423,0.015022983,139,GO:0003001;GO:0023061,signal release,0.04609792,BP
245,0.015094137,432,GO:0048878,chemical homeostasis,0.046252895,BP
-526,0.015143142,89,GO:0044106,cellular amine metabolic process,0.046339671,BP
572,0.015190978,75,GO:0001707,mesoderm formation,0.046422633,BP
-326,0.015249009,236,GO:0044770,cell cycle phase transition,0.046536487,BP
194,0.015397251,711,GO:0007267,cell-cell signaling,0.046924955,BP
742,0.015519921,44,GO:0120032;GO:0060491,regulation of plasma membrane bounded cell projection assembly,0.047020608,BP
831,0.015562127,35,GO:0032436;GO:1901800,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,0.047020608,BP
-798,0.015563797,38,GO:0042359,vitamin D metabolic process,0.047020608,BP
-532,0.01556434,86,GO:0034754,cellular hormone metabolic process,0.047020608,BP
-581,0.015567875,72,GO:0021536,diencephalon development,0.047020608,BP
-555,0.015575909,79,GO:0009411,response to UV,0.047020608,BP
856,0.015586205,33,GO:0051896,regulation of protein kinase B signaling,0.047020608,BP
526,0.015596568,88,GO:0007309,oocyte axis specification,0.047020608,BP
-818,0.01576467,36,GO:0009066,aspartate family amino acid metabolic process,0.047463524,BP
405,0.015860379,149,GO:0030111,regulation of Wnt signaling pathway,0.047687584,BP
319,0.015893491,244,GO:0021700,developmental maturation,0.047723084,BP
-756,0.015992697,42,GO:0001676,long-chain fatty acid metabolic process,0.047956682,BP
294,0.016156135,288,GO:2000145,regulation of cell motility,0.048382009,BP
-444,0.016225497,123,GO:0034470,ncRNA processing,0.048524851,BP
-863,0.016289193,32,GO:0030901,midbrain development,0.048650391,BP
850,0.016319576,33,GO:0016333,morphogenesis of follicular epithelium,0.048676231,BP
585,0.016362109,70,GO:0007413;GO:0106030,neuron projection fasciculation,0.048738197,BP
849,0.016408044,33,GO:1903725,regulation of phospholipid metabolic process,0.048810118,BP
-813,0.016473405,36,GO:0002377,immunoglobulin production,0.048939558,BP
348,0.016548781,201,GO:0051493,regulation of cytoskeleton organization,0.04909837,BP
615,0.016593801,63,GO:0043393,regulation of protein binding,0.049166818,BP
583,0.016663722,70,GO:1903708,positive regulation of hemopoiesis,0.049261738,BP
624,0.016700472,61,GO:0001736;GO:0007164,establishment of tissue polarity,0.049261738,BP
443,0.016719663,122,GO:0044774,mitotic DNA integrity checkpoint,0.049261738,BP
734,0.016730531,44,GO:0002011,morphogenesis of an epithelial sheet,0.049261738,BP
336,0.016735796,215,GO:0032386,regulation of intracellular transport,0.049261738,BP
844,0.017075107,33,GO:0030279,negative regulation of ossification,0.05019454,BP
438,0.017147882,124,GO:0051047,positive regulation of secretion,0.050342405,BP
666,0.017284471,53,GO:1903828,negative regulation of cellular protein localization,0.050676983,BP
-738,0.017363162,43,GO:0044550,secondary metabolite biosynthetic process,0.050841155,BP
794,0.017521137,37,GO:0007608,sensory perception of smell,0.051233904,BP
-526,0.017543038,85,GO:0006022,aminoglycan metabolic process,0.051233904,BP
-745,0.017695745,42,GO:0001523,retinoid metabolic process,0.051612589,BP
586,0.017721157,68,GO:0110053,regulation of actin filament organization,0.051619494,BP
-735,0.017910506,43,GO:0006637;GO:0035383,acyl-CoA metabolic process,0.052103291,BP
553,0.018013265,76,GO:0002702,positive regulation of production of molecular mediator of immune response,0.052334258,BP
355,0.018114944,187,GO:0010631;GO:0090132,epithelium migration,0.052561495,BP
275,0.018158886,317,GO:0051270,regulation of cellular component movement,0.052620835,BP
508,0.018199981,90,GO:0007308,oocyte construction,0.052671778,BP
269,0.01835632,332,GO:0051656,establishment of organelle localization,0.053055686,BP
-318,0.018612707,233,GO:0044772,mitotic cell cycle phase transition,0.053727403,BP
820,0.018673054,34,GO:0007006,mitochondrial membrane organization,0.053832228,BP
-754,0.019126053,40,GO:0009451,RNA modification,0.055067299,BP
313,0.019155692,238,GO:0051606,detection of stimulus,0.055081836,BP
-436,0.019201874,121,GO:0034504,protein localization to nucleus,0.055143844,BP
-320,0.019252868,227,GO:0006644,phospholipid metabolic process,0.055219494,BP
-441,0.019664068,117,GO:0051188,cofactor biosynthetic process,0.056326742,BP
593,0.019986269,64,GO:0042752,regulation of circadian rhythm,0.057101058,BP
188,0.020002289,701,GO:0048870,cell motility,0.057101058,BP
811,0.020010862,34,GO:0051489,regulation of filopodium assembly,0.057101058,BP
-241,0.020642569,401,GO:0005975,carbohydrate metabolic process,0.058828695,BP
-795,0.020689853,35,GO:0009124,nucleoside monophosphate biosynthetic process,0.058888528,BP
-308,0.020870527,240,GO:0051259,protein complex oligomerization,0.059327386,BP
-208,0.020925771,552,GO:0055114,oxidation-reduction process,0.059409033,BP
352,0.021207485,181,GO:0060627,regulation of vesicle-mediated transport,0.060132615,BP
-393,0.021274817,144,GO:0007605,sensory perception of sound,0.060213116,BP
-684,0.021294535,47,GO:0008645,hexose transmembrane transport,0.060213116,BP
616,0.021316518,58,GO:0033555,multicellular organismal response to stress,0.060213116,BP
290,0.021531663,269,GO:0072594,establishment of protein localization to organelle,0.060744237,BP
-661,0.021636485,50,GO:0006721,terpenoid metabolic process,0.060923297,BP
778,0.021669882,36,GO:0010906,regulation of glucose metabolic process,0.060923297,BP
-481,0.021688605,95,GO:0035725,sodium ion transmembrane transport,0.060923297,BP
393,0.021703925,143,GO:0098609,cell-cell adhesion,0.060923297,BP
-712,0.021802916,43,GO:0042078,germ-line stem cell division,0.061124569,BP
473,0.021933225,98,GO:0050906,detection of stimulus involved in sensory perception,0.061367845,BP
-588,0.021944484,63,GO:1903510,mucopolysaccharide metabolic process,0.061367845,BP
694,0.022199451,45,GO:0051048,negative regulation of secretion,0.061940363,BP
518,0.022204514,81,GO:0019932,second-messenger-mediated signaling,0.061940363,BP
708,0.022434827,43,GO:1902905,positive regulation of supramolecular fiber organization,0.062504992,BP
463,0.023318645,100,GO:0042742,defense response to bacterium,0.064886665,BP
-779,0.023452724,35,GO:0008345,larval locomotory behavior,0.065178786,BP
358,0.023517037,169,GO:0050865,regulation of cell activation,0.065276534,BP
265,0.023588481,315,GO:0044087,regulation of cellular component biogenesis,0.065393809,BP
-600,0.023630749,59,GO:0006308,DNA catabolic process,0.065430011,BP
-645,0.023727665,51,GO:0021532,neural tube patterning,0.065617247,BP
677,0.023969352,46,GO:0035088;GO:0061245,establishment or maintenance of bipolar cell polarity,0.066203881,BP
823,0.024142466,31,GO:0046887,positive regulation of hormone secretion,0.066599907,BP
501,0.02430518,84,GO:0042074,cell migration involved in gastrulation,0.066966303,BP
612,0.024633521,56,GO:0018209,peptidyl-serine modification,0.067787576,BP
327,0.024719123,200,GO:0009581,detection of external stimulus,0.067939674,BP
361,0.0248723,163,GO:0035272,exocrine system development,0.068276902,BP
793,0.024965028,33,GO:0045453,bone resorption,0.068447567,BP
779,0.025448617,34,GO:0030166,proteoglycan biosynthetic process,0.069688145,BP
790,0.02554347,33,GO:0060193,positive regulation of lipase activity,0.069862481,BP
415,0.025668777,121,GO:0016055,Wnt signaling pathway,0.070119585,BP
381,0.026385365,143,GO:0035148,tube formation,0.071989304,BP
615,0.026465476,54,GO:0018105,peptidyl-serine phosphorylation,0.072120033,BP
588,0.026724918,59,GO:0007616,long-term memory,0.072651771,BP
632,0.026725473,51,GO:2001233,regulation of apoptotic signaling pathway,0.072651771,BP
551,0.026821671,67,GO:0009593,detection of chemical stimulus,0.072824901,BP
624,0.027104888,52,GO:0010466,negative regulation of peptidase activity,0.073504782,BP
571,0.02730358,62,GO:0050714,positive regulation of protein secretion,0.073954073,BP
191,0.027542006,602,GO:0048667,cell morphogenesis involved in neuron differentiation,0.074509775,BP
-532,0.027767736,71,GO:0031572,G2 DNA damage checkpoint,0.07502983,BP
588,0.027884313,58,GO:0010770,positive regulation of cell morphogenesis involved in differentiation,0.075254049,BP
-311,0.02798953,212,GO:0000910,cytokinesis,0.075371655,BP
609,0.028047892,54,GO:0048661,positive regulation of smooth muscle cell proliferation,0.075371655,BP
802,0.028058894,31,GO:0046580;GO:0051058,negative regulation of Ras protein signal transduction,0.075371655,BP
402,0.028062482,125,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,0.075371655,BP
390,0.028253344,133,GO:0030335,positive regulation of cell migration,0.075793402,BP
503,0.028298595,79,GO:0009895,negative regulation of catabolic process,0.075823988,BP
631,0.028388666,50,GO:0010951,negative regulation of endopeptidase activity,0.075974447,BP
578,0.029415671,59,GO:0010810,regulation of cell-substrate adhesion,0.078538945,BP
-542,0.029417042,67,GO:0030326,embryonic limb morphogenesis,0.078538945,BP
-709,0.029574365,39,GO:0006493,protein O-linked glycosylation,0.07878444,BP
683,0.029579337,42,GO:0032655,regulation of interleukin-12 production,0.07878444,BP
-515,0.029782182,74,GO:0009108,coenzyme biosynthetic process,0.079204328,BP
407,0.0298077,119,GO:0033673,negative regulation of kinase activity,0.079204328,BP
459,0.030141195,93,GO:0060828,regulation of canonical Wnt signaling pathway,0.079995589,BP
-672,0.030216585,43,GO:0016101,diterpenoid metabolic process,0.08005906,BP
-319,0.030259222,195,GO:0007584,response to nutrient,0.08005906,BP
270,0.030272332,276,GO:0006909,phagocytosis,0.08005906,BP
791,0.030322967,31,GO:0010518,positive regulation of phospholipase activity,0.080098403,BP
-754,0.030528858,34,GO:0007619,courtship behavior,0.080547281,BP
-802,0.030643969,30,GO:0031497,chromatin assembly,0.080755871,BP
446,0.030720408,98,GO:0031346,positive regulation of cell projection organization,0.080806187,BP
502,0.030735211,77,GO:0006911,"phagocytosis, engulfment",0.080806187,BP
510,0.031501604,74,GO:0014020,primary neural tube formation,0.082696414,BP
389,0.031528008,128,GO:0048599,oocyte development,0.082696414,BP
773,0.031595614,32,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,0.082776813,BP
-433,0.03167068,103,GO:0006814,sodium ion transport,0.082876547,BP
242,0.031907517,340,GO:0045597,positive regulation of cell differentiation,0.083398878,BP
-543,0.033060576,64,GO:0007447,imaginal disc pattern formation,0.08626537,BP
694,0.033081229,39,GO:0042059;GO:1901185,negative regulation of ERBB signaling pathway,0.08626537,BP
580,0.033142203,56,GO:0043331,response to dsRNA,0.086323877,BP
492,0.033186462,78,GO:0035303,regulation of dephosphorylation,0.086338764,BP
-365,0.033407835,143,GO:0045017,glycerolipid biosynthetic process,0.086813864,BP
385,0.033479294,128,GO:0052548,regulation of endopeptidase activity,0.086898746,BP
-304,0.033518442,208,GO:0040029,"regulation of gene expression, epigenetic",0.086899665,BP
171,0.033557903,707,GO:0051674,localization of cell,0.086901392,BP
650,0.033993834,44,GO:0008355,olfactory learning,0.087875249,BP
536,0.034012429,65,GO:0007043,cell-cell junction assembly,0.087875249,BP
401,0.034585098,116,GO:0012502,induction of programmed cell death,0.089251865,BP
-578,0.035210006,55,GO:0007140,male meiotic nuclear division,0.090759971,BP
-594,0.035320108,52,GO:0006333,chromatin assembly or disassembly,0.090939128,BP
-548,0.035688269,61,GO:0072329,monocarboxylic acid catabolic process,0.091729878,BP
373,0.035709131,133,GO:0002237,response to molecule of bacterial origin,0.091729878,BP
-576,0.035799775,55,GO:0007095,mitotic G2 DNA damage checkpoint,0.091817376,BP
-473,0.035825173,82,GO:0007033,vacuole organization,0.091817376,BP
-314,0.036071354,189,GO:0006091,generation of precursor metabolites and energy,0.092342667,BP
-170,0.036372019,695,GO:0006811,ion transport,0.093006076,BP
408,0.036550968,110,GO:0042176,regulation of protein catabolic process,0.09335709,BP
-302,0.036670948,203,GO:0046486,glycerolipid metabolic process,0.09355686,BP
166,0.037044509,726,GO:0042127,regulation of cell population proliferation,0.094365122,BP
401,0.037072012,113,GO:0006469,negative regulation of protein kinase activity,0.094365122,BP
773,0.037233995,30,GO:0043550,regulation of lipid kinase activity,0.094607108,BP
396,0.037251549,116,GO:0097479,synaptic vesicle localization,0.094607108,BP
543,0.037439888,61,GO:0007314,oocyte anterior/posterior axis specification,0.094977746,BP
200,0.03797176,473,GO:0048638,regulation of developmental growth,0.096127017,BP
521,0.037978754,66,GO:1902107,positive regulation of leukocyte differentiation,0.096127017,BP
-643,0.038167821,43,GO:0070207,protein homotrimerization,0.096496523,BP
-635,0.03833681,44,GO:0051302,regulation of cell division,0.09671245,BP
628,0.038339578,45,GO:0050866,negative regulation of cell activation,0.09671245,BP
-531,0.038555874,63,GO:0034219,carbohydrate transmembrane transport,0.09714866,BP
-701,0.038678973,36,GO:0048566,embryonic digestive tract development,0.097349326,BP
-293,0.038923111,210,GO:0048545,response to steroid hormone,0.097806408,BP
648,0.038947909,42,GO:0051865,protein autoubiquitination,0.097806408,BP
468,0.039055793,81,GO:0043279,response to alkaloid,0.0979675,BP
599,0.03940535,49,GO:0040024,dauer larval development,0.098733763,BP
-698,0.039539832,36,GO:0031100,animal organ regeneration,0.098960027,BP
528,0.039712297,63,GO:0002793,positive regulation of peptide secretion,0.099280744,BP
310,0.039956358,185,GO:0009101,glycoprotein biosynthetic process,0.099779534,BP
615,0.040329653,46,GO:0042058;GO:1901184,regulation of epidermal growth factor receptor signaling pathway,0.100523714,BP
563,0.040344116,55,GO:1904018,positive regulation of vasculature development,0.100523714,BP
487,0.041085156,73,GO:0042048,olfactory behavior,0.102256387,BP
587,0.04129099,50,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,0.102597856,BP
612,0.041313958,46,GO:0072384,organelle transport along microtubule,0.102597856,BP
575,0.041594255,52,GO:0090382,phagosome maturation,0.103179548,BP
-492,0.04194453,71,GO:0006275,regulation of DNA replication,0.10393335,BP
538,0.042434122,59,GO:0071219,cellular response to molecule of bacterial origin,0.105030314,BP
-414,0.042576342,100,GO:0006869,lipid transport,0.105266012,BP
660,0.042727699,39,GO:0045792,negative regulation of cell size,0.105523754,BP
-369,0.042805264,126,GO:1901293,nucleoside phosphate biosynthetic process,0.10559889,BP
386,0.042856154,115,GO:0099003;GO:0048489;GO:0097480,vesicle-mediated transport in synapse,0.105608125,BP
-686,0.042918545,36,GO:0010043,response to zinc ion,0.105627572,BP
-546,0.042979278,57,GO:0044818,mitotic G2/M transition checkpoint,0.105627572,BP
464,0.043005511,79,GO:0010324,membrane invagination,0.105627572,BP
705,0.043128141,34,GO:0034341,response to interferon-gamma,0.105812745,BP
-550,0.043243562,56,GO:0048636,positive regulation of muscle organ development,0.105979844,BP
-340,0.044568742,147,GO:0008654,phospholipid biosynthetic process,0.108868002,BP
237,0.044569089,308,GO:0030097,hemopoiesis,0.108868002,BP
300,0.044609874,190,GO:0009582,detection of abiotic stimulus,0.108868002,BP
690,0.04461644,35,GO:0060281,regulation of oocyte development,0.108868002,BP
457,0.044988054,80,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,0.109655321,BP
367,0.0451678,125,GO:0009408,response to heat,0.109973775,BP
606,0.045685518,45,GO:1900424,regulation of defense response to bacterium,0.111113529,BP
558,0.046068389,53,GO:0045766,positive regulation of angiogenesis,0.111923202,BP
657,0.046296491,38,GO:0009187,cyclic nucleotide metabolic process,0.112355515,BP
-511,0.046436559,63,GO:0006354,"DNA-templated transcription, elongation",0.112493335,BP
457,0.046453721,79,GO:0048332,mesoderm morphogenesis,0.112493335,BP
430,0.046782506,89,GO:0002700,regulation of production of molecular mediator of immune response,0.113084181,BP
484,0.046808991,70,GO:0031330,negative regulation of cellular catabolic process,0.113084181,BP
274,0.046853392,224,GO:0048749,compound eye development,0.113084181,BP
402,0.046899645,102,GO:0030168,platelet activation,0.113084181,BP
513,0.047197898,62,GO:0008358,"maternal determination of anterior/posterior axis, embryo",0.113680958,BP
513,0.047499864,62,GO:0045667,regulation of osteoblast differentiation,0.114285388,BP
-211,0.048207646,380,GO:0045786,negative regulation of cell cycle,0.11586387,BP
-324,0.048428547,156,GO:0015980,energy derivation by oxidation of organic compounds,0.116270037,BP
-709,0.048620455,32,GO:0006040,amino sugar metabolic process,0.116605802,BP
470,0.048719914,73,GO:0001843;GO:0060606,neural tube closure,0.116719366,BP
-719,0.048839345,31,GO:1990542,mitochondrial transmembrane transport,0.116880485,BP
454,0.049296273,78,GO:0099024,plasma membrane invagination,0.11784808,BP
717,0.04944252,31,GO:0032680,regulation of tumor necrosis factor production,0.11807169,BP
-197,0.049547503,434,GO:0006396,RNA processing,0.118196385,BP
-508,0.049688674,62,GO:0010972;GO:1902750,negative regulation of G2/M transition of mitotic cell cycle,0.118407054,BP
195,0.049754725,445,GO:0060548,negative regulation of cell death,0.118438454,BP
446,0.05033025,80,GO:0010632,regulation of epithelial cell migration,0.119681275,BP
714,0.050510497,31,GO:1900274,regulation of phospholipase C activity,0.119982517,BP
390,0.050630316,105,GO:1903037,regulation of leukocyte cell-cell adhesion,0.120139733,BP
-427,0.05077026,87,GO:0009063,cellular amino acid catabolic process,0.120344321,BP
231,0.051038499,308,GO:0051050,positive regulation of transport,0.120852259,BP
-598,0.051175479,44,GO:0009112,nucleobase metabolic process,0.120919534,BP
335,0.051250906,142,GO:0010721,negative regulation of cell development,0.120919534,BP
296,0.051270084,183,GO:0009266,response to temperature stimulus,0.120919534,BP
-670,0.051282838,35,GO:0006835,dicarboxylic acid transport,0.120919534,BP
-444,0.051342101,80,GO:0030703,eggshell formation,0.120931973,BP
314,0.051555148,162,GO:0007424,open tracheal system development,0.121306231,BP
-492,0.051750399,65,GO:2001020,regulation of response to DNA damage stimulus,0.121637875,BP
199,0.052071815,419,GO:0043069,negative regulation of programmed cell death,0.122265059,BP
-495,0.052170782,64,GO:0015695,organic cation transport,0.122369163,BP
708,0.052401679,31,GO:0045475,locomotor rhythm,0.122782177,BP
-707,0.052661143,31,GO:0032506,cytokinetic process,0.123261191,BP
337,0.053364175,138,GO:0051249,regulation of lymphocyte activation,0.124776359,BP
567,0.053527126,48,GO:0051495,positive regulation of cytoskeleton organization,0.125026863,BP
-621,0.053665667,40,GO:0048844,artery morphogenesis,0.125219889,BP
572,0.053842952,47,GO:0019751,polyol metabolic process,0.125502823,BP
218,0.054284801,336,GO:0048534,hematopoietic or lymphoid organ development,0.126401199,BP
-462,0.054420551,72,GO:0010389;GO:1902749,regulation of cell cycle G2/M phase transition,0.126585706,BP
207,0.054495317,376,GO:0002064,epithelial cell development,0.126628124,BP
-350,0.055989065,125,GO:0009165,nucleotide biosynthetic process,0.129964255,BP
-343,0.056114036,130,GO:0046474,glycerophospholipid biosynthetic process,0.130119503,BP
310,0.057135262,158,GO:0002694,regulation of leukocyte activation,0.132301402,BP
663,0.057233745,34,GO:0070252,actin-mediated cell contraction,0.132301402,BP
348,0.057281811,125,GO:0016197,endosomal transport,0.132301402,BP
604,0.057291232,41,GO:0045444,fat cell differentiation,0.132301402,BP
384,0.05752715,102,GO:0001841,neural tube formation,0.132695793,BP
-552,0.057629679,49,GO:0061640,cytoskeleton-dependent cytokinesis,0.132695793,BP
-536,0.057653535,52,GO:0031646,positive regulation of neurological system process,0.132695793,BP
652,0.057698974,35,GO:0008333,endosome to lysosome transport,0.132695793,BP
154,0.057762987,695,GO:0044270,cellular nitrogen compound catabolic process,0.13270676,BP
-332,0.057998965,137,GO:0017038,protein import,0.133112379,BP
459,0.061222974,69,GO:0071229,cellular response to acid chemical,0.140228272,BP
-574,0.061224665,44,GO:0070206,protein trimerization,0.140228272,BP
-538,0.061502272,50,GO:0009062,fatty acid catabolic process,0.140720215,BP
609,0.061680144,39,GO:0008088,axo-dendritic transport,0.140983185,BP
331,0.062544523,133,GO:0052547,regulation of peptidase activity,0.14267862,BP
382,0.062549288,99,GO:0071559,response to transforming growth factor beta,0.14267862,BP
303,0.06360927,158,GO:0006887,exocytosis,0.144948897,BP
-688,0.063870657,30,GO:0043038,amino acid activation,0.145396617,BP
561,0.064321647,45,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,0.146274607,BP
-161,0.06460564,592,GO:1903047,mitotic cell cycle process,0.146660388,BP
-573,0.064622233,43,GO:0000096,sulfur amino acid metabolic process,0.146660388,BP
353,0.064972629,114,GO:0050982,detection of mechanical stimulus,0.147306366,BP
-208,0.065117663,341,GO:0051301,cell division,0.147450004,BP
184,0.065168334,440,GO:0009203,ribonucleoside triphosphate catabolic process,0.147450004,BP
653,0.065233462,33,GO:0046688,response to copper ion,0.147450004,BP
-289,0.065418376,171,GO:0006650,glycerophospholipid metabolic process,0.147718914,BP
375,0.06617799,100,GO:0045665,negative regulation of neuron differentiation,0.149283684,BP
467,0.066617026,64,GO:0050796,regulation of insulin secretion,0.150122875,BP
-474,0.066893407,62,GO:0006720,isoprenoid metabolic process,0.150594202,BP
-555,0.067090229,45,GO:0030204,chondroitin sulfate metabolic process,0.150885656,BP
188,0.067333916,415,GO:0043066,negative regulation of apoptotic process,0.151281818,BP
341,0.067500751,120,GO:0032496,response to lipopolysaccharide,0.151504691,BP
180,0.06760387,452,GO:0009154;GO:0009261,purine ribonucleotide catabolic process,0.151584252,BP
480,0.067709412,60,GO:0002443,leukocyte mediated immunity,0.151669082,BP
438,0.068220213,72,GO:0010976,positive regulation of neuron projection development,0.152660616,BP
-426,0.068776081,76,GO:0030203,glycosaminoglycan metabolic process,0.153626286,BP
-327,0.068788913,130,GO:0031503,protein-containing complex localization,0.153626286,BP
518,0.069115912,51,GO:0040015,negative regulation of multicellular organism growth,0.154202833,BP
-673,0.069701836,30,GO:0042693,muscle cell fate commitment,0.155355335,BP
181,0.07001698,441,GO:0009146,purine nucleoside triphosphate catabolic process,0.155902619,BP
582,0.070356788,40,GO:0071359,cellular response to dsRNA,0.156503679,BP
511,0.07053986,52,GO:0048488;GO:0140238,presynaptic endocytosis,0.156755245,BP
176,0.070800852,463,GO:0032774,RNA biosynthetic process,0.157179295,BP
338,0.071242507,119,GO:0007612,learning,0.157893543,BP
595,0.071296457,38,GO:0016203,muscle attachment,0.157893543,BP
-430,0.071334047,73,GO:0007304,chorion-containing eggshell formation,0.157893543,BP
529,0.071526933,48,GO:0070372,regulation of ERK1 and ERK2 cascade,0.158164196,BP
-403,0.071636018,83,GO:0061333,renal tubule morphogenesis,0.158249192,BP
667,0.072196419,30,GO:0098930,axonal transport,0.159330028,BP
-593,0.072283326,38,GO:0060079,excitatory postsynaptic potential,0.159364813,BP
465,0.07254831,62,GO:0010921,regulation of phosphatase activity,0.159791754,BP
284,0.073311134,168,GO:0001894,tissue homeostasis,0.161313301,BP
-347,0.073593577,111,GO:0006352,"DNA-templated transcription, initiation",0.161775871,BP
-575,0.073859363,40,GO:0061180,mammary gland epithelium development,0.162200953,BP
-525,0.074160286,48,GO:0007306,eggshell chorion assembly,0.162702293,BP
662,0.074396583,30,GO:0035304,regulation of protein dephosphorylation,0.16301887,BP
178,0.074450136,439,GO:0009207,purine ribonucleoside triphosphate catabolic process,0.16301887,BP
524,0.074717301,48,GO:1990778,protein localization to cell periphery,0.163444095,BP
611,0.075278395,35,GO:1901616,organic hydroxy compound catabolic process,0.164452911,BP
436,0.075325307,69,GO:0043652,engulfment of apoptotic cell,0.164452911,BP
565,0.075519149,41,GO:0032006,regulation of TOR signaling,0.164715573,BP
-312,0.076012736,136,GO:0031023,microtubule organizing center organization,0.165630864,BP
-562,0.076707656,41,GO:0033212,iron import into cell,0.166982653,BP
310,0.077141659,136,GO:0090068,positive regulation of cell cycle process,0.167764386,BP
434,0.077293697,69,GO:0018279,protein N-linked glycosylation via asparagine,0.167867286,BP
514,0.077338857,49,GO:0008064;GO:0030832,regulation of actin polymerization or depolymerization,0.167867286,BP
-567,0.07789793,40,GO:0002440,production of molecular mediator of immune response,0.168917098,BP
316,0.07802947,130,GO:0051098,regulation of binding,0.169038697,BP
511,0.078747507,49,GO:0035006,melanization defense response,0.170429386,BP
630,0.079451603,32,GO:0050907,detection of chemical stimulus involved in sensory perception,0.171714311,BP
172,0.079494527,458,GO:0006195,purine nucleotide catabolic process,0.171714311,BP
316,0.079910904,129,GO:0045055,regulated exocytosis,0.172447423,BP
435,0.080320416,67,GO:0090276,regulation of peptide hormone secretion,0.173164324,BP
-649,0.080480451,30,GO:2000179,positive regulation of neural precursor cell proliferation,0.17321076,BP
-355,0.080496608,101,GO:0019827;GO:0098727,stem cell population maintenance,0.17321076,BP
-354,0.081408024,101,GO:0097164,ammonium ion metabolic process,0.175003814,BP
-567,0.08152146,39,GO:0009954,proximal/distal pattern formation,0.175079645,BP
-582,0.081755492,37,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,0.175414083,BP
481,0.08231103,54,GO:0072347,response to anesthetic,0.176437041,BP
370,0.082594834,92,GO:0030178,negative regulation of Wnt signaling pathway,0.176876126,BP
139,0.083222897,709,GO:0019439,aromatic compound catabolic process,0.178050898,BP
-642,0.083606122,30,GO:0033077,T cell differentiation in thymus,0.178659812,BP
-484,0.083667028,53,GO:0045844;GO:1901863,positive regulation of striated muscle tissue development,0.178659812,BP
542,0.084066468,42,GO:0050830,defense response to Gram-positive bacterium,0.179341797,BP
-199,0.084190735,324,GO:0009314,response to radiation,0.179436009,BP
421,0.084363318,70,GO:0050974,detection of mechanical stimulus involved in sensory perception,0.179632921,BP
428,0.085329356,67,GO:0002920,regulation of humoral immune response,0.181517338,BP
-638,0.085442933,30,GO:0060349,bone morphogenesis,0.1815865,BP
160,0.085714719,511,GO:0009144,purine nucleoside triphosphate metabolic process,0.18199144,BP
434,0.08593891,65,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.182294657,BP
286,0.08609051,151,GO:0050803,regulation of synapse structure or activity,0.182443466,BP
504,0.086383565,48,GO:0060359,response to ammonium ion,0.182891479,BP
616,0.086472377,32,GO:0032104;GO:0032107,regulation of response to extracellular stimulus,0.182906632,BP
405,0.087279896,74,GO:0051701,interaction with host,0.184440535,BP
-634,0.087512663,30,GO:0048665,neuron fate specification,0.18475812,BP
244,0.087734672,207,GO:0006875,cellular metal ion homeostasis,0.185052415,BP
-496,0.087932443,49,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,0.185295082,BP
603,0.088293529,33,GO:1903312,negative regulation of mRNA metabolic process,0.185881114,BP
321,0.089360686,117,GO:0050807,regulation of synapse organization,0.187951114,BP
465,0.090108538,55,GO:0006582,melanin metabolic process,0.189346271,BP
168,0.090297293,445,GO:0009143,nucleoside triphosphate catabolic process,0.189565076,BP
478,0.090676549,52,GO:0043297,apical junction assembly,0.190014666,BP
-538,0.090681106,41,GO:0060323,head morphogenesis,0.190014666,BP
403,0.091026968,73,GO:1905952,regulation of lipid localization,0.190561129,BP
617,0.091298126,31,GO:0050919,negative chemotaxis,0.190950328,BP
361,0.091488173,91,GO:0030307,positive regulation of cell growth,0.191169317,BP
371,0.091663111,86,GO:0008593,regulation of Notch signaling pathway,0.191240663,BP
373,0.091693068,85,GO:0043524,negative regulation of neuron apoptotic process,0.191240663,BP
411,0.091819281,70,GO:0018196,peptidyl-asparagine modification,0.191325758,BP
517,0.092083668,44,GO:0022408,negative regulation of cell-cell adhesion,0.191698343,BP
-605,0.092182421,32,GO:0021952,central nervous system projection neuron axonogenesis,0.191725742,BP
210,0.092344609,275,GO:0060541,respiratory system development,0.191884902,BP
-334,0.092863143,106,GO:0061008,hepaticobiliary system development,0.192783541,BP
153,0.093222385,535,GO:0003002,regionalization,0.193175227,BP
623,0.093224295,30,GO:0044126;GO:0044130;GO:0044146;GO:0044144,negative regulation of growth of symbiont involved in interaction with host,0.193175227,BP
289,0.094045901,141,GO:2000147,positive regulation of cell motility,0.194697615,BP
-451,0.094366299,57,GO:0006694,steroid biosynthetic process,0.195086989,BP
184,0.094447619,360,GO:0010608,posttranscriptional regulation of gene expression,0.195086989,BP
251,0.09449526,187,GO:0001745,compound eye morphogenesis,0.195086989,BP
180,0.095941429,373,GO:0051130,positive regulation of cellular component organization,0.197890241,BP
-269,0.096633403,161,GO:0018205,peptidyl-lysine modification,0.199134151,BP
433,0.097176363,61,GO:0048678,response to axon injury,0.200068984,BP
514,0.097308147,43,GO:0048259,regulation of receptor-mediated endocytosis,0.200156335,BP
595,0.097996292,32,GO:0090263,positive regulation of canonical Wnt signaling pathway,0.201386875,BP
-545,0.098530582,38,GO:0033206,meiotic cytokinesis,0.20229927,BP
490,0.099042894,47,GO:0072659,protein localization to plasma membrane,0.203112212,BP
530,0.099107878,40,GO:1905879,regulation of oogenesis,0.203112212,BP
162,0.099317512,458,GO:0034656,nucleobase-containing small molecule catabolic process,0.203355782,BP
-410,0.099712397,67,GO:0006353,"DNA-templated transcription, termination",0.203405987,BP
238,0.099715448,202,GO:0007472,wing disc morphogenesis,0.203405987,BP
-340,0.09971932,98,GO:0010212,response to ionizing radiation,0.203405987,BP
383,0.099787628,77,GO:0042990,obsolete regulation of transcription factor import into nucleus,0.203405987,BP
158,0.099796062,477,GO:0009166,nucleotide catabolic process,0.203405987,BP
564,0.100571228,35,GO:0048013,ephrin receptor signaling pathway,0.204767051,BP
162,0.100704766,450,GO:0042454,ribonucleoside catabolic process,0.204767051,BP
487,0.100738076,47,GO:0071222,cellular response to lipopolysaccharide,0.204767051,BP
-442,0.1011923,57,GO:0022037,metencephalon development,0.205503854,BP
148,0.101462234,549,GO:0072358;GO:0072359,cardiovascular system development,0.205865403,BP
-597,0.101828282,31,GO:0055081,anion homeostasis,0.206110273,BP
393,0.101834756,72,GO:0048771,tissue remodeling,0.206110273,BP
496,0.101858961,45,GO:2000736,regulation of stem cell differentiation,0.206110273,BP
-356,0.102255379,88,GO:0048066,developmental pigmentation,0.206725675,BP
532,0.102469859,39,GO:0043534,blood vessel endothelial cell migration,0.20687087,BP
162,0.102511905,449,GO:0006152;GO:0046130,purine nucleoside catabolic process,0.20687087,BP
212,0.102812533,253,GO:0035220,wing disc development,0.207196087,BP
-569,0.102858058,34,GO:0009072,aromatic amino acid family metabolic process,0.207196087,BP
323,0.104029737,106,GO:0006839,mitochondrial transport,0.209368025,BP
266,0.105155556,156,GO:0051961,negative regulation of nervous system development,0.211443848,BP
159,0.105378996,455,GO:0009164,nucleoside catabolic process,0.211703095,BP
549,0.105511069,36,GO:0006446,regulation of translational initiation,0.211739428,BP
564,0.105586134,34,GO:0030148,sphingolipid biosynthetic process,0.211739428,BP
-258,0.105791814,166,GO:0048864,stem cell development,0.211962132,BP
-527,0.105979821,39,GO:0042733,embryonic digit morphogenesis,0.21214906,BP
335,0.106132553,97,GO:0071560,cellular response to transforming growth factor beta stimulus,0.212265107,BP
399,0.106514094,68,GO:0002250,adaptive immune response,0.212653547,BP
-338,0.106600164,95,GO:0048593,camera-type eye morphogenesis,0.212653547,BP
474,0.106611577,48,GO:0062013,positive regulation of small molecule metabolic process,0.212653547,BP
220,0.107126937,228,GO:0030003,cellular cation homeostasis,0.213491406,BP
398,0.107639338,68,GO:2000242,negative regulation of reproductive process,0.214321882,BP
-231,0.107805219,205,GO:0030900,forebrain development,0.214461536,BP
422,0.108408361,60,GO:0031334,positive regulation of protein complex assembly,0.215470033,BP
498,0.108786177,43,GO:0017015;GO:1903844,regulation of transforming growth factor beta receptor signaling pathway,0.215693114,BP
440,0.108803606,55,GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.215693114,BP
-347,0.108825114,89,GO:0006367,transcription initiation from RNA polymerase II promoter,0.215693114,BP
432,0.10905638,57,GO:0090090,negative regulation of canonical Wnt signaling pathway,0.215693114,BP
-448,0.109095765,53,GO:0042439,ethanolamine-containing compound metabolic process,0.215693114,BP
-471,0.109098347,48,GO:0021515,cell differentiation in spinal cord,0.215693114,BP
-515,0.109195253,40,GO:0071383,cellular response to steroid hormone stimulus,0.215694326,BP
-515,0.109558857,40,GO:0016571,histone methylation,0.216221885,BP
-435,0.109817101,56,GO:0060042,retina morphogenesis in camera-type eye,0.216540762,BP
438,0.110984582,55,GO:0007632,visual behavior,0.21849094,BP
442,0.111001201,54,GO:0051668,localization within membrane,0.21849094,BP
506,0.111131379,41,GO:1900371;GO:0030808,regulation of purine nucleotide biosynthetic process,0.218535255,BP
248,0.111218835,174,GO:0010720,positive regulation of cell development,0.218535255,BP
159,0.111520196,442,GO:0040012,regulation of locomotion,0.218935353,BP
-477,0.112157187,46,GO:0050654,chondroitin sulfate proteoglycan metabolic process,0.219956903,BP
-511,0.112236938,40,GO:0043401,steroid hormone mediated signaling pathway,0.219956903,BP
199,0.11233764,273,GO:0006979,response to oxidative stress,0.219961812,BP
154,0.113921416,466,GO:0072523,purine-containing compound catabolic process,0.222868098,BP
363,0.114127183,79,GO:0010950,positive regulation of endopeptidase activity,0.223075819,BP
-441,0.11450244,53,GO:0021549,cerebellum development,0.223510146,BP
125,0.11454895,726,GO:1901361,organic cyclic compound catabolic process,0.223510146,BP
141,0.114854108,562,GO:0006898,receptor-mediated endocytosis,0.223910532,BP
147,0.115030022,507,GO:0009205,purine ribonucleoside triphosphate metabolic process,0.224058478,BP
-549,0.115304736,34,GO:0035601;GO:0098732,macromolecule deacylation,0.224398444,BP
305,0.115738854,111,GO:0042335,cuticle development,0.225047771,BP
482,0.116019605,44,GO:0051817;GO:0035821,modification of morphology or physiology of other organism involved in symbiotic interaction,0.225398018,BP
583,0.116199554,30,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,0.225551994,BP
334,0.116463143,92,GO:0050870;GO:1903039,positive regulation of leukocyte cell-cell adhesion,0.225867913,BP
-554,0.11755692,33,GO:0060968,regulation of gene silencing,0.227751472,BP
503,0.117637702,40,GO:0046849,bone remodeling,0.227751472,BP
366,0.11779996,76,GO:1903362,regulation of cellular protein catabolic process,0.227868663,BP
-381,0.118179374,70,GO:0006029,proteoglycan metabolic process,0.228405348,BP
-570,0.118528944,31,GO:0006635,fatty acid beta-oxidation,0.228798878,BP
228,0.118665962,199,GO:0048871,multicellular organismal homeostasis,0.228798878,BP
370,0.118689418,74,GO:0006487,protein N-linked glycosylation,0.228798878,BP
138,0.118873456,576,GO:0007423,sensory organ development,0.228938908,BP
449,0.118966468,50,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,0.228938908,BP
-333,0.119524722,91,GO:0051170,import into nucleus,0.229815774,BP
294,0.119703393,117,GO:0001838,embryonic epithelial tube formation,0.229961921,BP
526,0.120608689,36,GO:0055057;GO:0036445,neuronal stem cell division,0.231502538,BP
575,0.12120644,30,GO:0045793,positive regulation of cell size,0.232261803,BP
-475,0.121211628,44,GO:0016052,carbohydrate catabolic process,0.232261803,BP
144,0.121349407,510,GO:0009199,ribonucleoside triphosphate metabolic process,0.23232707,BP
261,0.122328552,147,GO:0033157,regulation of intracellular protein transport,0.23400167,BP
182,0.122504665,311,GO:0044057,regulation of system process,0.23413861,BP
381,0.123329531,68,GO:0043409,negative regulation of MAPK cascade,0.235514193,BP
-309,0.124659786,103,GO:0001889,liver development,0.237851721,BP
387,0.125538822,65,GO:0090288,negative regulation of cellular response to growth factor stimulus,0.239325074,BP
248,0.125991283,160,GO:0048511,rhythmic process,0.239983396,BP
454,0.126225109,47,GO:0006458,'de novo' protein folding,0.240092935,BP
558,0.126388868,31,GO:0099518,vesicle cytoskeletal trafficking,0.240092935,BP
486,0.126447119,41,GO:0000186,activation of MAPKK activity,0.240092935,BP
334,0.126477529,87,GO:0051963,regulation of synapse assembly,0.240092935,BP
291,0.126682788,115,GO:0043523,regulation of neuron apoptotic process,0.240278954,BP
-336,0.127128848,86,GO:0006338,chromatin remodeling,0.240920997,BP
-457,0.127483144,46,GO:0042490,mechanoreceptor differentiation,0.241388202,BP
-420,0.129232983,54,GO:0045814,"negative regulation of gene expression, epigenetic",0.244494833,BP
-385,0.130813365,64,GO:0007040;GO:0080171,lysosome organization,0.247275897,BP
473,0.131992352,42,GO:0016579,protein deubiquitination,0.249201763,BP
279,0.132054684,122,GO:1901214,regulation of neuron death,0.249201763,BP
121,0.132863303,704,GO:0046700,heterocycle catabolic process,0.250516666,BP
-432,0.133904388,50,GO:0007525,somatic muscle development,0.252267308,BP
384,0.134848494,63,GO:0035152,"regulation of tube architecture, open tracheal system",0.253832459,BP
439,0.135415451,48,GO:0048145,regulation of fibroblast proliferation,0.254685651,BP
-289,0.135978461,111,GO:0043627,response to estrogen,0.255351207,BP
319,0.135997317,91,GO:0046546,development of primary male sexual characteristics,0.255351207,BP
-544,0.136251751,31,GO:0036342,post-anal tail morphogenesis,0.25543709,BP
-553,0.136315109,30,GO:0015889;GO:0020028,endocytic hemoglobin import,0.25543709,BP
-447,0.13638516,46,GO:0031056,regulation of histone modification,0.25543709,BP
382,0.136516696,63,GO:0045834,positive regulation of lipid metabolic process,0.255469841,BP
317,0.136766153,92,GO:0007528,neuromuscular junction development,0.255723024,BP
-296,0.137283723,105,GO:0006643,membrane lipid metabolic process,0.256476679,BP
356,0.138226494,72,GO:0071901,negative regulation of protein serine/threonine kinase activity,0.258022788,BP
203,0.138358954,227,GO:0007626,locomotory behavior,0.258055002,BP
217,0.138606621,198,GO:0007476,imaginal disc-derived wing morphogenesis,0.258301856,BP
-322,0.139535085,88,GO:0006606,protein import into nucleus,0.259815952,BP
-409,0.139731524,54,GO:0072524,pyridine-containing compound metabolic process,0.259965626,BP
469,0.139947782,41,GO:0050909,sensory perception of taste,0.260151893,BP
178,0.14038949,295,GO:0008285,negative regulation of cell population proliferation,0.260756598,BP
-407,0.141856733,54,GO:0051899,membrane depolarization,0.263069895,BP
536,0.141869836,31,GO:0043488,regulation of mRNA stability,0.263069895,BP
200,0.142001829,230,GO:0040017,positive regulation of locomotion,0.263096854,BP
-122,0.142229225,654,GO:0000278,mitotic cell cycle,0.263286643,BP
317,0.142371021,89,GO:1901215,negative regulation of neuron death,0.263286643,BP
-317,0.14245688,89,GO:0046390,ribose phosphate biosynthetic process,0.263286643,BP
455,0.142883308,43,GO:0019730,antimicrobial humoral response,0.263857057,BP
-421,0.143222364,50,GO:0006342;GO:0097549,chromatin silencing,0.264265317,BP
281,0.143434178,113,GO:0007422,peripheral nervous system development,0.26443832,BP
260,0.143840652,133,GO:0072507,divalent inorganic cation homeostasis,0.264969622,BP
453,0.144163085,43,GO:0051084,'de novo' posttranslational protein folding,0.265345366,BP
-401,0.144407721,55,GO:0035264,multicellular organism growth,0.265574853,BP
-404,0.144524887,54,GO:0008203;GO:1902652,cholesterol metabolic process,0.265574853,BP
294,0.144816731,103,GO:0043277,apoptotic cell clearance,0.265893014,BP
-380,0.14531868,61,GO:0022904;GO:0022900,respiratory electron transport chain,0.266596105,BP
-452,0.145493344,43,GO:1901678,iron coordination entity transport,0.26669811,BP
-432,0.145873436,47,GO:2000177,regulation of neural precursor cell proliferation,0.267176203,BP
312,0.146612255,90,GO:0030705,cytoskeleton-dependent intracellular transport,0.26788989,BP
539,0.146615949,30,GO:0001706,endoderm formation,0.26788989,BP
-456,0.146702276,42,GO:0042136,neurotransmitter biosynthetic process,0.26788989,BP
539,0.146741471,30,GO:0043113,receptor clustering,0.26788989,BP
265,0.147197232,125,GO:0072503,cellular divalent inorganic cation homeostasis,0.268503094,BP
-330,0.147487294,80,GO:0051384,response to glucocorticoid,0.268813294,BP
384,0.147982959,59,GO:0051101,regulation of DNA binding,0.269293497,BP
520,0.147991203,32,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,0.269293497,BP
-428,0.149506958,47,GO:0007280,pole cell migration,0.271830833,BP
-463,0.149778687,40,GO:0060078,regulation of postsynaptic membrane potential,0.272104021,BP
-383,0.152423821,58,GO:0051181,cofactor transport,0.276685056,BP
514,0.15287341,32,GO:0030799,obsolete regulation of cyclic nucleotide metabolic process,0.277150469,BP
498,0.152927669,34,GO:0070374,positive regulation of ERK1 and ERK2 cascade,0.277150469,BP
-242,0.154014083,146,GO:0016311,dephosphorylation,0.278893731,BP
-447,0.154192292,42,GO:0003279,cardiac septum development,0.278949012,BP
-529,0.154293672,30,GO:1902692,regulation of neuroblast proliferation,0.278949012,BP
255,0.155032437,130,GO:0031032,actomyosin structure organization,0.280058595,BP
397,0.15569906,53,GO:0002263;GO:0002366,cell activation involved in immune response,0.281036175,BP
-361,0.156052664,64,GO:0051494,negative regulation of cytoskeleton organization,0.28144764,BP
480,0.156350832,36,GO:0044003,modification by symbiont of host morphology or physiology,0.281700724,BP
526,0.156444509,30,GO:0034103,regulation of tissue remodeling,0.281700724,BP
461,0.156819741,39,GO:0072009,nephron epithelium development,0.282149575,BP
-330,0.158477103,76,GO:0015696,ammonium transport,0.284902658,BP
238,0.159087795,147,GO:0009994,oocyte differentiation,0.28577118,BP
128,0.16012358,533,GO:0060562,epithelial tube morphogenesis,0.287401297,BP
330,0.160609247,75,GO:0071248,cellular response to metal ion,0.288042204,BP
456,0.16124789,39,GO:0120192;GO:0120193,tight junction assembly,0.28895622,BP
-315,0.161510296,82,GO:0031960,response to corticosteroid,0.289195094,BP
487,0.16216643,34,GO:0010821,regulation of mitochondrion organization,0.290138022,BP
-433,0.162742182,43,GO:0048069,eye pigmentation,0.290935744,BP
285,0.162884948,100,GO:0007623,circadian rhythm,0.290958758,BP
-460,0.163112487,38,GO:0003158,endothelium development,0.290979448,BP
245,0.163156333,136,GO:0051222,positive regulation of protein transport,0.290979448,BP
386,0.163474376,54,GO:0008045,motor neuron axon guidance,0.291314719,BP
459,0.163863784,38,GO:0002695,negative regulation of leukocyte activation,0.291776531,BP
459,0.164033792,38,GO:0010517,regulation of phospholipase activity,0.291847256,BP
-508,0.164375907,31,GO:0060443,mammary gland morphogenesis,0.292223835,BP
-287,0.164516966,98,GO:0042157,lipoprotein metabolic process,0.292241735,BP
465,0.164646906,37,GO:0006885,regulation of pH,0.292241735,BP
-303,0.165494907,87,GO:0035113,embryonic appendage morphogenesis,0.293514324,BP
326,0.165668746,75,GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,0.293590183,BP
269,0.165923951,111,GO:0030239,myofibril assembly,0.29381,BP
151,0.166437544,363,GO:0042060,wound healing,0.29448665,BP
132,0.166670129,483,GO:1901292,nucleoside phosphate catabolic process,0.294665422,BP
-343,0.168120099,67,GO:0030879,mammary gland development,0.296958329,BP
-343,0.168232196,67,GO:0006937,regulation of muscle contraction,0.296958329,BP
-273,0.168948352,106,GO:0009566,fertilization,0.297987645,BP
-510,0.16940919,30,GO:0060428,lung epithelium development,0.29856537,BP
493,0.169825564,32,GO:0043487,regulation of RNA stability,0.299063886,BP
115,0.170244313,643,GO:0010628,positive regulation of gene expression,0.299565798,BP
-373,0.170432184,56,GO:0006733,oxidoreduction coenzyme metabolic process,0.299660982,BP
-210,0.171704743,179,GO:0003013,circulatory system process,0.301661666,BP
288,0.172239975,94,GO:0046916,cellular transition metal ion homeostasis,0.302364847,BP
-261,0.1737602,114,GO:0005996,monosaccharide metabolic process,0.304468109,BP
-380,0.173764466,53,GO:0015698,inorganic anion transport,0.304468109,BP
264,0.173845853,111,GO:0034599,cellular response to oxidative stress,0.304468109,BP
308,0.174000732,81,GO:0010970;GO:0099111,transport along microtubule,0.304501281,BP
-314,0.174276293,78,GO:0007338,single fertilization,0.30474543,BP
228,0.175293446,149,GO:0051272,positive regulation of cellular component movement,0.30628496,BP
375,0.175710228,54,GO:0042551,neuron maturation,0.306773898,BP
382,0.176543377,52,GO:0060191,regulation of lipase activity,0.307988445,BP
314,0.17733366,77,GO:0050920,regulation of chemotaxis,0.308944363,BP
-231,0.177597191,143,GO:0010638,positive regulation of organelle organization,0.308944363,BP
-409,0.177707675,45,GO:0019218,regulation of steroid metabolic process,0.308944363,BP
-367,0.177765901,56,GO:0034401,chromatin organization involved in regulation of transcription,0.308944363,BP
124,0.177837207,523,GO:0009141,nucleoside triphosphate metabolic process,0.308944363,BP
-236,0.177918852,137,GO:0045168,cell-cell signaling involved in cell fate commitment,0.308944363,BP
-145,0.178294633,373,GO:0007346,regulation of mitotic cell cycle,0.309225278,BP
404,0.17848744,46,GO:0035011,melanotic encapsulation of foreign target,0.309225278,BP
-309,0.17849477,79,GO:0061351,neural precursor cell proliferation,0.309225278,BP
251,0.17942907,120,GO:1902903,regulation of supramolecular fiber organization,0.310603645,BP
425,0.180521375,41,GO:0060027,convergent extension involved in gastrulation,0.312191198,BP
-454,0.180642259,36,GO:0010464,regulation of mesenchymal cell proliferation,0.312191198,BP
364,0.180764279,56,GO:0032271,regulation of protein polymerization,0.312191198,BP
108,0.181025406,694,GO:0031328,positive regulation of cellular biosynthetic process,0.312401317,BP
305,0.181409548,80,GO:0071241,cellular response to inorganic substance,0.312823238,BP
414,0.181613566,43,GO:0030833,regulation of actin filament polymerization,0.312934144,BP
240,0.182207068,130,GO:0050768,negative regulation of neurogenesis,0.313568991,BP
458,0.182261976,35,GO:0060047,heart contraction,0.313568991,BP
388,0.182431183,49,GO:0060446,branching involved in open tracheal system development,0.313619225,BP
-413,0.182973395,43,GO:0018208,peptidyl-proline modification,0.314293498,BP
-494,0.183104024,30,GO:0002244,hematopoietic progenitor cell differentiation,0.314293498,BP
-116,0.184158667,585,GO:0070271,obsolete protein complex biogenesis,0.315705608,BP
378,0.184288011,51,GO:0048859,formation of anatomical boundary,0.315705608,BP
-407,0.184482135,44,GO:0000079;GO:1904029,regulation of cyclin-dependent protein serine/threonine kinase activity,0.315705608,BP
-403,0.184490465,45,GO:0003014,renal system process,0.315705608,BP
421,0.184908483,41,GO:0140253,cell-cell fusion,0.316179391,BP
-482,0.186406389,31,GO:0009156,ribonucleoside monophosphate biosynthetic process,0.318348384,BP
369,0.186461197,53,GO:0051341,regulation of oxidoreductase activity,0.318348384,BP
-285,0.189666675,88,GO:0007617,mating behavior,0.323415819,BP
-487,0.18971803,30,GO:0045685,regulation of glial cell differentiation,0.323415819,BP
438,0.190177523,37,GO:0003015,heart process,0.323952587,BP
152,0.191519827,320,GO:0051146,striated muscle cell differentiation,0.325991195,BP
-309,0.195561221,73,GO:0072073,kidney epithelium development,0.332617414,BP
-358,0.195779409,54,GO:0030510,regulation of BMP signaling pathway,0.33273587,BP
-421,0.196043169,39,GO:0060415,muscle tissue morphogenesis,0.332931538,BP
138,0.196453813,379,GO:0030855,epithelial cell differentiation,0.333185759,BP
464,0.196490351,32,GO:0040040,thermosensory behavior,0.333185759,BP
120,0.196836682,517,GO:0048477,oogenesis,0.333520551,BP
-471,0.19746582,31,GO:0006383,transcription by RNA polymerase III,0.334333664,BP
236,0.197795192,125,GO:0072175,epithelial tube formation,0.334638391,BP
419,0.198270405,39,GO:0006941,striated muscle contraction,0.334839587,BP
-297,0.198322359,78,GO:0016573,histone acetylation,0.334839587,BP
-146,0.198362559,336,GO:0009123,nucleoside monophosphate metabolic process,0.334839587,BP
142,0.198672408,357,GO:0002520,immune system development,0.335110086,BP
143,0.199540411,346,GO:0008284,positive regulation of cell population proliferation,0.336320934,BP
-224,0.199893967,137,GO:0009410,response to xenobiotic stimulus,0.336663524,BP
474,0.201299408,30,GO:0046843,dorsal appendage formation,0.338775863,BP
-179,0.201586437,215,GO:0043010,camera-type eye development,0.339004219,BP
-432,0.202711055,36,GO:0051155,positive regulation of striated muscle cell differentiation,0.340639732,BP
-465,0.202951856,31,GO:0045446,endothelial cell differentiation,0.340788724,BP
-400,0.203166306,42,GO:0031111,negative regulation of microtubule polymerization or depolymerization,0.340893278,BP
305,0.204388815,72,GO:0048512,circadian behavior,0.342438809,BP
-442,0.204473194,34,GO:0002053,positive regulation of mesenchymal cell proliferation,0.342438809,BP
381,0.204546039,46,GO:0045747,positive regulation of Notch signaling pathway,0.342438809,BP
-365,0.205156034,50,GO:1901879,regulation of protein depolymerization,0.343203521,BP
221,0.206066381,137,GO:1904951,positive regulation of establishment of protein localization,0.344362592,BP
417,0.206156355,38,GO:0043954,cellular component maintenance,0.344362592,BP
469,0.206630658,30,GO:0062014,negative regulation of small molecule metabolic process,0.344816288,BP
168,0.206735837,240,GO:0006873,cellular ion homeostasis,0.344816288,BP
-447,0.207023596,33,GO:0042441;GO:0043324;GO:0043474,pigment metabolic process involved in developmental pigmentation,0.345039326,BP
250,0.208041192,106,GO:0018958,phenol-containing compound metabolic process,0.346477524,BP
101,0.20843214,716,GO:0009891,positive regulation of biosynthetic process,0.346870724,BP
189,0.208992874,187,GO:0043588,skin development,0.347545685,BP
-237,0.209241514,117,GO:0048705,skeletal system morphogenesis,0.347701033,BP
272,0.211123682,88,GO:0006959,humoral immune response,0.350568604,BP
294,0.214777398,74,GO:0007622,rhythmic behavior,0.356371387,BP
326,0.215086089,60,GO:0010634,positive regulation of epithelial cell migration,0.356619423,BP
136,0.216242106,358,GO:0002165,instar larval or pupal development,0.358270945,BP
-346,0.216503869,53,GO:0009755,hormone-mediated signaling pathway,0.358439517,BP
328,0.216726157,59,GO:0042051,compound eye photoreceptor development,0.358542535,BP
-296,0.217446498,72,GO:0007034,vacuolar transport,0.359468749,BP
-423,0.218923415,35,GO:0043966,histone H3 acetylation,0.3616434,BP
234,0.21937455,115,GO:0042306;GO:1904589,regulation of protein import,0.362071692,BP
115,0.219644247,503,GO:0046434,organophosphate catabolic process,0.362071692,BP
-441,0.219667602,32,GO:0042632,cholesterol homeostasis,0.362071692,BP
219,0.219952097,132,GO:0019216,regulation of lipid metabolic process,0.362122764,BP
268,0.220021912,87,GO:0007635,chemosensory behavior,0.362122764,BP
415,0.220476498,36,GO:0060811;GO:0060810,intracellular mRNA localization involved in anterior/posterior axis specification,0.36260452,BP
433,0.220844395,33,GO:0030183,B cell differentiation,0.362943099,BP
-427,0.221275991,34,GO:0045138,nematode male tail tip morphogenesis,0.363385791,BP
359,0.221640271,48,GO:0050864,regulation of B cell activation,0.363717368,BP
-201,0.22180612,156,GO:0008015,blood circulation,0.363723066,BP
425,0.222751796,34,GO:0048070,regulation of developmental pigmentation,0.365006601,BP
275,0.22310859,82,GO:0010952,positive regulation of peptidase activity,0.365324007,BP
-325,0.224112448,58,GO:0016125,sterol metabolic process,0.366699696,BP
-273,0.225028362,82,GO:0046683,response to organophosphorus,0.367929585,BP
-313,0.22571217,62,GO:0006479;GO:0008213,protein methylation,0.368778454,BP
140,0.227218154,321,GO:0019098,reproductive behavior,0.370706206,BP
-115,0.227223045,492,GO:0033043,regulation of organelle organization,0.370706206,BP
201,0.227560826,152,GO:0021915,neural tube development,0.37096018,BP
-344,0.227737222,51,GO:0019395,fatty acid oxidation,0.37096018,BP
427,0.228064072,33,GO:1903305,regulation of regulated secretory pathway,0.37096018,BP
109,0.228118155,548,GO:0007292,female gamete generation,0.37096018,BP
99,0.228206754,680,GO:0007417,central nervous system development,0.37096018,BP
226,0.228841549,119,GO:0055074,calcium ion homeostasis,0.371722313,BP
-392,0.229107859,39,GO:0001824,blastocyst development,0.37188522,BP
344,0.231678048,50,GO:0007028,cytoplasm organization,0.375784814,BP
422,0.233655619,33,GO:0007316;GO:0019094,pole plasm mRNA localization,0.378718224,BP
345,0.234974085,49,GO:0006024,glycosaminoglycan biosynthetic process,0.380579862,BP
-183,0.235426585,178,GO:0051325,interphase,0.381037247,BP
-309,0.236048604,61,GO:0051054,positive regulation of DNA metabolic process,0.38176814,BP
256,0.237031221,89,GO:0072089,stem cell proliferation,0.383080761,BP
115,0.23814674,465,GO:1901658,glycosyl compound catabolic process,0.384606126,BP
379,0.238749319,40,GO:0000768,syncytium formation by plasma membrane fusion,0.385301494,BP
279,0.239661242,74,GO:0097237,cellular response to toxic substance,0.386300152,BP
-179,0.239837152,182,GO:0050954,sensory perception of mechanical stimulus,0.386300152,BP
154,0.240008282,249,GO:0055002,striated muscle cell development,0.386300152,BP
332,0.240057952,52,GO:0070646,protein modification by small protein removal,0.386300152,BP
-422,0.240693621,32,GO:0030509,BMP signaling pathway,0.387045018,BP
147,0.240977938,273,GO:0097435,supramolecular fiber organization,0.387224233,BP
173,0.241372536,193,GO:0036293,response to decreased oxygen levels,0.387580272,BP
-110,0.241726611,502,GO:0048806,genitalia development,0.387736551,BP
421,0.241816054,32,GO:0051646,mitochondrion localization,0.387736551,BP
244,0.242095001,96,GO:0046661,male sex differentiation,0.387906153,BP
289,0.242375279,68,GO:0061136,regulation of proteasomal protein catabolic process,0.388015512,BP
427,0.242509695,31,GO:2000117,negative regulation of cysteine-type endopeptidase activity,0.388015512,BP
317,0.244484973,56,GO:0035010,encapsulation of foreign target,0.390523569,BP
-239,0.244542387,99,GO:0030902,hindbrain development,0.390523569,BP
400,0.244600253,35,GO:0045669,positive regulation of osteoblast differentiation,0.390523569,BP
405,0.245462789,34,GO:0030539,male genitalia development,0.391621544,BP
-191,0.245810404,156,GO:0016458,gene silencing,0.391897014,BP
-387,0.246495555,37,GO:0035046,pronuclear migration,0.392709846,BP
355,0.246931176,44,GO:0030866,cortical actin cytoskeleton organization,0.39312426,BP
429,0.247978802,30,GO:0045451,pole plasm oskar mRNA localization,0.394343656,BP
-254,0.248049201,86,GO:0035051,cardiocyte differentiation,0.394343656,BP
-396,0.248962961,35,GO:0042446,hormone biosynthetic process,0.395515626,BP
322,0.250078002,53,GO:0017157,regulation of exocytosis,0.396842155,BP
204,0.250204217,133,GO:0040028,regulation of vulval development,0.396842155,BP
96,0.250329449,648,GO:0010557,positive regulation of macromolecule biosynthetic process,0.396842155,BP
-259,0.250635004,82,GO:0048663,neuron fate commitment,0.396875439,BP
-177,0.250704797,177,GO:0001822,kidney development,0.396875439,BP
-339,0.25352208,47,GO:1901880;GO:0043242,negative regulation of protein depolymerization,0.401050973,BP
-251,0.253700548,86,GO:0009260,ribonucleotide biosynthetic process,0.401050973,BP
-338,0.254754057,47,GO:0032409,regulation of transporter activity,0.402432361,BP
357,0.25503003,42,GO:0021987,cerebral cortex development,0.402584403,BP
110,0.255253669,476,GO:0009725,response to hormone,0.402653676,BP
-370,0.256352668,39,GO:0050810,regulation of steroid biosynthetic process,0.404102727,BP
-343,0.257648249,45,GO:0048644,muscle organ morphogenesis,0.405859408,BP
162,0.258049849,206,GO:0070482,response to oxygen levels,0.406034647,BP
196,0.258122025,140,GO:0061062,regulation of nematode larval development,0.406034647,BP
-325,0.258684812,50,GO:0060326,cell chemotaxis,0.406426468,BP
144,0.258733993,264,GO:0055080,cation homeostasis,0.406426468,BP
363,0.259217003,40,GO:0061013,regulation of mRNA catabolic process,0.406899851,BP
419,0.259420967,30,GO:2001235,positive regulation of apoptotic signaling pathway,0.40693485,BP
214,0.259979896,116,GO:1900180,regulation of protein localization to nucleus,0.407359625,BP
-405,0.260055475,32,GO:0015886,heme transport,0.407359625,BP
357,0.260842409,41,GO:0010595,positive regulation of endothelial cell migration,0.408301003,BP
386,0.261239919,35,GO:0060581,cell fate commitment involved in pattern specification,0.408301003,BP
234,0.261307106,96,GO:0009913,epidermal cell differentiation,0.408301003,BP
-398,0.261385553,33,GO:0030518,intracellular steroid hormone receptor signaling pathway,0.408301003,BP
-199,0.261635639,133,GO:0043473,pigmentation,0.40840685,BP
-361,0.262265843,40,GO:0042953;GO:0044872,lipoprotein transport,0.409105493,BP
-148,0.263287097,243,GO:0009416,response to light stimulus,0.410412734,BP
415,0.263751607,30,GO:0061077,chaperone-mediated protein folding,0.410850904,BP
389,0.264997963,34,GO:0042220,response to cocaine,0.412238075,BP
378,0.265010191,36,GO:0034606;GO:0034608,response to hermaphrodite contact,0.412238075,BP
224,0.265422592,103,GO:2000116,regulation of cysteine-type endopeptidase activity,0.412593065,BP
89,0.266757255,721,GO:0035239,tube morphogenesis,0.414380203,BP
-361,0.268383652,39,GO:0032412,regulation of ion transmembrane transporter activity,0.416430419,BP
352,0.268448895,41,GO:0045778,positive regulation of ossification,0.416430419,BP
-298,0.268906259,57,GO:0030856,regulation of epithelial cell differentiation,0.41681367,BP
-397,0.269107128,32,GO:0042398,cellular modified amino acid biosynthetic process,0.41681367,BP
-369,0.269254187,37,GO:0007026,negative regulation of microtubule depolymerization,0.41681367,BP
132,0.269981402,299,GO:0045596,negative regulation of cell differentiation,0.417650788,BP
175,0.270217959,168,GO:0018991,oviposition,0.417728245,BP
-373,0.270774001,36,GO:0055092,sterol homeostasis,0.418299146,BP
-248,0.271135272,82,GO:0018393;GO:0018394,peptidyl-lysine acetylation,0.41856858,BP
121,0.271898878,357,GO:0007444,imaginal disc development,0.419458324,BP
282,0.272261028,63,GO:0060026,convergent extension,0.41949825,BP
-170,0.27229931,177,GO:0051329,mitotic interphase,0.41949825,BP
-315,0.273175436,50,GO:0009914,hormone transport,0.420558746,BP
-315,0.274341004,50,GO:0060348,bone development,0.421688224,BP
181,0.27435364,153,GO:0000077,DNA damage checkpoint,0.421688224,BP
343,0.274473853,42,GO:0033339,pectoral fin development,0.421688224,BP
-317,0.275695891,49,GO:2000648,positive regulation of stem cell proliferation,0.423058774,BP
-392,0.275901457,32,GO:0044070,regulation of anion transport,0.423058774,BP
-338,0.275932531,43,GO:0007365,periodic partitioning,0.423058774,BP
374,0.27628087,35,GO:0007585,respiratory gaseous exchange,0.423303112,BP
86,0.276790957,728,GO:0042592,homeostatic process,0.423794766,BP
-98,0.279358504,542,GO:0034220,ion transmembrane transport,0.427433776,BP
348,0.279615683,40,GO:0007270,neuron-neuron synaptic transmission,0.427535242,BP
-231,0.27985639,91,GO:0070507,regulation of microtubule cytoskeleton organization,0.427611401,BP
376,0.280334961,34,GO:0002042,cell migration involved in sprouting angiogenesis,0.428050656,BP
293,0.281923059,56,GO:0097306,cellular response to alcohol,0.42994859,BP
-375,0.281961821,34,GO:0034644,cellular response to UV,0.42994859,BP
337,0.282664541,42,GO:0001938,positive regulation of endothelial cell proliferation,0.430538905,BP
117,0.282733361,369,GO:0019725,cellular homeostasis,0.430538905,BP
-386,0.28300766,32,GO:0006726,eye pigment biosynthetic process,0.430663831,BP
332,0.284361356,43,GO:0002922,positive regulation of humoral immune response,0.432430032,BP
198,0.285773963,122,GO:0030099,myeloid cell differentiation,0.434283363,BP
366,0.286466465,35,GO:0030316,osteoclast differentiation,0.435040598,BP
241,0.290852562,80,GO:0048742,regulation of skeletal muscle fiber development,0.441402263,BP
150,0.291363278,211,GO:0009612,response to mechanical stimulus,0.441877957,BP
177,0.291667024,150,GO:0006486;GO:0043413,protein glycosylation,0.442039333,BP
357,0.292110921,36,GO:0008542,visual learning,0.442065515,BP
156,0.292306869,192,GO:0001666,response to hypoxia,0.442065515,BP
250,0.292394291,74,GO:0051298,centrosome duplication,0.442065515,BP
378,0.292473702,32,GO:0042451;GO:0046129,purine ribonucleoside biosynthetic process,0.442065515,BP
191,0.293841404,126,GO:0046822,regulation of nucleocytoplasmic transport,0.443833273,BP
-217,0.294361573,97,GO:0010001,glial cell differentiation,0.444319356,BP
299,0.295041256,51,GO:0042129,regulation of T cell proliferation,0.445045397,BP
-382,0.295435311,31,GO:0090184,positive regulation of kidney development,0.445119115,BP
376,0.295487555,32,GO:0008586,imaginal disc-derived wing vein morphogenesis,0.445119115,BP
198,0.295998514,117,GO:0019221,cytokine-mediated signaling pathway,0.445589161,BP
199,0.297051431,115,GO:0043254,regulation of protein complex assembly,0.446873879,BP
291,0.297470282,53,GO:0042698,ovulation cycle,0.447203646,BP
-254,0.297866734,70,GO:0060322,head development,0.447499318,BP
-337,0.300969113,39,GO:0031114,regulation of microtubule depolymerization,0.451644159,BP
182,0.301028897,135,GO:0001709,cell fate determination,0.451644159,BP
-249,0.303285229,71,GO:0007224,smoothened signaling pathway,0.454724842,BP
-136,0.304262615,242,GO:0001701,in utero embryonic development,0.455885123,BP
168,0.305087593,156,GO:0070085,glycosylation,0.456815648,BP
-363,0.305539954,33,GO:0005976,polysaccharide metabolic process,0.457187372,BP
126,0.306295681,283,GO:0014706,striated muscle tissue development,0.458012233,BP
-361,0.307289293,33,GO:0006378;GO:0043631,mRNA polyadenylation,0.459191472,BP
-288,0.307778921,52,GO:0021782,glial cell development,0.459321228,BP
379,0.307786233,30,GO:0043052,thermotaxis,0.459321228,BP
134,0.308137689,248,GO:0060538,skeletal muscle organ development,0.459539564,BP
-306,0.308619792,46,GO:0046686,response to cadmium ion,0.459952318,BP
335,0.309778633,38,GO:0006906,vesicle fusion,0.461372432,BP
242,0.311040947,73,GO:0071688,striated muscle myosin thick filament assembly,0.462944665,BP
83,0.312106475,673,GO:0007281,germ cell development,0.464222114,BP
110,0.312590598,364,GO:0042692,muscle cell differentiation,0.464633669,BP
320,0.313216953,41,GO:0002807;GO:0002225;GO:0002760,positive regulation of antimicrobial peptide biosynthetic process,0.464968739,BP
-204,0.313231173,102,GO:0001508,action potential,0.464968739,BP
-142,0.315272749,213,GO:0006066,alcohol metabolic process,0.467228746,BP
-258,0.315303445,63,GO:0072091,regulation of stem cell proliferation,0.467228746,BP
93,0.315379403,520,GO:0034404,nucleobase-containing small molecule biosynthetic process,0.467228746,BP
319,0.316115832,41,GO:0043407,negative regulation of MAP kinase activity,0.467639886,BP
-128,0.31624297,264,GO:0010817,regulation of hormone levels,0.467639886,BP
145,0.316387018,201,GO:0007519,skeletal muscle tissue development,0.467639886,BP
-335,0.316626638,37,GO:0007412,axon target recognition,0.467639886,BP
-237,0.316700762,74,GO:0006665,sphingolipid metabolic process,0.467639886,BP
101,0.317115988,428,GO:0045165,cell fate commitment,0.467944542,BP
-238,0.317708826,73,GO:0007565,female pregnancy,0.468510712,BP
86,0.318407244,612,GO:0006163,purine nucleotide metabolic process,0.468945984,BP
325,0.318422697,39,GO:0007520,myoblast fusion,0.468945984,BP
124,0.321418117,273,GO:0098771,inorganic ion homeostasis,0.473046374,BP
-335,0.3226634,36,GO:0034767,positive regulation of ion transmembrane transport,0.474256399,BP
-220,0.322772767,84,GO:0006914;GO:0061919,autophagy,0.474256399,BP
-127,0.32287545,259,GO:0001655,urogenital system development,0.474256399,BP
-366,0.323842031,30,GO:0045621,positive regulation of lymphocyte differentiation,0.474946463,BP
-293,0.32399948,47,GO:0003231,cardiac ventricle development,0.474946463,BP
259,0.32400697,60,GO:0002573,myeloid leukocyte differentiation,0.474946463,BP
281,0.324193367,51,GO:0007492,endoderm development,0.474946463,BP
147,0.325094837,190,GO:0007005,mitochondrion organization,0.475955839,BP
-320,0.325812167,39,GO:0035215,genital disc development,0.476423901,BP
-97,0.325839918,448,GO:0040035,hermaphrodite genitalia development,0.476423901,BP
111,0.326978017,338,GO:0009886,post-embryonic animal morphogenesis,0.477776097,BP
92,0.327427208,504,GO:0009611,response to wounding,0.478118204,BP
151,0.327639037,177,GO:0050804;GO:0099177,modulation of chemical synaptic transmission,0.478118204,BP
-296,0.328429113,45,GO:0060993,kidney morphogenesis,0.478959124,BP
-254,0.329304675,61,GO:0042737,drug catabolic process,0.47965364,BP
310,0.329607829,41,GO:0007315,pole plasm assembly,0.47965364,BP
185,0.329744693,116,GO:0006874,cellular calcium ion homeostasis,0.47965364,BP
155,0.329761877,167,GO:0050795,regulation of behavior,0.47965364,BP
309,0.330259476,41,GO:0006949,syncytium formation,0.480065689,BP
96,0.332424046,451,GO:0043603,cellular amide metabolic process,0.482898744,BP
254,0.334559008,60,GO:0008016,regulation of heart contraction,0.485685145,BP
186,0.335786357,112,GO:0051251,positive regulation of lymphocyte activation,0.487151191,BP
-269,0.336458819,53,GO:0010827,regulation of glucose transmembrane transport,0.487810845,BP
-219,0.336824023,80,GO:0090257,regulation of muscle system process,0.488024458,BP
350,0.337137111,31,GO:0019217,regulation of fatty acid metabolic process,0.488162333,BP
312,0.338600083,39,GO:0002786;GO:0002808;GO:0006963;GO:0002803;GO:1900426,regulation of antibacterial peptide biosynthetic process,0.489963944,BP
131,0.338966224,228,GO:0002066,columnar/cuboidal epithelial cell development,0.49017711,BP
182,0.340816962,114,GO:0001751,compound eye photoreceptor cell differentiation,0.492535481,BP
140,0.342220264,196,GO:0015672,monovalent inorganic cation transport,0.494244611,BP
154,0.342847227,160,GO:0031570,DNA integrity checkpoint,0.494831049,BP
300,0.344530453,41,GO:0071684,organism emergence from protective structure,0.496940255,BP
-303,0.345815321,40,GO:0051971,positive regulation of transmission of nerve impulse,0.498472535,BP
109,0.346167817,324,GO:0048736,appendage development,0.49865975,BP
154,0.346893432,157,GO:1903827,regulation of cellular protein localization,0.499383861,BP
273,0.347692349,49,GO:0008347,glial cell migration,0.500212499,BP
306,0.348033453,39,GO:0046716,muscle cell cellular homeostasis,0.500381857,BP
219,0.351369929,75,GO:0042472,inner ear morphogenesis,0.504854805,BP
320,0.351860888,35,GO:0035316;GO:0035317,non-sensory hair organization,0.504998329,BP
-208,0.351920711,83,GO:0044272,sulfur compound biosynthetic process,0.504998329,BP
-199,0.352535257,91,GO:0031123,RNA 3'-end processing,0.505258306,BP
-123,0.352553006,243,GO:0072001,renal system development,0.505258306,BP
87,0.352997226,501,GO:0046128,purine ribonucleoside metabolic process,0.5055548,BP
-213,0.353211278,79,GO:0043270,positive regulation of ion transport,0.5055548,BP
-343,0.355208456,30,GO:0060688,regulation of morphogenesis of a branching structure,0.507927356,BP
-277,0.355463274,46,GO:0048524,positive regulation of viral process,0.507927356,BP
78,0.355642426,632,GO:0009890,negative regulation of biosynthetic process,0.507927356,BP
223,0.355775902,71,GO:0045807,positive regulation of endocytosis,0.507927356,BP
160,0.357028839,139,GO:0002521,leukocyte differentiation,0.509370246,BP
-289,0.35737528,42,GO:0006641,triglyceride metabolic process,0.509370246,BP
331,0.357468762,32,GO:0051193,regulation of cofactor metabolic process,0.509370246,BP
186,0.360390276,101,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.51320675,BP
85,0.360849745,508,GO:0061061,muscle structure development,0.513223085,BP
181,0.360859982,107,GO:0045471,response to ethanol,0.513223085,BP
123,0.361838199,233,GO:0055065,metal ion homeostasis,0.514111251,BP
-338,0.362056001,30,GO:0061035,regulation of cartilage development,0.514111251,BP
271,0.362173015,47,GO:0030865,cortical cytoskeleton organization,0.514111251,BP
-327,0.362787539,32,GO:0034968,histone lysine methylation,0.514248369,BP
222,0.362811009,70,GO:0071236,cellular response to antibiotic,0.514248369,BP
100,0.363085765,356,GO:0048568,embryonic organ development,0.514248369,BP
216,0.363187911,74,GO:0006006,glucose metabolic process,0.514248369,BP
224,0.364558234,68,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,0.515862567,BP
132,0.365055924,198,GO:0045787,positive regulation of cell cycle,0.5162407,BP
78,0.366697729,601,GO:0009150,purine ribonucleotide metabolic process,0.518235276,BP
138,0.367245004,179,GO:0008544,epidermis development,0.518681468,BP
-158,0.367636546,136,GO:0051705,multi-organism behavior,0.518907287,BP
-305,0.368367216,36,GO:0007474,imaginal disc-derived wing vein specification,0.519611187,BP
-304,0.369376808,36,GO:0018022,peptidyl-lysine methylation,0.520707394,BP
96,0.369762671,382,GO:0007507,heart development,0.520923511,BP
84,0.37005107,503,GO:0042278,purine nucleoside metabolic process,0.521002135,BP
-196,0.370807759,87,GO:0016072,rRNA metabolic process,0.521739561,BP
281,0.371374542,42,GO:0046928,regulation of neurotransmitter secretion,0.522209024,BP
173,0.371637474,111,GO:0007435,salivary gland morphogenesis,0.522250904,BP
257,0.372567663,50,GO:0042993,obsolete positive regulation of transcription factor import into nucleus,0.522952997,BP
-236,0.37260401,59,GO:0006406,mRNA export from nucleus,0.522952997,BP
153,0.372993871,143,GO:0050769,positive regulation of neurogenesis,0.523172368,BP
189,0.37331781,93,GO:0051168,nuclear export,0.523299057,BP
246,0.373765384,54,GO:0010594,regulation of endothelial cell migration,0.523598786,BP
-202,0.374985853,80,GO:0032355,response to estradiol,0.524952434,BP
-258,0.375200378,49,GO:0030537,larval behavior,0.524952434,BP
-281,0.375687961,41,GO:0022898,regulation of transmembrane transporter activity,0.525306513,BP
96,0.376147263,372,GO:0010171,body morphogenesis,0.52562063,BP
166,0.377407376,119,GO:0050867,positive regulation of cell activation,0.527052694,BP
-107,0.378029671,293,GO:0006397,mRNA processing,0.527592812,BP
-93,0.380981812,382,GO:0070925,organelle assembly,0.53113039,BP
263,0.381038632,46,GO:0022602,ovulation cycle process,0.53113039,BP
108,0.383262851,279,GO:0001944,vasculature development,0.533898498,BP
-291,0.38376197,37,GO:0021522,spinal cord motor neuron differentiation,0.534261537,BP
-312,0.38531888,32,GO:0021575,hindbrain morphogenesis,0.536095832,BP
-306,0.386868666,33,GO:0019229,regulation of vasoconstriction,0.537917947,BP
-99,0.387461347,327,GO:1901615,organic hydroxy compound metabolic process,0.538121375,BP
182,0.387524199,94,GO:0051236,establishment of RNA localization,0.538121375,BP
-301,0.387847993,34,GO:0034243,regulation of transcription elongation from RNA polymerase II promoter,0.538121375,BP
212,0.387975902,69,GO:0006970,response to osmotic stress,0.538121375,BP
109,0.388755387,266,GO:0001505,regulation of neurotransmitter levels,0.538868853,BP
145,0.390068597,148,GO:0030534,adult behavior,0.540354767,BP
-180,0.390435098,95,GO:0007618,mating,0.540528195,BP
170,0.390990015,107,GO:0045666,positive regulation of neuron differentiation,0.540962096,BP
-98,0.391413872,331,GO:0009161,ribonucleoside monophosphate metabolic process,0.541214243,BP
262,0.393882017,44,GO:0010172,embryonic body morphogenesis,0.544291004,BP
305,0.396217184,32,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,0.547180328,BP
-266,0.396838051,42,GO:0060113,inner ear receptor cell differentiation,0.547700082,BP
-90,0.397399469,388,GO:0030001,metal ion transport,0.547959586,BP
295,0.397515325,34,GO:1905207,regulation of cardiocyte differentiation,0.547959586,BP
-309,0.397811006,31,GO:0007589,body fluid secretion,0.548029922,BP
-156,0.398964073,122,GO:0097190,apoptotic signaling pathway,0.548775864,BP
82,0.39898876,462,GO:0001654,eye development,0.548775864,BP
-303,0.399190357,32,GO:0010332,response to gamma radiation,0.548775864,BP
157,0.399332437,120,GO:0035050,embryonic heart tube development,0.548775864,BP
-190,0.399806648,82,GO:0003143,embryonic heart tube morphogenesis,0.549090676,BP
-67,0.400576831,716,GO:0061458,reproductive system development,0.549811337,BP
-239,0.401047424,51,GO:0006638;GO:0006639,neutral lipid metabolic process,0.550105892,BP
175,0.401282601,96,GO:0045861,negative regulation of proteolysis,0.550105892,BP
-306,0.40213374,31,GO:0055008,cardiac muscle tissue morphogenesis,0.550935521,BP
235,0.405095347,52,GO:0006919;GO:0097202,activation of cysteine-type endopeptidase activity involved in apoptotic process,0.554653776,BP
71,0.405628476,623,GO:0031327,negative regulation of cellular biosynthetic process,0.555007994,BP
-258,0.406067968,43,GO:0021766,hippocampus development,0.555007994,BP
129,0.406097367,174,GO:0006836,neurotransmitter transport,0.555007994,BP
103,0.407494392,278,GO:1902850,microtubule cytoskeleton organization involved in mitosis,0.556489838,BP
177,0.407678493,91,GO:0001503,ossification,0.556489838,BP
302,0.408745913,31,GO:0007257,activation of JUN kinase activity,0.557607092,BP
306,0.409451252,30,GO:0030512;GO:1903845,negative regulation of transforming growth factor beta receptor signaling pathway,0.558229339,BP
145,0.411919817,135,GO:0042063,gliogenesis,0.561253278,BP
163,0.412481316,105,GO:0035690,cellular response to drug,0.561676685,BP
-304,0.412736942,30,GO:0009247,glycolipid biosynthetic process,0.561683323,BP
215,0.413492311,60,GO:0007349,cellularization,0.562369628,BP
277,0.414168199,36,GO:0014075,response to amine,0.562947066,BP
-153,0.414892549,119,GO:0021537,telencephalon development,0.563589636,BP
112,0.416254713,223,GO:0009798,axis specification,0.565097307,BP
-178,0.416857765,87,GO:0006475,internal protein amino acid acetylation,0.565573224,BP
-248,0.418954192,44,GO:0051928,positive regulation of calcium ion transport,0.568073481,BP
112,0.421018731,218,GO:0007596,blood coagulation,0.5705275,BP
194,0.422718552,71,GO:0070663,regulation of leukocyte proliferation,0.572484618,BP
-73,0.423249521,530,GO:0006812,cation transport,0.572857358,BP
193,0.424285397,71,GO:0043280;GO:2001056,positive regulation of cysteine-type endopeptidase activity,0.573692412,BP
176,0.424406139,86,GO:1903522,regulation of blood circulation,0.573692412,BP
-221,0.424646093,54,GO:0034440,lipid oxidation,0.573692412,BP
-87,0.425070412,367,GO:0033993,response to lipid,0.573692412,BP
-282,0.425147056,33,GO:0035019,somatic stem cell population maintenance,0.573692412,BP
155,0.426317112,110,GO:0031647,regulation of protein stability,0.574924944,BP
213,0.430401657,57,GO:0043542,endothelial cell migration,0.580084063,BP
-224,0.431104989,51,GO:0097746,regulation of blood vessel diameter,0.580682606,BP
274,0.431583817,34,GO:1903429,regulation of cell maturation,0.580978215,BP
72,0.432290618,535,GO:0051253,negative regulation of RNA metabolic process,0.58158017,BP
208,0.433059834,59,GO:0031638,zymogen activation,0.582265323,BP
230,0.433641699,48,GO:0033333,fin development,0.582697904,BP
-87,0.434909811,347,GO:0009991,response to extracellular stimulus,0.584051545,BP
-91,0.435595816,313,GO:0007283,spermatogenesis,0.584428085,BP
-207,0.43571201,59,GO:0007530,sex determination,0.584428085,BP
-271,0.436963657,34,GO:0090183,regulation of kidney development,0.585641294,BP
-91,0.437139394,315,GO:0048232,male gamete generation,0.585641294,BP
91,0.437427221,312,GO:0009952,anterior/posterior pattern specification,0.585676614,BP
175,0.438151177,82,GO:0010830,regulation of myotube differentiation,0.586295482,BP
-205,0.439059427,59,GO:1902904,negative regulation of supramolecular fiber organization,0.58716007,BP
-188,0.44005772,70,GO:0006364,rRNA processing,0.58814397,BP
-213,0.442799966,54,GO:0030217,T cell differentiation,0.591456126,BP
-227,0.444973487,47,GO:0046496;GO:0019362,nicotinamide nucleotide metabolic process,0.594005132,BP
-157,0.445649928,98,GO:0051216,cartilage development,0.594553805,BP
-233,0.446899056,44,GO:0001656,metanephros development,0.595865408,BP
173,0.447352655,80,GO:0008543,fibroblast growth factor receptor signaling pathway,0.596115376,BP
178,0.448655191,75,GO:0031033;GO:0031034,myosin filament organization,0.597495617,BP
-151,0.44922362,105,GO:0046331,lateral inhibition,0.597897154,BP
-277,0.455980865,30,GO:0002260,lymphocyte homeostasis,0.606530367,BP
-231,0.45722229,43,GO:0006368,transcription elongation from RNA polymerase II promoter,0.607820729,BP
-267,0.457556446,32,GO:0044264,cellular polysaccharide metabolic process,0.607904175,BP
141,0.458340916,116,GO:0002696,positive regulation of leukocyte activation,0.608585448,BP
-139,0.459661504,118,GO:0043687,post-translational protein modification,0.609977351,BP
-186,0.460692594,65,GO:0035296,regulation of tube diameter,0.610288846,BP
-92,0.461072149,272,GO:0060249,anatomical structure homeostasis,0.610288846,BP
121,0.461343443,155,GO:0016358,dendrite development,0.610288846,BP
-229,0.461386403,43,GO:0071805,potassium ion transmembrane transport,0.610288846,BP
199,0.461699541,57,GO:1903034,regulation of response to wounding,0.610288846,BP
-158,0.461802169,90,GO:0006473,protein acetylation,0.610288846,BP
260,0.462034679,33,GO:0048854,brain morphogenesis,0.610288846,BP
176,0.462075841,73,GO:1905330,regulation of morphogenesis of an epithelium,0.610288846,BP
187,0.462826185,64,GO:0007179,transforming growth factor beta receptor signaling pathway,0.610808526,BP
-167,0.463014677,80,GO:0009152,purine ribonucleotide biosynthetic process,0.610808526,BP
127,0.464972489,139,GO:2000027,regulation of animal organ morphogenesis,0.612945468,BP
147,0.465361815,103,GO:0008344,adult locomotory behavior,0.612945468,BP
-195,0.465455465,58,GO:0016051,carbohydrate biosynthetic process,0.612945468,BP
-72,0.466161974,451,GO:0014070,response to organic cyclic compound,0.613515172,BP
68,0.467245448,509,GO:0009119,ribonucleoside metabolic process,0.614580038,BP
90,0.468839362,277,GO:0051129,negative regulation of cellular component organization,0.616314654,BP
183,0.469740628,65,GO:0034614,cellular response to reactive oxygen species,0.616882006,BP
256,0.469821742,33,GO:0035188,hatching,0.616882006,BP
180,0.47018483,67,GO:0050900,leukocyte migration,0.616997082,BP
195,0.470685424,57,GO:0046467,membrane lipid biosynthetic process,0.617175611,BP
-101,0.470871928,215,GO:0048863,stem cell differentiation,0.617175611,BP
100,0.471709123,222,GO:0035114,imaginal disc-derived appendage morphogenesis,0.617758373,BP
234,0.471868115,39,GO:0007602,phototransduction,0.617758373,BP
176,0.472573432,69,GO:0009306,protein secretion,0.618032059,BP
99,0.472679506,224,GO:0048737,imaginal disc-derived appendage development,0.618032059,BP
-181,0.473030898,65,GO:0003205,cardiac chamber development,0.618032059,BP
101,0.473180795,216,GO:0009880,embryonic pattern specification,0.618032059,BP
-210,0.47399217,48,GO:0043112,receptor metabolic process,0.618731038,BP
-210,0.474477294,48,GO:0030218,erythrocyte differentiation,0.618894965,BP
103,0.474670335,204,GO:0030031,cell projection assembly,0.618894965,BP
246,0.475002819,35,GO:0051607,defense response to virus,0.618968188,BP
182,0.475943072,64,GO:0001703,gastrulation with mouth forming first,0.619832838,BP
256,0.476222676,32,GO:0009225,nucleotide-sugar metabolic process,0.619836603,BP
180,0.476714265,65,GO:0008582;GO:1904396,regulation of neuromuscular junction development,0.620116117,BP
-225,0.479405449,41,GO:0055025,positive regulation of cardiac muscle tissue development,0.623254908,BP
-157,0.48195552,83,GO:0061371,determination of heart left/right asymmetry,0.626206708,BP
-238,0.482273561,36,GO:0014032,neural crest cell development,0.626256682,BP
-212,0.484534387,45,GO:0042246,tissue regeneration,0.628827941,BP
-207,0.485572561,47,GO:0009163;GO:1901659,glycosyl compound biosynthetic process,0.629810386,BP
-147,0.486622735,93,GO:0035150,regulation of tube size,0.630546028,BP
-176,0.486702715,65,GO:0048284,organelle fusion,0.630546028,BP
153,0.488476873,85,GO:0030098,lymphocyte differentiation,0.632478726,BP
-159,0.488778074,79,GO:0040039,inductive cell migration,0.632503111,BP
121,0.48927689,138,GO:0051147,regulation of muscle cell differentiation,0.632783045,BP
195,0.49026293,52,GO:0002040,sprouting angiogenesis,0.632976405,BP
-209,0.490266012,45,GO:0040019,positive regulation of embryonic development,0.632976405,BP
77,0.490274135,352,GO:0048569,post-embryonic animal organ development,0.632976405,BP
-82,0.492991728,299,GO:0010876,lipid localization,0.636118359,BP
-254,0.493941642,30,GO:0008407,chaeta morphogenesis,0.636627054,BP
-232,0.493954384,36,GO:0060135,maternal process involved in female pregnancy,0.636627054,BP
-151,0.495664143,85,GO:0040020,regulation of meiotic nuclear division,0.638101793,BP
94,0.495879821,225,GO:0055123,digestive system development,0.638101793,BP
164,0.495953224,72,GO:0017156,calcium ion regulated exocytosis,0.638101793,BP
75,0.497646329,357,GO:0033365,protein localization to organelle,0.639694077,BP
206,0.497761954,45,GO:0010923,negative regulation of phosphatase activity,0.639694077,BP
217,0.499730587,40,GO:0060795,cell fate commitment involved in formation of primary germ layer,0.641556829,BP
-56,0.499784226,663,GO:0044282,small molecule catabolic process,0.641556829,BP
190,0.500461025,52,GO:0002759,regulation of antimicrobial humoral response,0.642057673,BP
127,0.501132163,117,GO:0042440,pigment metabolic process,0.642550684,BP
-199,0.501694832,47,GO:0046552,photoreceptor cell fate commitment,0.642904132,BP
58,0.502815584,608,GO:0009259,ribonucleotide metabolic process,0.643971931,BP
240,0.503788434,32,GO:0030431,sleep,0.644849196,BP
-77,0.504232617,326,GO:0009126;GO:0009167,purine nucleoside monophosphate metabolic process,0.644890198,BP
188,0.504396262,52,GO:0060033,anatomical structure regression,0.644890198,BP
-103,0.504804483,177,GO:0034762,regulation of transmembrane transport,0.645043948,BP
117,0.506520692,135,GO:0007498,mesoderm development,0.64686793,BP
-180,0.508686026,56,GO:0090598,male anatomical structure morphogenesis,0.648922005,BP
131,0.509042758,106,GO:0071214;GO:0104004,cellular response to abiotic stimulus,0.648922005,BP
141,0.509176388,91,GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",0.648922005,BP
194,0.509287895,48,GO:0003206,cardiac chamber morphogenesis,0.648922005,BP
-179,0.510894479,56,GO:0050806,positive regulation of synaptic transmission,0.650297646,BP
-164,0.51094815,67,GO:0043200,response to amino acid,0.650297646,BP
166,0.511627253,65,GO:0042475,odontogenesis of dentin-containing tooth,0.65079219,BP
171,0.51248598,61,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,0.651514527,BP
-87,0.513159075,239,GO:0048514,blood vessel morphogenesis,0.652000185,BP
176,0.514108518,57,GO:0040001,establishment of mitotic spindle localization,0.652522755,BP
124,0.514152975,115,GO:0030010,establishment of cell polarity,0.652522755,BP
159,0.514824566,70,GO:0002790,peptide secretion,0.653005112,BP
98,0.51687804,186,GO:0051962,positive regulation of nervous system development,0.655238715,BP
-62,0.517904615,474,GO:0000226,microtubule cytoskeleton organization,0.656084186,BP
165,0.51813077,64,GO:0030177,positive regulation of Wnt signaling pathway,0.656084186,BP
-181,0.522126336,52,GO:0031110,regulation of microtubule polymerization or depolymerization,0.660770053,BP
-72,0.523099101,342,GO:0031667,response to nutrient levels,0.661627321,BP
85,0.525993344,238,GO:0046677,response to antibiotic,0.664912579,BP
-128,0.52865779,101,GO:0035270,endocrine system development,0.667903807,BP
105,0.529980254,150,GO:0070588,calcium ion transmembrane transport,0.668905512,BP
213,0.530047895,36,GO:0046662,regulation of oviposition,0.668905512,BP
-107,0.531143577,144,GO:0048634,regulation of muscle organ development,0.669910818,BP
-175,0.531943104,53,GO:0001895,retina homeostasis,0.670293495,BP
-109,0.532278034,138,GO:0044782,cilium organization,0.670293495,BP
175,0.5323447,53,GO:0008277,regulation of G protein-coupled receptor signaling pathway,0.670293495,BP
143,0.533192646,79,GO:0006879,cellular iron ion homeostasis,0.670984004,BP
-220,0.533805307,33,GO:0001578,microtubule bundle formation,0.671377815,BP
104,0.53469981,149,GO:0048580,regulation of post-embryonic development,0.671889823,BP
179,0.534812301,50,GO:0055007,cardiac muscle cell differentiation,0.671889823,BP
-230,0.535192419,30,GO:0008293,torso signaling pathway,0.671990481,BP
110,0.5367746,133,GO:0045995,regulation of embryonic development,0.673599499,BP
-187,0.537110319,45,GO:0031290,retinal ganglion cell axon guidance,0.673643401,BP
91,0.538505604,194,GO:0070838;GO:0072511,divalent metal ion transport,0.675015419,BP
53,0.539057093,607,GO:0010558,negative regulation of macromolecule biosynthetic process,0.675328796,BP
-160,0.539707502,61,GO:0007442;GO:0061525,hindgut morphogenesis,0.675765681,BP
180,0.540231084,48,GO:0051588,regulation of neurotransmitter transport,0.67593923,BP
190,0.540449625,43,GO:0045619,regulation of lymphocyte differentiation,0.67593923,BP
102,0.540788751,151,GO:0016049,cell growth,0.675985939,BP
155,0.544995417,63,GO:0048645,animal organ formation,0.68069768,BP
192,0.545165909,41,GO:0045580,regulation of T cell differentiation,0.68069768,BP
-199,0.546660384,38,GO:0048709,oligodendrocyte differentiation,0.682183432,BP
83,0.547127456,221,GO:0050817,coagulation,0.682186011,BP
-191,0.547271545,41,GO:0050673,epithelial cell proliferation,0.682186011,BP
-48,0.547900644,702,GO:0055085,transmembrane transport,0.682590347,BP
70,0.550872143,309,GO:0035107,appendage morphogenesis,0.68591084,BP
-71,0.552255555,300,GO:0010927,cellular component assembly involved in morphogenesis,0.687251358,BP
-120,0.552784822,102,GO:0006936,muscle contraction,0.687528041,BP
169,0.553768765,51,GO:0035305,negative regulation of dephosphorylation,0.688224708,BP
-163,0.553959441,55,GO:0050880,regulation of blood vessel size,0.688224708,BP
202,0.557116896,35,GO:0061097,regulation of protein tyrosine kinase activity,0.691092767,BP
-137,0.557169778,76,GO:0032507,maintenance of protein location in cell,0.691092767,BP
157,0.55732445,58,GO:0008589,regulation of smoothened signaling pathway,0.691092767,BP
-98,0.557529463,151,GO:0043583,ear development,0.691092767,BP
70,0.558023535,298,GO:0048639,positive regulation of developmental growth,0.691092767,BP
-116,0.558119114,106,GO:0007286,spermatid development,0.691092767,BP
-144,0.558512422,69,GO:0007638,mechanosensory behavior,0.691197693,BP
-151,0.559033315,62,GO:0046148,pigment biosynthetic process,0.691460312,BP
75,0.560256223,260,GO:0055001,muscle cell development,0.692305949,BP
-103,0.560335128,134,GO:0060271,cilium assembly,0.692305949,BP
102,0.561317407,137,GO:0043902,positive regulation of multi-organism process,0.693137261,BP
182,0.562583541,42,GO:0000132,establishment of mitotic spindle orientation,0.694317979,BP
-215,0.56291594,30,GO:0050931,pigment cell differentiation,0.694345652,BP
69,0.565777407,300,GO:0050801,ion homeostasis,0.697491134,BP
209,0.566818619,31,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",0.698390378,BP
-128,0.567380519,83,GO:0048704,embryonic skeletal system morphogenesis,0.698698385,BP
-84,0.568788425,196,GO:0001101,response to acid chemical,0.700047292,BP
-201,0.569559,33,GO:0006369,termination of RNA polymerase II transcription,0.700610742,BP
139,0.571051849,69,GO:0050670;GO:0032944,regulation of mononuclear cell proliferation,0.701221554,BP
-174,0.571139903,44,GO:0042659,regulation of cell fate specification,0.701221554,BP
-68,0.571261952,300,GO:0009125,nucleoside monophosphate catabolic process,0.701221554,BP
98,0.571307739,141,GO:0000082;GO:0044843,G1/S transition of mitotic cell cycle,0.701221554,BP
79,0.572012083,219,GO:0035120,post-embryonic appendage morphogenesis,0.701701569,BP
138,0.572552553,69,GO:0008584,male gonad development,0.701980142,BP
148,0.572971596,60,GO:0046165,alcohol biosynthetic process,0.702109614,BP
82,0.573640176,198,GO:0031644,regulation of neurological system process,0.702544556,BP
-133,0.579482935,72,GO:0021675,nerve development,0.708911132,BP
47,0.579689751,615,GO:0019693,ribose phosphate metabolic process,0.708911132,BP
-82,0.579788033,194,GO:0051169,nuclear transport,0.708911132,BP
-182,0.582096032,38,GO:0007569,cell aging,0.710422131,BP
118,0.58221472,91,GO:0046620,regulation of organ growth,0.710422131,BP
117,0.582522919,92,GO:0050658;GO:0050657,RNA transport,0.710422131,BP
-184,0.582546754,37,GO:0050434,positive regulation of viral transcription,0.710422131,BP
-137,0.582609578,67,GO:0060179,male mating behavior,0.710422131,BP
-173,0.58600557,41,GO:0009060,aerobic respiration,0.714174362,BP
145,0.586766446,58,GO:0002262,myeloid cell homeostasis,0.7147128,BP
-172,0.587706557,41,GO:0051100,negative regulation of binding,0.715468852,BP
63,0.589589213,311,GO:0048707,instar larval or pupal morphogenesis,0.717370905,BP
158,0.590682737,48,GO:0002784;GO:0002805,regulation of antimicrobial peptide production,0.718311254,BP
66,0.592120071,281,GO:0045137,development of primary sexual characteristics,0.719668453,BP
146,0.592458866,56,GO:0040025,vulval development,0.719689729,BP
-154,0.593450218,50,GO:0040002,collagen and cuticulin-based cuticle development,0.720351724,BP
114,0.593647001,91,GO:0044344;GO:0071774,cellular response to fibroblast growth factor stimulus,0.720351724,BP
-99,0.594550656,121,GO:0021953,central nervous system neuron differentiation,0.721057645,BP
-188,0.595164541,33,GO:0060325,face morphogenesis,0.721411565,BP
128,0.595971507,71,GO:0031016,pancreas development,0.721561697,BP
-100,0.596115128,117,GO:0031047,gene silencing by RNA,0.721561697,BP
92,0.596350301,140,GO:0006403,RNA localization,0.721561697,BP
-105,0.596576903,106,GO:0032886,regulation of microtubule-based process,0.721561697,BP
187,0.597192509,33,GO:0007427,"epithelial cell migration, open tracheal system",0.721572717,BP
128,0.59776655,71,GO:0050821,protein stabilization,0.721572717,BP
-174,0.597978184,38,GO:0030706,germarium-derived oocyte differentiation,0.721572717,BP
193,0.598041989,31,GO:0030004,cellular monovalent inorganic cation homeostasis,0.721572717,BP
-43,0.598196668,690,GO:0007548,sex differentiation,0.721572717,BP
60,0.598764789,333,GO:0007552,metamorphosis,0.721742301,BP
-178,0.598981668,36,GO:0007294;GO:0030716,oocyte fate determination,0.721742301,BP
-108,0.599466988,98,GO:0019318,hexose metabolic process,0.721938738,BP
175,0.600229567,37,GO:0001541,ovarian follicle development,0.722468689,BP
-58,0.601783857,348,GO:0048589,developmental growth,0.723950505,BP
183,0.605035364,33,GO:0042052,rhabdomere development,0.727471399,BP
109,0.605654053,93,GO:0001756,somitogenesis,0.727824613,BP
-99,0.606457576,114,GO:0035194;GO:0016441,posttranscriptional gene silencing by RNA,0.728194381,BP
162,0.606611926,42,GO:0055067,monovalent inorganic cation homeostasis,0.728194381,BP
42,0.607582048,666,GO:0045935,positive regulation of nucleobase-containing compound metabolic process,0.728623274,BP
-182,0.607619766,33,GO:0030262,apoptotic nuclear changes,0.728623274,BP
-159,0.608081901,43,GO:0021517,ventral spinal cord development,0.728709699,BP
-64,0.608342472,272,GO:0007051,spindle organization,0.728709699,BP
138,0.610113236,57,GO:0016079,synaptic vesicle exocytosis,0.730126073,BP
71,0.61017679,222,GO:0007599,hemostasis,0.730126073,BP
58,0.612717226,323,GO:0006366,transcription by RNA polymerase II,0.732448464,BP
143,0.612771617,52,GO:0001570,vasculogenesis,0.732448464,BP
122,0.615842546,70,GO:0071478,cellular response to radiation,0.735726562,BP
72,0.617424344,204,GO:0045930,negative regulation of mitotic cell cycle,0.736978594,BP
-74,0.617861648,190,GO:0042391,regulation of membrane potential,0.736978594,BP
-147,0.617877589,48,GO:0045494,photoreceptor cell maintenance,0.736978594,BP
-103,0.618722979,97,GO:0042462,eye photoreceptor cell development,0.737594184,BP
-88,0.619350262,134,GO:0071396,cellular response to lipid,0.737949248,BP
156,0.620222303,42,GO:0006119,oxidative phosphorylation,0.738595406,BP
-85,0.621448063,143,GO:0016202;GO:1901861,regulation of striated muscle tissue development,0.739543709,BP
-159,0.62167893,40,GO:0033059,cellular pigmentation,0.739543709,BP
-98,0.622457953,106,GO:0019748,secondary metabolic process,0.740077397,BP
-124,0.622828541,65,GO:0050680,negative regulation of epithelial cell proliferation,0.740125162,BP
41,0.624196396,641,GO:0072521,purine-containing compound metabolic process,0.741357331,BP
-157,0.626491397,40,GO:0046532,regulation of photoreceptor cell differentiation,0.743688781,BP
117,0.630028387,71,GO:0060070,canonical Wnt signaling pathway,0.747491307,BP
-153,0.630458652,41,GO:0032784,"regulation of DNA-templated transcription, elongation",0.747605813,BP
-57,0.633370225,299,GO:0009158,ribonucleoside monophosphate catabolic process,0.750661008,BP
168,0.634403774,33,GO:2000106,regulation of leukocyte apoptotic process,0.751488341,BP
-144,0.635495506,45,GO:0001752;GO:0042706,compound eye photoreceptor fate commitment,0.752383686,BP
-168,0.63599839,33,GO:0010522,regulation of calcium ion transport into cytosol,0.752581296,BP
61,0.636805015,252,GO:2000241,regulation of reproductive process,0.753137927,BP
92,0.63807009,109,GO:0000041,transition metal ion transport,0.753955464,BP
159,0.638169447,36,GO:0009409,response to cold,0.753955464,BP
-90,0.639467231,113,GO:0042461,photoreceptor cell development,0.754887938,BP
-88,0.639632726,118,GO:0048741;GO:0014904,skeletal muscle fiber development,0.754887938,BP
-127,0.640773211,56,GO:0060563,neuroepithelial cell differentiation,0.755625116,BP
136,0.641187642,49,GO:0001936,regulation of endothelial cell proliferation,0.755625116,BP
69,0.641563992,191,GO:0051969,regulation of transmission of nerve impulse,0.755625116,BP
-141,0.641606684,45,GO:0014033,neural crest cell differentiation,0.755625116,BP
-100,0.642491029,90,GO:0048706,embryonic skeletal system development,0.756268999,BP
-108,0.643091915,76,GO:0001947,heart looping,0.756578723,BP
55,0.644911082,302,GO:0040014,regulation of multicellular organism growth,0.758320642,BP
-90,0.648848945,106,GO:0051445,regulation of meiotic cell cycle,0.761776034,BP
92,0.648951413,102,GO:0040027,negative regulation of vulval development,0.761776034,BP
96,0.649197478,94,GO:0048738,cardiac muscle tissue development,0.761776034,BP
-143,0.649314718,42,GO:0006672,ceramide metabolic process,0.761776034,BP
-52,0.6495501,326,GO:0009636,response to toxic substance,0.761776034,BP
54,0.651161942,301,GO:0060537,muscle tissue development,0.763266745,BP
113,0.652488896,66,GO:0007204,positive regulation of cytosolic calcium ion concentration,0.763794158,BP
-102,0.652528955,81,GO:0045185,maintenance of protein location,0.763794158,BP
77,0.65263483,143,GO:0090287,regulation of cellular response to growth factor stimulus,0.763794158,BP
-114,0.653975083,64,GO:0055088,lipid homeostasis,0.76460449,BP
-129,0.654009912,50,GO:0016236,macroautophagy,0.76460449,BP
-117,0.65508659,61,GO:0008217,regulation of blood pressure,0.765463726,BP
-140,0.656302262,42,GO:1903707,negative regulation of hemopoiesis,0.766484393,BP
154,0.657908486,34,GO:0051703,intraspecies interaction between organisms,0.767333426,BP
142,0.657955647,40,GO:0030718,germ-line stem cell population maintenance,0.767333426,BP
134,0.658056925,45,GO:0007443,Malpighian tubule morphogenesis,0.767333426,BP
85,0.658488333,114,GO:0055076,transition metal ion homeostasis,0.767335621,BP
108,0.658962802,70,GO:0051291,protein heterooligomerization,0.767335621,BP
-131,0.659366129,47,GO:0001890,placenta development,0.767335621,BP
-145,0.659429049,38,GO:0035151,"regulation of tube size, open tracheal system",0.767335621,BP
59,0.661876055,235,GO:0009100,glycoprotein metabolic process,0.769783159,BP
103,0.665346114,74,GO:0061025,membrane fusion,0.773417382,BP
-108,0.665750361,67,GO:0008354,germ cell migration,0.773485896,BP
123,0.66679841,51,GO:1901264,carbohydrate derivative transport,0.773957606,BP
-86,0.666847402,104,GO:0043543,protein acylation,0.773957606,BP
-157,0.667614512,31,GO:0006513,protein monoubiquitination,0.774446663,BP
47,0.668000132,354,GO:0007517,muscle organ development,0.774492906,BP
130,0.668598142,45,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",0.774785224,BP
53,0.670020657,275,GO:0048563,post-embryonic animal organ morphogenesis,0.775712749,BP
58,0.670091147,231,GO:0007052,mitotic spindle organization,0.775712749,BP
100,0.670546789,76,GO:0021543,pallium development,0.77583926,BP
113,0.671012683,59,GO:0008585,female gonad development,0.775977496,BP
124,0.673263413,48,GO:0007559;GO:0016271,obsolete histolysis,0.777832134,BP
-118,0.673324775,53,GO:0055024,regulation of cardiac muscle tissue development,0.777832134,BP
-44,0.674221416,390,GO:0034622,cellular protein-containing complex assembly,0.777832134,BP
-137,0.674279524,39,GO:0046782,regulation of viral transcription,0.777832134,BP
94,0.674352681,84,GO:0007601,visual perception,0.777832134,BP
77,0.675025853,125,GO:0048813,dendrite morphogenesis,0.77820788,BP
-116,0.675799009,54,GO:0051149,positive regulation of muscle cell differentiation,0.778293366,BP
-146,0.676093412,34,GO:0016064;GO:0019724,B cell mediated immunity,0.778293366,BP
111,0.676142362,59,GO:0072002,Malpighian tubule development,0.778293366,BP
84,0.677577457,103,GO:0061064,negative regulation of nematode larval development,0.779544686,BP
-132,0.678042783,41,GO:0033334,fin morphogenesis,0.779679587,BP
76,0.67951043,123,GO:0030198,extracellular matrix organization,0.780966323,BP
105,0.680317087,64,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,0.781492449,BP
-49,0.684462171,298,GO:0009128;GO:0009169,purine nucleoside monophosphate catabolic process,0.78585098,BP
35,0.687467237,599,GO:2000113,negative regulation of cellular macromolecule biosynthetic process,0.788788801,BP
-99,0.687725236,69,GO:0021510,spinal cord development,0.788788801,BP
63,0.691062495,166,GO:0071407,cellular response to organic cyclic compound,0.792210844,BP
-141,0.69539013,32,GO:0034698,response to gonadotropin,0.796764138,BP
87,0.696990024,83,GO:0042471,ear morphogenesis,0.797561679,BP
102,0.697124909,61,GO:0051294,establishment of spindle orientation,0.797561679,BP
109,0.697154361,53,GO:0034764,positive regulation of transmembrane transport,0.797561679,BP
68,0.698688133,136,GO:0000578,embryonic axis specification,0.79890833,BP
112,0.699157865,49,GO:2000243,positive regulation of reproductive process,0.799037561,BP
-132,0.700020247,35,GO:0046364,monosaccharide biosynthetic process,0.799298796,BP
112,0.700100106,49,GO:0002576,platelet degranulation,0.799298796,BP
-91,0.700483927,75,GO:0007050,cell cycle arrest,0.799329596,BP
-113,0.702902168,47,GO:0032368,regulation of lipid transport,0.801432892,BP
-118,0.703042693,43,GO:0048015,phosphatidylinositol-mediated signaling,0.801432892,BP
79,0.703636592,97,GO:0048641,regulation of skeletal muscle tissue development,0.801701915,BP
-33,0.709176567,574,GO:0051254,positive regulation of RNA metabolic process,0.8073963,BP
-72,0.709355321,111,GO:0007351;GO:0008595,tripartite regional subdivision,0.8073963,BP
119,0.710656983,40,GO:0019722,calcium-mediated signaling,0.808467061,BP
-92,0.712678831,67,GO:0051028,mRNA transport,0.810355626,BP
61,0.71511026,152,GO:0043062,extracellular structure organization,0.812557463,BP
-86,0.715340766,75,GO:0050684,regulation of mRNA processing,0.812557463,BP
71,0.71675919,109,GO:0060485,mesenchyme development,0.813755999,BP
-131,0.719025497,31,GO:0043589,skin morphogenesis,0.815915458,BP
108,0.719601091,46,GO:0048619,embryonic hindgut morphogenesis,0.816155161,BP
69,0.720550912,111,GO:0030258,lipid modification,0.816818848,BP
75,0.723397277,92,GO:0048588,developmental cell growth,0.819630703,BP
128,0.725007243,31,GO:0046579,positive regulation of Ras protein signal transduction,0.821039548,BP
65,0.725513393,122,GO:0071695,anatomical structure maturation,0.821197574,BP
50,0.726419167,204,GO:0030707,ovarian follicle cell development,0.821807542,BP
-77,0.727248685,85,GO:0006164,purine nucleotide biosynthetic process,0.822330669,BP
-95,0.729864898,55,GO:0051591,response to cAMP,0.824872539,BP
-107,0.731158456,43,GO:0097285,obsolete cell-type specific apoptotic process,0.825917772,BP
-70,0.733474506,98,GO:0040013,negative regulation of locomotion,0.828116378,BP
113,0.735074907,37,GO:0060324,face development,0.829505185,BP
78,0.735544417,79,GO:0061326,renal tubule development,0.829617067,BP
68,0.737813474,100,GO:1903311,regulation of mRNA metabolic process,0.831649196,BP
78,0.738088662,77,GO:0007631,feeding behavior,0.831649196,BP
76,0.74004719,79,GO:0042476,odontogenesis,0.833310159,BP
58,0.740436301,135,GO:0048839,inner ear development,0.833310159,BP
104,0.740678807,42,GO:0009584,detection of visible light,0.833310159,BP
51,0.741967013,175,GO:1901991,negative regulation of mitotic cell cycle phase transition,0.834340416,BP
37,0.742717968,340,GO:0010035,response to inorganic substance,0.834765805,BP
-76,0.746848431,75,GO:0007009,plasma membrane organization,0.838987204,BP
34,0.747309095,399,GO:0018193,peptidyl-amino acid modification,0.839083896,BP
-112,0.74794616,34,GO:0018210,peptidyl-threonine modification,0.839378456,BP
-43,0.748996009,233,GO:0040018,positive regulation of multicellular organism growth,0.840135734,BP
-47,0.749877266,197,GO:0022613,ribonucleoprotein complex biogenesis,0.840703241,BP
80,0.750542481,65,GO:0046890,regulation of lipid biosynthetic process,0.840960876,BP
-48,0.750857925,188,GO:0006913,nucleocytoplasmic transport,0.840960876,BP
59,0.752027309,120,GO:0051153,regulation of striated muscle cell differentiation,0.841578716,BP
-106,0.752160978,37,GO:0000245,spliceosomal complex assembly,0.841578716,BP
-68,0.753629937,88,GO:0014074,response to purine-containing compound,0.842423517,BP
102,0.753668182,39,GO:0045214,sarcomere organization,0.842423517,BP
54,0.754698141,142,GO:0051604,protein maturation,0.842750561,BP
42,0.754713226,235,GO:0010038,response to metal ion,0.842750561,BP
85,0.760824599,53,GO:0008039,synaptic target recognition,0.84915152,BP
76,0.761704471,66,GO:0035914,skeletal muscle cell differentiation,0.849710166,BP
84,0.762991773,54,GO:0006023,aminoglycan biosynthetic process,0.850722534,BP
-82,0.764177598,56,GO:0006813,potassium ion transport,0.851620806,BP
-79,0.764608704,60,GO:0010469,regulation of signaling receptor activity,0.851677522,BP
-64,0.771952014,85,GO:0051651,maintenance of location in cell,0.859429678,BP
47,0.774060416,156,GO:0050678,regulation of epithelial cell proliferation,0.861348898,BP
-62,0.776691343,86,GO:2000146,negative regulation of cell motility,0.863847372,BP
-37,0.777347535,252,GO:0048562,embryonic organ morphogenesis,0.864148128,BP
-67,0.778598812,73,GO:0014031,mesenchymal cell development,0.865109791,BP
35,0.779020004,271,GO:0007560,imaginal disc morphogenesis,0.865148642,BP
52,0.779431166,120,GO:0031099,regeneration,0.865176319,BP
-94,0.781338174,36,GO:1905954,positive regulation of lipid localization,0.866309909,BP
-71,0.781472896,63,GO:0042307;GO:1900182;GO:1904591,positive regulation of protein localization to nucleus,0.866309909,BP
29,0.781612646,391,GO:0045944,positive regulation of transcription by RNA polymerase II,0.866309909,BP
-63,0.782258479,80,GO:0046660,female sex differentiation,0.86659693,BP
54,0.784871779,106,GO:0048581,negative regulation of post-embryonic development,0.869062177,BP
83,0.786579976,44,GO:0001569,branching involved in blood vessel morphogenesis,0.870523294,BP
-77,0.788573514,50,GO:0008298,intracellular mRNA localization,0.871824823,BP
-66,0.788804573,69,GO:0032526,response to retinoic acid,0.871824823,BP
-25,0.788923623,498,GO:0042493,response to drug,0.871824823,BP
80,0.78950316,46,GO:0022404,molting cycle process,0.872035049,BP
31,0.790366623,322,GO:0051235,maintenance of location,0.872558519,BP
69,0.791116914,62,GO:0007588,excretion,0.872956595,BP
-30,0.791828908,343,GO:1901137,carbohydrate derivative biosynthetic process,0.873190814,BP
-46,0.792622551,136,GO:0048754,branching morphogenesis of an epithelial tube,0.873190814,BP
27,0.792877451,407,GO:0006351;GO:0097659,"transcription, DNA-templated",0.873190814,BP
40,0.792888444,179,GO:0046530,photoreceptor cell differentiation,0.873190814,BP
-31,0.794988613,312,GO:0098662,inorganic cation transmembrane transport,0.875073461,BP
-66,0.795974843,64,GO:0007272;GO:0008366,ensheathment of neurons,0.875728707,BP
44,0.796567535,143,GO:0007368,determination of left/right symmetry,0.875950554,BP
-93,0.798139667,31,GO:0002067,glandular epithelial cell differentiation,0.877248702,BP
35,0.798810382,224,GO:0001501,skeletal system development,0.877249982,BP
-62,0.798924091,70,GO:0019228,neuronal action potential,0.877249982,BP
44,0.800827835,139,GO:0048747,muscle fiber development,0.87890953,BP
90,0.803027595,32,GO:0018992,germ-line sex determination,0.880892171,BP
-62,0.805642194,66,GO:0072593,reactive oxygen species metabolic process,0.883327711,BP
53,0.806515414,89,GO:1901617,organic hydroxy compound biosynthetic process,0.883852508,BP
-71,0.80757919,49,GO:0010453,regulation of cell fate commitment,0.884585518,BP
-50,0.809961208,95,GO:0016246,RNA interference,0.886761048,BP
78,0.810801579,39,GO:0042455,ribonucleoside biosynthetic process,0.886814723,BP
-38,0.810802032,167,GO:0007350,blastoderm segmentation,0.886814723,BP
-49,0.811856918,99,GO:0048872,homeostasis of number of cells,0.887535137,BP
57,0.812413643,72,GO:0006661,phosphatidylinositol biosynthetic process,0.887710517,BP
55,0.812984129,78,GO:0051293,establishment of spindle localization,0.887900755,BP
27,0.813982043,331,GO:0044706,multi-multicellular organism process,0.88838795,BP
58,0.814718646,69,GO:0009583,detection of light stimulus,0.88838795,BP
72,0.814928913,44,GO:0042745,circadian sleep/wake cycle,0.88838795,BP
-28,0.815197811,293,GO:0006200,obsolete ATP catabolic process,0.88838795,BP
57,0.815413226,69,GO:0010623,programmed cell death involved in cell development,0.88838795,BP
-32,0.817220008,215,GO:0000377;GO:0000398,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",0.889923587,BP
-84,0.818627795,31,GO:0003401,axis elongation,0.890716933,BP
68,0.818743823,47,GO:0048102,autophagic cell death,0.890716933,BP
-58,0.819515509,65,GO:1901654,response to ketone,0.89112366,BP
50,0.820433889,86,GO:0097193,intrinsic apoptotic signaling pathway,0.891400223,BP
-21,0.820635667,538,GO:1901657,glycosyl compound metabolic process,0.891400223,BP
-58,0.820963688,64,GO:0006405,RNA export from nucleus,0.891400223,BP
-81,0.821796826,32,GO:0001945,lymph vessel development,0.891872524,BP
20,0.82363688,527,GO:0009116,nucleoside metabolic process,0.893436616,BP
22,0.825339435,451,GO:0008283,cell population proliferation,0.894850114,BP
63,0.826045073,51,GO:0032835,glomerulus development,0.895181889,BP
-37,0.827491811,148,GO:0001763,morphogenesis of a branching structure,0.896316082,BP
-69,0.827976554,41,GO:0048793,pronephros development,0.896407675,BP
-50,0.828874579,78,GO:0046545,development of primary female sexual characteristics,0.896946404,BP
-45,0.83028505,96,GO:0055072,iron ion homeostasis,0.898038876,BP
-40,0.833282544,113,GO:0051320,S phase,0.900845994,BP
-42,0.833848742,106,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.901023243,BP
-61,0.835369587,48,GO:0014902,myotube differentiation,0.902231377,BP
66,0.836281252,40,GO:0001942;GO:0022405,hair cycle process,0.902780725,BP
65,0.837677603,41,GO:0140029,exocytic process,0.90385252,BP
-37,0.838506918,126,GO:0016485,protein processing,0.904311746,BP
30,0.840074527,195,GO:0009953,dorsal/ventral pattern formation,0.905566382,BP
-45,0.840900018,84,GO:1903829,positive regulation of cellular protein localization,0.906020221,BP
19,0.842704137,456,GO:0043009,chordate embryonic development,0.907527533,BP
-52,0.845910022,57,GO:0022416,chaeta development,0.910542263,BP
-51,0.846602992,60,GO:0048103,somatic stem cell division,0.910850481,BP
-49,0.848602312,62,GO:0007097,nuclear migration,0.912315975,BP
40,0.848779684,96,GO:0072522,purine-containing compound biosynthetic process,0.912315975,BP
20,0.849718113,378,GO:0048732,gland development,0.912886606,BP
60,0.851575133,40,GO:0035071,salivary gland cell autophagic cell death,0.913449919,BP
24,0.851781455,267,GO:0035282,segmentation,0.913449919,BP
-50,0.851875322,59,GO:0048701,embryonic cranial skeleton morphogenesis,0.913449919,BP
49,0.851962432,60,GO:0007405,neuroblast proliferation,0.913449919,BP
-47,0.852281398,65,GO:0007041,lysosomal transport,0.913449919,BP
-35,0.854851867,117,GO:0048546,digestive tract morphogenesis,0.915500282,BP
-57,0.85501187,43,GO:0006081,cellular aldehyde metabolic process,0.915500282,BP
35,0.856358173,115,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,0.916340162,BP
-65,0.856614419,32,GO:0035112,genitalia morphogenesis,0.916340162,BP
-51,0.858086411,50,GO:0090174,organelle membrane fusion,0.91747664,BP
-33,0.861928466,115,GO:0001708,cell fate specification,0.921144925,BP
22,0.863567737,262,GO:0001568,blood vessel development,0.922097107,BP
-23,0.864402372,225,GO:1901990,regulation of mitotic cell cycle phase transition,0.922097107,BP
-56,0.864529667,38,GO:0043967,histone H4 acetylation,0.922097107,BP
39,0.864947952,79,GO:0051653,spindle localization,0.922097107,BP
-24,0.865381195,216,GO:0097305,response to alcohol,0.922097107,BP
15,0.865659482,542,GO:0045893,"positive regulation of transcription, DNA-templated",0.922097107,BP
55,0.865909197,39,GO:1904062,regulation of cation transmembrane transport,0.922097107,BP
41,0.866720651,68,GO:0021954,central nervous system neuron development,0.922097107,BP
-34,0.866812944,103,GO:0030324,lung development,0.922097107,BP
62,0.866935941,30,GO:1901343,negative regulation of vasculature development,0.922097107,BP
61,0.869917546,30,GO:0006972,hyperosmotic response,0.924829285,BP
19,0.872529931,322,GO:0007600,sensory perception,0.926849382,BP
-31,0.872645244,112,GO:0071826,ribonucleoprotein complex subunit organization,0.926849382,BP
18,0.8745578,334,GO:0000122,negative regulation of transcription by RNA polymerase II,0.928294756,BP
-13,0.874834924,634,GO:0008406,gonad development,0.928294756,BP
56,0.876404733,32,GO:0055006,cardiac cell development,0.929520172,BP
-28,0.876950068,125,GO:0034765,regulation of ion transmembrane transport,0.929658378,BP
-37,0.880257076,68,GO:0035315,hair cell differentiation,0.932258333,BP
53,0.880269898,33,GO:0042044,fluid transport,0.932258333,BP
-43,0.880651175,51,GO:0034101,erythrocyte homeostasis,0.932258333,BP
-36,0.881360829,73,GO:0043484,regulation of RNA splicing,0.932265987,BP
12,0.881715755,721,GO:0009117,nucleotide metabolic process,0.932265987,BP
-37,0.881936601,67,GO:0051647,nucleus localization,0.932265987,BP
-35,0.882584495,76,GO:0048762,mesenchymal cell differentiation,0.932265987,BP
-38,0.882739356,63,GO:0003018,vascular process in circulatory system,0.932265987,BP
-54,0.884211546,30,GO:0007367,segment polarity determination,0.933380709,BP
-35,0.885048596,72,GO:0044262,cellular carbohydrate metabolic process,0.933824237,BP
-16,0.886498102,351,GO:0046034,ATP metabolic process,0.934447559,BP
31,0.886833976,86,GO:0050953,sensory perception of light stimulus,0.934447559,BP
-45,0.886890853,41,GO:0060021,roof of mouth development,0.934447559,BP
-33,0.887707306,78,GO:0009950,dorsal/ventral axis specification,0.934868061,BP
21,0.889509136,185,GO:0001525,angiogenesis,0.935595056,BP
34,0.889661132,69,GO:0046824,positive regulation of nucleocytoplasmic transport,0.935595056,BP
24,0.890236822,144,GO:0009948,anterior/posterior axis specification,0.935595056,BP
23,0.890272391,152,GO:0009855;GO:0009799,specification of symmetry,0.935595056,BP
43,0.891009659,43,GO:0070301,cellular response to hydrogen peroxide,0.935595056,BP
37,0.891643357,56,GO:0050792,regulation of viral process,0.935595056,BP
45,0.891656768,38,GO:0046622,positive regulation of organ growth,0.935595056,BP
16,0.891851438,309,GO:0048592,eye morphogenesis,0.935595056,BP
-12,0.892156714,591,GO:0045934,negative regulation of nucleobase-containing compound metabolic process,0.935595056,BP
-41,0.893684312,44,GO:0048017,inositol lipid-mediated signaling,0.936758474,BP
41,0.895919553,42,GO:0001837,epithelial to mesenchymal transition,0.938662207,BP
14,0.897010289,365,GO:0090596,sensory organ morphogenesis,0.938932538,BP
-31,0.897015907,74,GO:0031124,mRNA 3'-end processing,0.938932538,BP
-45,0.899314056,32,GO:0035159,"regulation of tube length, open tracheal system",0.938982813,BP
18,0.899991346,202,GO:0048565,digestive tract development,0.938982813,BP
-24,0.90007233,117,GO:0003012,muscle system process,0.938982813,BP
37,0.900190849,48,GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",0.938982813,BP
31,0.900228538,69,GO:0097194,execution phase of apoptosis,0.938982813,BP
11,0.900268026,543,GO:1903508;GO:1902680,positive regulation of nucleic acid-templated transcription,0.938982813,BP
-17,0.900306004,220,GO:0000375,"RNA splicing, via transesterification reactions",0.938982813,BP
19,0.900417447,186,GO:0120031,plasma membrane bounded cell projection assembly,0.938982813,BP
-28,0.901525123,83,GO:0006470,protein dephosphorylation,0.939700454,BP
-44,0.903325464,32,GO:0033013,tetrapyrrole metabolic process,0.941139088,BP
19,0.904160189,174,GO:0006816,calcium ion transport,0.941570816,BP
36,0.906794874,45,GO:0021955,central nervous system neuron axonogenesis,0.943659049,BP
-24,0.907008005,103,GO:0042254,ribosome biogenesis,0.943659049,BP
28,0.907598558,69,GO:0007274,neuromuscular synaptic transmission,0.943835083,BP
-39,0.908868846,36,GO:0060438,trachea development,0.944568491,BP
-15,0.909147172,239,GO:0008380,RNA splicing,0.944568491,BP
37,0.909658496,40,GO:0006497,protein lipidation,0.944661581,BP
21,0.911555419,116,GO:0006954,inflammatory response,0.945975065,BP
21,0.911767931,121,GO:0015931,nucleobase-containing compound transport,0.945975065,BP
-30,0.912808854,57,GO:0021761,limbic system development,0.946616589,BP
-21,0.914601959,114,GO:0048515,spermatid differentiation,0.948037199,BP
-33,0.91651461,43,GO:0002449,lymphocyte mediated immunity,0.949580354,BP
-38,0.918777083,30,GO:0002088,lens development in camera-type eye,0.95142107,BP
22,0.919140712,88,GO:0010959,regulation of metal ion transport,0.95142107,BP
26,0.919596955,64,GO:0051924,regulation of calcium ion transport,0.951453662,BP
30,0.922920318,43,GO:0031018,endocrine pancreas development,0.954352778,BP
-19,0.923251102,112,GO:0000084,mitotic S phase,0.954352778,BP
21,0.923715614,83,GO:0002065,columnar/cuboidal epithelial cell differentiation,0.954392516,BP
26,0.925816362,54,GO:0002168,instar larval development,0.955955336,BP
22,0.926081732,75,GO:0048675;GO:1990138,axon extension,0.955955336,BP
33,0.926593858,33,GO:0045598,regulation of fat cell differentiation,0.956043409,BP
-8,0.927387026,599,GO:0007017,microtubule-based process,0.956170362,BP
9,0.927667669,502,GO:0045892;GO:1903507;GO:1902679,negative regulation of nucleic acid-templated transcription,0.956170362,BP
32,0.927997485,32,GO:0032873;GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,0.956170362,BP
-18,0.929646038,102,GO:0061053,somite development,0.957428563,BP
-30,0.930252192,36,GO:0001776,leukocyte homeostasis,0.95761255,BP
16,0.932236814,117,GO:0032388,positive regulation of intracellular transport,0.959214728,BP
14,0.933181799,161,GO:0007093,mitotic cell cycle checkpoint,0.959723688,BP
-8,0.933588355,479,GO:0007420,brain development,0.959723688,BP
13,0.935114267,156,GO:0007018,microtubule-based movement,0.960851357,BP
28,0.936646323,33,GO:0007586,digestion,0.961984302,BP
-19,0.937769657,73,GO:0016319,mushroom body development,0.962696623,BP
13,0.939192608,153,GO:0022612,gland morphogenesis,0.963622077,BP
-9,0.939531525,315,GO:0098660,inorganic ion transmembrane transport,0.963622077,BP
-9,0.939966732,276,GO:0050878,regulation of body fluid levels,0.963627222,BP
16,0.941695773,91,GO:0051271,negative regulation of cellular component movement,0.964958157,BP
-19,0.944434553,57,GO:0042113,B cell activation,0.967081539,BP
21,0.944631431,44,GO:0042158,lipoprotein biosynthetic process,0.967081539,BP
8,0.945102778,317,GO:0098655,cation transmembrane transport,0.967122075,BP
20,0.946786775,47,GO:0071482,cellular response to light stimulus,0.968063498,BP
-22,0.947815708,36,GO:0035335,peptidyl-tyrosine dephosphorylation,0.968063498,BP
18,0.947969138,53,GO:0050671;GO:0032946;GO:0070665,positive regulation of mononuclear cell proliferation,0.968063498,BP
-13,0.948039282,110,GO:0046488,phosphatidylinositol metabolic process,0.968063498,BP
-9,0.948183623,223,GO:0019915,lipid storage,0.968063498,BP
-14,0.948976695,84,GO:0030336,negative regulation of cell migration,0.968431798,BP
6,0.949869506,537,GO:1901136,carbohydrate derivative catabolic process,0.9689015,BP
18,0.950948722,46,GO:0110110,positive regulation of animal organ morphogenesis,0.969560827,BP
20,0.954141898,34,GO:0042773;GO:0042775,ATP synthesis coupled electron transport,0.972351905,BP
18,0.954554393,41,GO:0001649,osteoblast differentiation,0.972351905,BP
-11,0.956594337,104,GO:0030323,respiratory tube development,0.973986962,BP
12,0.95807469,78,GO:0051480,regulation of cytosolic calcium ion concentration,0.975051025,BP
18,0.96011566,32,GO:0051057,positive regulation of small GTPase mediated signal transduction,0.976684414,BP
-4,0.960649676,728,GO:0006753,nucleoside phosphate metabolic process,0.976784055,BP
11,0.961655468,75,GO:0006826,iron ion transport,0.977363089,BP
-16,0.963237739,36,GO:0050871,positive regulation of B cell activation,0.978257528,BP
-14,0.963480862,45,GO:0014013,regulation of gliogenesis,0.978257528,BP
-14,0.963845698,41,GO:0042633,hair cycle,0.978257528,BP
12,0.96457266,56,GO:0051592,response to calcium ion,0.978551974,BP
-9,0.965230995,92,GO:0050679,positive regulation of epithelial cell proliferation,0.978776563,BP
-9,0.966608757,83,GO:0090316,positive regulation of intracellular protein transport,0.979730143,BP
-9,0.967990945,89,GO:0017145,stem cell division,0.980270649,BP
15,0.968017265,30,GO:1903035,negative regulation of response to wounding,0.980270649,BP
11,0.969669848,48,GO:0061041,regulation of wound healing,0.981500434,BP
13,0.971541333,30,GO:0051282,regulation of sequestering of calcium ion,0.982950581,BP
-6,0.973756119,144,GO:0061138,morphogenesis of a branching epithelium,0.984746594,BP
7,0.975168673,78,GO:0007219,Notch signaling pathway,0.985730067,BP
-6,0.977094248,98,GO:0007098,centrosome cycle,0.987230995,BP
-5,0.978106996,121,GO:0061448,connective tissue development,0.987808688,BP
8,0.979151825,44,GO:0015748,organophosphate ester transport,0.988418246,BP
-8,0.980610632,39,GO:0042102,positive regulation of T cell proliferation,0.989444962,BP
9,0.981167312,31,GO:0007379,segment specification,0.989560909,BP
-6,0.983105932,61,GO:0042552,myelination,0.991069886,BP
6,0.984859861,47,GO:0035265,organ growth,0.991507359,BP
-6,0.985094218,39,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.991507359,BP
5,0.985241102,59,GO:0019233,sensory perception of pain,0.991507359,BP
-6,0.985310438,36,GO:0003073,regulation of systemic arterial blood pressure,0.991507359,BP
-3,0.986294155,155,GO:0060560,developmental growth involved in morphogenesis,0.991882102,BP
-3,0.986568448,186,GO:0043269,regulation of ion transport,0.991882102,BP
-3,0.987317148,108,GO:0022618,ribonucleoprotein complex assembly,0.991930111,BP
-3,0.987815813,106,GO:0008356,asymmetric cell division,0.991930111,BP
4,0.987944677,75,GO:0007293,germarium-derived egg chamber formation,0.991930111,BP
3,0.990891845,54,GO:0048024,"regulation of mRNA splicing, via spliceosome",0.994443429,BP
3,0.991568388,42,GO:0035070,salivary gland histolysis,0.99449517,BP
-3,0.991831344,58,GO:0043244,regulation of protein complex disassembly,0.99449517,BP
2,0.993732708,72,GO:0072006,nephron development,0.995955824,BP
-2,0.996077572,30,GO:0006090,pyruvate metabolic process,0.997859464,BP
-1,0.996744086,160,GO:0001754,eye photoreceptor cell differentiation,0.998080801,BP
-1,0.997673101,61,GO:0006112,energy reserve metabolic process,0.998298103,BP
1,0.997852434,39,GO:0048520,positive regulation of behavior,0.998298103,BP
0,0.999722732,167,GO:0003007,heart morphogenesis,0.999722732,BP
1674,9.51E-14,51,GO:0000502;GO:1905369,proteasome complex,4.92E-11,CC
-599,2.50E-13,411,GO:0044427,chromosomal part,6.47E-11,CC
-1113,4.03E-12,101,GO:0000775,"chromosome, centromeric region",6.94E-10,CC
-490,2.79E-11,521,GO:0005694,chromosome,3.60E-09,CC
-1131,1.47E-09,74,GO:0000776,kinetochore,1.52E-07,CC
1234,2.00E-09,61,GO:0022626,cytosolic ribosome,1.72E-07,CC
-1172,1.20E-08,61,GO:0000779,"condensed chromosome, centromeric region",8.85E-07,CC
-1197,2.41E-08,56,GO:0000777,condensed chromosome kinetochore,1.56E-06,CC
2009,4.44E-08,19,GO:0005838,proteasome regulatory particle,2.36E-06,CC
-598,5.08E-08,221,GO:0044454,nuclear chromosome part,2.36E-06,CC
-546,5.21E-08,267,GO:0000228,nuclear chromosome,2.36E-06,CC
1037,5.48E-08,71,GO:1905368,peptidase complex,2.36E-06,CC
-722,7.71E-08,145,GO:0000793,condensed chromosome,2.97E-06,CC
1718,8.04E-08,25,GO:0005839,proteasome core complex,2.97E-06,CC
-499,9.67E-08,308,GO:0005813,centrosome,3.33E-06,CC
-1185,2.32E-07,49,GO:0005657,replication fork,7.38E-06,CC
-660,2.43E-07,161,GO:0098687,chromosomal region,7.38E-06,CC
-448,3.47E-07,353,GO:0005815,microtubule organizing center,9.97E-06,CC
1796,5.16E-07,20,GO:0022624,proteasome accessory complex,1.41E-05,CC
-536,5.98E-07,231,GO:0005819,spindle,1.54E-05,CC
1222,7.80E-07,42,GO:0022625,cytosolic large ribosomal subunit,1.92E-05,CC
-303,1.12E-06,766,GO:0015630,microtubule cytoskeleton,2.64E-05,CC
-517,3.29E-06,215,GO:0000785,chromatin,7.21E-05,CC
-1519,3.35E-06,24,GO:1990391,DNA repair complex,7.21E-05,CC
513,6.51E-06,205,GO:0030135,coated vesicle,1.35E-04,CC
318,7.62E-06,564,GO:0098805,whole membrane,1.50E-04,CC
357,7.84E-06,434,GO:0044433,cytoplasmic vesicle part,1.50E-04,CC
462,1.01E-05,244,GO:0098791,Golgi subcompartment,1.86E-04,CC
294,1.04E-05,651,GO:0043005,neuron projection,1.86E-04,CC
-860,1.60E-05,65,GO:0032993,protein-DNA complex,2.75E-04,CC
437,2.19E-05,252,GO:0031984,organelle subcompartment,3.66E-04,CC
578,2.55E-05,139,GO:0005912,adherens junction,4.11E-04,CC
-690,3.62E-05,93,GO:0000922,spindle pole,5.67E-04,CC
560,3.94E-05,141,GO:0070161,anchoring junction,5.97E-04,CC
610,4.04E-05,118,GO:0005840,ribosome,5.97E-04,CC
695,4.25E-05,90,GO:0030662,coated vesicle membrane,6.11E-04,CC
480,5.09E-05,188,GO:0005811,lipid droplet,7.11E-04,CC
1794,5.23E-05,13,GO:0030867,rough endoplasmic reticulum membrane,7.12E-04,CC
-827,5.79E-05,61,GO:0044450,microtubule organizing center part,7.67E-04,CC
-497,6.16E-05,171,GO:0099513,polymeric cytoskeletal fiber,7.95E-04,CC
1365,6.31E-05,22,GO:0036452,ESCRT complex,7.95E-04,CC
328,6.97E-05,405,GO:0044297,cell body,8.58E-04,CC
338,7.56E-05,376,GO:0043025,neuronal cell body,8.99E-04,CC
288,7.65E-05,532,GO:0044431,Golgi apparatus part,8.99E-04,CC
707,8.49E-05,80,GO:0005798,Golgi-associated vesicle,9.75E-04,CC
-934,9.38E-05,45,GO:0051233,spindle midzone,0.001054637,CC
615,9.94E-05,104,GO:0044391,ribosomal subunit,0.001093413,CC
-1033,1.10E-04,36,GO:0005814,centriole,0.001181792,CC
-1769,1.27E-04,12,GO:0005680,anaphase-promoting complex,0.001342936,CC
414,1.34E-04,226,GO:0030133,transport vesicle,0.001379264,CC
-804,1.36E-04,58,GO:0005643,nuclear pore,0.001379264,CC
575,1.44E-04,114,GO:0044445,cytosolic part,0.00143444,CC
508,1.96E-04,141,GO:0005795,Golgi stack,0.001908385,CC
-682,2.00E-04,77,GO:0005775;GO:0043202,lysosomal lumen,0.001918032,CC
-1008,2.45E-04,34,GO:0043596,nuclear replication fork,0.002298948,CC
-1165,2.73E-04,25,GO:0030894;GO:0043601,nuclear replisome,0.002524566,CC
786,2.81E-04,55,GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,0.002546359,CC
676,3.01E-04,74,GO:0042470;GO:0048770,pigment granule,0.002683827,CC
484,3.13E-04,145,GO:0044449,contractile fiber part,0.002745986,CC
450,3.52E-04,166,GO:0030136,clathrin-coated vesicle,0.003030297,CC
281,3.70E-04,446,GO:0005768,endosome,0.003135395,CC
689,4.10E-04,68,GO:0015934,large ribosomal subunit,0.003417847,CC
530,4.54E-04,114,GO:0030017,sarcomere,0.003722647,CC
-465,4.94E-04,147,GO:0061695,"transferase complex, transferring phosphorus-containing groups",0.003994038,CC
255,5.75E-04,514,GO:0098796,membrane protein complex,0.004576164,CC
-718,5.99E-04,59,GO:0005876,spindle microtubule,0.004690665,CC
-481,6.27E-04,132,GO:0005874,microtubule,0.004839934,CC
1458,6.46E-04,14,GO:0031201,SNARE complex,0.004911257,CC
266,6.61E-04,457,GO:0045202,synapse,0.004950115,CC
1283,6.71E-04,18,GO:0022627,cytosolic small ribosomal subunit,0.004958709,CC
282,8.09E-04,387,GO:0000139,Golgi membrane,0.005892464,CC
1298,8.26E-04,17,GO:0045179,apical cortex,0.005932393,CC
-486,8.40E-04,123,GO:0016323,basolateral plasma membrane,0.005951703,CC
-610,8.74E-04,77,GO:0000794,condensed nuclear chromosome,0.006105384,CC
532,9.13E-04,101,GO:0031985,Golgi cisterna,0.006290222,CC
-1413,9.49E-04,14,GO:0045120,pronucleus,0.006457133,CC
-1464,9.66E-04,13,GO:0000805,X chromosome,0.00648905,CC
-665,0.001114999,62,GO:0046930,pore complex,0.007299818,CC
-631,0.001115446,69,GO:0034399,nuclear periphery,0.007299818,CC
1192,0.001163912,19,GO:0030137,COPI-coated vesicle,0.007521783,CC
811,0.001195301,41,GO:0030660,Golgi-associated vesicle membrane,0.007629266,CC
330,0.0013991,250,GO:0030659,cytoplasmic vesicle membrane,0.008821154,CC
926,0.001540868,30,GO:0030120,vesicle coat,0.009577632,CC
994,0.001556134,26,GO:0035631,CD40 receptor complex,0.009577632,CC
330,0.001797947,239,GO:0044440,endosomal part,0.010747713,CC
-501,0.001800497,101,GO:0030880,RNA polymerase complex,0.010747713,CC
449,0.001808609,126,GO:0030016,myofibril,0.010747713,CC
1559,0.002044887,10,GO:0002102,podosome,0.011907082,CC
555,0.002049768,80,GO:0030658,transport vesicle membrane,0.011907082,CC
716,0.002213554,47,GO:0005913,cell-cell adherens junction,0.01271564,CC
1258,0.002313401,15,GO:0033176,proton-transporting V-type ATPase complex,0.012886708,CC
1017,0.002317764,23,GO:0099738,cell cortex region,0.012886708,CC
665,0.002318112,54,GO:0005925,focal adhesion,0.012886708,CC
597,0.002353459,67,GO:0030055,cell-substrate junction,0.012944022,CC
-1348,0.002378985,13,GO:0008278,cohesin complex,0.012946689,CC
307,0.002524812,260,GO:0012506,vesicle membrane,0.013499529,CC
-491,0.002555485,98,GO:0000428;GO:0055029,nuclear DNA-directed RNA polymerase complex,0.013499529,CC
677,0.002585913,51,GO:0030117;GO:0048475,membrane coat,0.013499529,CC
-1522,0.002608017,10,GO:0000940,condensed chromosome outer kinetochore,0.013499529,CC
1243,0.002611128,15,GO:0030126,COPI vesicle coat,0.013499529,CC
301,0.002706522,266,GO:0045177,apical part of cell,0.013753452,CC
444,0.002713447,119,GO:0008021;GO:0070382,synaptic vesicle,0.013753452,CC
-917,0.002910818,27,GO:0099023,tethering complex,0.014610611,CC
758,0.003157926,39,GO:0031430,M band,0.015635987,CC
1491,0.003191161,10,GO:0033565,ESCRT-0 complex,0.015635987,CC
1179,0.003205831,16,GO:0030663,COPI-coated vesicle membrane,0.015635987,CC
921,0.003366175,26,GO:0010494,cytoplasmic stress granule,0.016264604,CC
-1409,0.003483478,11,GO:0005828,kinetochore microtubule,0.01667554,CC
934,0.003550758,25,GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,0.016727978,CC
450,0.003585455,109,GO:0030427,site of polarized growth,0.016727978,CC
352,0.0035915,180,GO:0031252,cell leading edge,0.016727978,CC
-1338,0.003738608,12,GO:0000780,"condensed nuclear chromosome, centromeric region",0.017257684,CC
-1464,0.003786799,10,GO:0005721,pericentric heterochromatin,0.017325441,CC
672,0.004074365,47,GO:0005791,rough endoplasmic reticulum,0.018477602,CC
574,0.004271928,64,GO:0005924,cell-substrate adherens junction,0.019205103,CC
-644,0.004571615,50,GO:0072686,mitotic spindle,0.020375216,CC
-903,0.004794241,25,GO:0000803,sex chromosome,0.02118481,CC
1163,0.004875935,15,GO:0012507,ER to Golgi transport vesicle membrane,0.021363207,CC
1200,0.004998746,14,GO:0016471,vacuolar proton-transporting V-type ATPase complex,0.021548627,CC
703,0.005022837,41,GO:0000932,P-body,0.021548627,CC
686,0.005043296,43,GO:0031672,A band,0.021548627,CC
301,0.00516666,229,GO:0010008,endosome membrane,0.021894781,CC
313,0.005605042,208,GO:0098552,side of membrane,0.023559402,CC
1209,0.006432015,13,GO:0033181,plasma membrane proton-transporting V-type ATPase complex,0.026817354,CC
-1375,0.006547024,10,GO:0005656;GO:0036387,nuclear pre-replicative complex,0.027078493,CC
208,0.006938811,472,GO:0042175,nuclear outer membrane-endoplasmic reticulum membrane network,0.028471154,CC
298,0.007078683,217,GO:0098797,plasma membrane protein complex,0.028816372,CC
-1073,0.007285628,16,GO:0005652,nuclear lamina,0.029427107,CC
-231,0.007557814,367,GO:1990234,transferase complex,0.030289842,CC
212,0.007683458,438,GO:1990904,ribonucleoprotein complex,0.030556522,CC
182,0.007948036,608,GO:0005887,integral component of plasma membrane,0.031367441,CC
337,0.008172571,162,GO:0043292,contractile fiber,0.032009238,CC
-944,0.008369147,20,GO:0005747;GO:0045271;GO:0030964,mitochondrial respiratory chain complex I,0.0325327,CC
-632,0.008968011,44,GO:0046658,anchored component of plasma membrane,0.034600461,CC
-804,0.009045373,27,GO:0000152,nuclear ubiquitin ligase complex,0.034640429,CC
488,0.009113409,74,GO:0009898,cytoplasmic side of plasma membrane,0.034644355,CC
-575,0.009808587,52,GO:0005901;GO:0044853,plasma membrane raft,0.037014888,CC
922,0.009992745,20,GO:0016327,apicolateral plasma membrane,0.037436589,CC
-878,0.010113591,22,GO:0070461,SAGA-type complex,0.037616737,CC
-606,0.010416985,46,GO:0031225,anchored component of membrane,0.038468438,CC
-908,0.011177681,20,GO:0043073,germ cell nucleus,0.040984829,CC
195,0.011682244,465,GO:0005789,endoplasmic reticulum membrane,0.04253324,CC
-679,0.012125793,35,GO:0015030,Cajal body,0.043622889,CC
1072,0.012150282,14,GO:0034774,secretory granule lumen,0.043622889,CC
361,0.012544003,125,GO:0005802,trans-Golgi network,0.04472586,CC
715,0.012949948,31,GO:0005797,Golgi medial cisterna,0.045857007,CC
-724,0.013319614,30,GO:0005778;GO:0031903,peroxisomal membrane,0.046845174,CC
430,0.01383272,85,GO:0030027,lamellipodium,0.048321056,CC
445,0.013987336,79,GO:0098802,plasma membrane receptor complex,0.048533239,CC
-173,0.014174628,573,GO:0044451,nucleoplasm part,0.048793084,CC
165,0.014250978,638,GO:0031226,intrinsic component of plasma membrane,0.048793084,CC
446,0.014390478,78,GO:0098562,cytoplasmic side of membrane,0.048946561,CC
727,0.016274614,28,GO:0005923,bicellular tight junction,0.054993305,CC
397,0.016426489,95,GO:0030426,growth cone,0.055146069,CC
-1212,0.016536095,10,GO:0000808;GO:0005664,nuclear origin of replication recognition complex,0.055155877,CC
371,0.017276045,107,GO:0043235,receptor complex,0.057254584,CC
-314,0.017545393,150,GO:0044441,ciliary part,0.057776867,CC
485,0.018267111,61,GO:0030665,clathrin-coated vesicle membrane,0.059772761,CC
-260,0.018914203,216,GO:0005759,mitochondrial matrix,0.061311868,CC
-654,0.018974659,33,GO:0044452,nucleolar part,0.061311868,CC
1034,0.019790014,13,GO:0035003,subapical complex,0.063549299,CC
214,0.02042335,319,GO:0009986,cell surface,0.06517822,CC
989,0.020681075,14,GO:0016442;GO:0031332,RISC complex,0.065595802,CC
-1107,0.021723822,11,GO:0001673,male germ cell nucleus,0.068483026,CC
-1058,0.021879779,12,GO:0045239,tricarboxylic acid cycle enzyme complex,0.068556642,CC
-813,0.023083683,20,GO:0005858,axonemal dynein complex,0.071893156,CC
-1000,0.024240376,13,GO:0042575,DNA polymerase complex,0.075043559,CC
1036,0.024811473,12,GO:0070069,cytochrome complex,0.076340929,CC
481,0.024954772,56,GO:0032580,Golgi cisterna membrane,0.076340929,CC
-625,0.025140353,33,GO:0000792,heterochromatin,0.07645625,CC
-950,0.026196,14,GO:0005671,Ada2/Gcn5/Ada3 transcription activator complex,0.079200773,CC
292,0.027226142,150,GO:0005769,early endosome,0.081355609,CC
522,0.027369166,46,GO:0005801,cis-Golgi network,0.081355609,CC
-911,0.027380805,15,GO:0000307,cyclin-dependent protein kinase holoenzyme complex,0.081355609,CC
269,0.027666642,177,GO:0005911,cell-cell junction,0.081735164,CC
850,0.028403849,17,GO:0005703,polytene chromosome puff,0.083436307,CC
-898,0.029644581,15,GO:0031523,Myb complex,0.086588975,CC
524,0.030287047,44,GO:0032154,cleavage furrow,0.087968557,CC
958,0.030749631,13,GO:0043209,myelin sheath,0.088448097,CC
692,0.030794308,25,GO:0030134,COPII-coated ER to Golgi transport vesicle,0.088448097,CC
-636,0.032447656,29,GO:0000781,"chromosome, telomeric region",0.092681978,CC
-480,0.034283789,50,GO:0031526,brush border membrane,0.097388565,CC
-514,0.035408231,43,GO:0005881,cytoplasmic microtubule,0.10003309,CC
-599,0.037379192,31,GO:1902554,serine/threonine protein kinase complex,0.105027403,CC
181,0.038057321,358,GO:0030424,axon,0.106354784,CC
1047,0.038459492,10,GO:0016580,Sin3 complex,0.106900846,CC
-352,0.039025118,89,GO:0030496,midbody,0.107892973,CC
450,0.039301773,54,GO:0031594,neuromuscular junction,0.108079874,CC
736,0.039815164,20,GO:0005844,polysome,0.108636364,CC
-822,0.039924389,16,GO:0000784,"nuclear chromosome, telomeric region",0.108636364,CC
1033,0.040996009,10,GO:0044298,cell body membrane,0.110429615,CC
-338,0.041010612,95,GO:0019898,extrinsic component of membrane,0.110429615,CC
-584,0.042280735,31,GO:0030286,dynein complex,0.113259792,CC
447,0.04259686,53,GO:0032153,cell division site,0.113518435,CC
208,0.043454462,252,GO:0099503,secretory vesicle,0.115210034,CC
-931,0.043685315,12,GO:0071547,piP-body,0.115231164,CC
161,0.045389383,430,GO:0048471,perinuclear region of cytoplasm,0.11911833,CC
-533,0.045995858,36,GO:0070603,SWI/SNF superfamily-type complex,0.119744517,CC
-962,0.046091216,11,GO:0030062,mitochondrial tricarboxylic acid cycle enzyme complex,0.119744517,CC
-394,0.0465368,66,GO:0005903,brush border,0.12026662,CC
-465,0.046757429,47,GO:0044439;GO:0044438,microbody part,0.12026662,CC
480,0.047223146,44,GO:0042734,presynaptic membrane,0.120863202,CC
-954,0.047872665,11,GO:0005666,RNA polymerase III complex,0.121922009,CC
364,0.048253014,76,GO:0045335,phagocytic vesicle,0.122288277,CC
910,0.048583228,12,GO:0034706,sodium channel complex,0.122524532,CC
-373,0.050433425,71,GO:0016591,"RNA polymerase II, holoenzyme",0.126573208,CC
757,0.051190809,17,GO:0045334,clathrin-coated endocytic vesicle,0.127853374,CC
-775,0.052747686,16,GO:0033202,DNA helicase complex,0.131108431,CC
974,0.053947342,10,GO:0043194,axon initial segment,0.133448689,CC
604,0.059257094,25,GO:0016469,proton-transporting two-sector ATPase complex,0.145176626,CC
629,0.05943041,23,GO:0044304,main axon,0.145176626,CC
-836,0.059530841,13,GO:0000242,pericentriolar material,0.145176626,CC
774,0.060920148,15,GO:0005790,smooth endoplasmic reticulum,0.147867213,CC
798,0.061788843,14,GO:0033106,cis-Golgi network membrane,0.149274915,CC
-389,0.062876363,59,GO:0045495,pole plasm,0.15119572,CC
562,0.063431715,28,GO:0030670,phagocytic vesicle membrane,0.151824984,CC
-373,0.065365988,63,GO:0000123,histone acetyltransferase complex,0.155733713,CC
848,0.066276972,12,GO:0005915,zonula adherens,0.156890194,CC
928,0.066458322,10,GO:0031093,platelet alpha granule lumen,0.156890194,CC
-281,0.067016576,111,GO:0044420,extracellular matrix component,0.157488955,CC
432,0.067640392,46,GO:0032588,trans-Golgi network membrane,0.158013356,CC
-257,0.067850996,132,GO:0031514,motile cilium,0.158013356,CC
-254,0.069337968,134,GO:0098798,mitochondrial protein complex,0.160752151,CC
353,0.06999448,68,GO:0031674,I band,0.161116625,CC
-364,0.070118454,64,GO:0031248;GO:1902493,acetyltransferase complex,0.161116625,CC
-722,0.070925788,16,GO:0000124,SAGA complex,0.162250586,CC
-404,0.072088037,51,GO:0016363,nuclear matrix,0.162828367,CC
290,0.072394884,100,GO:0016607,nuclear speck,0.162828367,CC
455,0.072499574,40,GO:0030667,secretory granule membrane,0.162828367,CC
718,0.072531948,16,GO:0070822,Sin3-type complex,0.162828367,CC
-181,0.0727531,263,GO:0000323,lytic vacuole,0.162828367,CC
410,0.073872169,49,GO:0043204,perikaryon,0.164620307,CC
-790,0.075083622,13,GO:0030914,STAGA complex,0.166492788,CC
-898,0.075655374,10,GO:0036038,MKS complex,0.166492788,CC
856,0.07567854,11,GO:0005850,eukaryotic translation initiation factor 2 complex,0.166492788,CC
-261,0.076477942,120,GO:0000790,nuclear chromatin,0.167538541,CC
402,0.079632993,49,GO:0032155,cell division site part,0.173714166,CC
-347,0.081723487,65,GO:1904949,ATPase complex,0.177525391,CC
-604,0.083955386,21,GO:0000795;GO:0099086,synaptonemal complex,0.180216801,CC
209,0.084151408,180,GO:0033267,axon part,0.180216801,CC
364,0.084295206,58,GO:0030176,integral component of endoplasmic reticulum membrane,0.180216801,CC
-276,0.084356801,102,GO:0098862,cluster of actin-based cell projections,0.180216801,CC
-177,0.08592671,253,GO:0005764,lysosome,0.182815264,CC
706,0.087484778,15,GO:0014704;GO:0044291,intercalated disc,0.185367337,CC
402,0.089297607,46,GO:0031901,early endosome membrane,0.188436175,CC
-543,0.090116117,25,GO:0009925,basal plasma membrane,0.189390376,CC
429,0.090749055,40,GO:0030175,filopodium,0.189948426,CC
-780,0.091165394,12,GO:0032039,integrator complex,0.190050439,CC
-615,0.093714448,19,GO:0097431,mitotic spindle pole,0.194579798,CC
189,0.094932862,208,GO:0005938,cell cortex,0.195674468,CC
-497,0.09499863,29,GO:0005884,actin filament,0.195674468,CC
338,0.097549188,62,GO:0030018,Z disc,0.200130676,CC
-102,0.098362161,773,GO:1902494,catalytic complex,0.201000938,CC
159,0.100146745,287,GO:0030054,cell junction,0.203841996,CC
337,0.10098818,61,GO:0031227,intrinsic component of endoplasmic reticulum membrane,0.204748584,CC
534,0.102223557,24,GO:0030140,trans-Golgi network transport vesicle,0.206443668,CC
283,0.102859631,86,GO:0019867,outer membrane,0.206919958,CC
-596,0.104582062,19,GO:1990023,mitotic spindle midzone,0.20956948,CC
330,0.106043241,62,GO:0031256,leading edge membrane,0.211677048,CC
-426,0.110423456,36,GO:1902562,H4 histone acetyltransferase complex,0.219572796,CC
148,0.114837526,308,GO:0030425,dendrite,0.227198454,CC
-409,0.115446501,38,GO:0016234,inclusion body,0.227198454,CC
223,0.115576776,130,GO:0009897,external side of plasma membrane,0.227198454,CC
546,0.11770319,21,GO:0017090,meprin A complex,0.229233859,CC
362,0.117861172,48,GO:0055120,striated muscle dense body,0.229233859,CC
646,0.117942372,15,GO:0001917,photoreceptor inner segment,0.229233859,CC
-453,0.121526947,30,GO:0031232,extrinsic component of external side of plasma membrane,0.235316223,CC
110,0.123294634,553,GO:0044432,endoplasmic reticulum part,0.237848231,CC
-682,0.124436753,13,GO:0033276,transcription factor TFTC complex,0.239159113,CC
-519,0.128520249,22,GO:0005796,Golgi lumen,0.245297799,CC
-674,0.128579698,13,GO:0005658,alpha DNA polymerase:primase complex,0.245297799,CC
-334,0.129554774,53,GO:0060293,germ plasm,0.246249332,CC
260,0.138744495,84,GO:0031968,organelle outer membrane,0.262750564,CC
-309,0.139917892,59,GO:0044798,nuclear transcription factor complex,0.264005658,CC
-336,0.14697988,48,GO:0090575,RNA polymerase II transcription factor complex,0.276322175,CC
579,0.147931168,16,GO:0005705,polytene chromosome interband,0.277006316,CC
-517,0.148832406,20,GO:0032420,stereocilium,0.277006316,CC
370,0.148951172,39,GO:0015935,small ribosomal subunit,0.277006316,CC
125,0.150672,359,GO:0044456,synapse part,0.279202237,CC
-512,0.152296324,20,GO:0000314;GO:0005763,organellar small ribosomal subunit,0.281204284,CC
-270,0.160059497,70,GO:0019897,extrinsic component of plasma membrane,0.29448669,CC
440,0.16128512,26,GO:0032589,neuron projection membrane,0.295689386,CC
-525,0.163515574,18,GO:0000178;GO:1905354,exoribonuclease complex,0.298719264,CC
-307,0.171257279,51,GO:0043186,P granule,0.311760609,CC
657,0.173143908,11,GO:0002116,semaphorin receptor complex,0.314089124,CC
553,0.180316612,15,GO:0044295,axonal growth cone,0.324821214,CC
553,0.180316612,15,GO:0060473,cortical granule,0.324821214,CC
-592,0.181724315,13,GO:0005882,intermediate filament,0.326220384,CC
669,0.186126947,10,GO:0005744,TIM23 mitochondrial import inner membrane translocase complex,0.332967583,CC
-497,0.187761577,18,GO:0000791,euchromatin,0.334130435,CC
544,0.188069549,15,GO:0016461,unconventional myosin complex,0.334130435,CC
582,0.18916936,13,GO:0001891,phagocytic cup,0.334634316,CC
663,0.189647688,10,GO:0035145,exon-exon junction complex,0.334634316,CC
237,0.190831091,79,GO:0005741,mitochondrial outer membrane,0.335577122,CC
86,0.191668092,672,GO:0044463,cell projection part,0.335906453,CC
-305,0.192514169,47,GO:0000313;GO:0005761,mitochondrial ribosome,0.33624941,CC
-537,0.193890937,15,GO:0036126;GO:0097729,sperm flagellum,0.337513854,CC
423,0.195921085,24,GO:0032587,ruffle membrane,0.339903359,CC
327,0.203328051,39,GO:0030672;GO:0099501,exocytic vesicle membrane,0.351086564,CC
-587,0.203725279,12,GO:0000235,astral microtubule,0.351086564,CC
405,0.206100911,25,GO:0016028,rhabdomere,0.354000568,CC
-535,0.210939992,14,GO:0031011;GO:0097346,INO80-type complex,0.361112504,CC
621,0.219519562,10,GO:0033270,paranode region of axon,0.37322041,CC
-378,0.219914631,27,GO:0005892,acetylcholine-gated channel complex,0.37322041,CC
196,0.220178385,102,GO:0035770,ribonucleoprotein granule,0.37322041,CC
427,0.221744394,21,GO:0005771,multivesicular body,0.374646575,CC
-325,0.224185808,36,GO:1902911,protein kinase complex,0.377537663,CC
195,0.228555889,99,GO:0036464,cytoplasmic ribonucleoprotein granule,0.383647385,CC
363,0.230041502,28,GO:0043198,dendritic shaft,0.384891445,CC
251,0.233013425,58,GO:0031902,late endosome membrane,0.388606261,CC
-108,0.236259226,324,GO:0005875,microtubule associated complex,0.392069824,CC
-570,0.237236961,11,GO:0000177,cytoplasmic exosome (RNase complex),0.392069824,CC
230,0.23736529,68,GO:0043296,apical junction complex,0.392069824,CC
-120,0.238149159,258,GO:0005635,nuclear envelope,0.392111832,CC
469,0.240643768,16,GO:0005852,eukaryotic translation initiation factor 3 complex,0.394961359,CC
-367,0.242339882,26,GO:0044815,DNA packaging complex,0.396486452,CC
440,0.243779678,18,GO:0060076,excitatory synapse,0.397583891,CC
114,0.247472325,275,GO:0099568,cytoplasmic region,0.402337081,CC
221,0.26080798,67,GO:0001726,ruffle,0.422688796,CC
135,0.263883755,182,GO:0016324,apical plasma membrane,0.426337191,CC
157,0.270522553,128,GO:0031301,integral component of organelle membrane,0.435701433,CC
-235,0.272502063,56,GO:0030532;GO:0120114,small nuclear ribonucleoprotein complex,0.437526605,CC
-553,0.274103092,10,GO:0005675,transcription factor TFIIH holo complex,0.438734671,CC
-141,0.278357239,156,GO:0031965,nuclear membrane,0.443520883,CC
-419,0.280050174,17,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,0.443520883,CC
-281,0.280260563,38,GO:0005902,microvillus,0.443520883,CC
-258,0.280524814,45,GO:0035869,ciliary transition zone,0.443520883,CC
-356,0.285945219,23,GO:0035327,transcriptionally active chromatin,0.450269179,CC
134,0.286780464,167,GO:0005774,vacuolar membrane,0.450269179,CC
-221,0.287405859,60,GO:1990204,oxidoreductase complex,0.450269179,CC
-226,0.288313656,57,GO:0031461,cullin-RING ubiquitin ligase complex,0.450326768,CC
317,0.295094672,28,GO:0016459,myosin complex,0.459529955,CC
371,0.299744639,20,GO:0019005,SCF ubiquitin ligase complex,0.465369304,CC
-91,0.312401057,331,GO:0099080,supramolecular complex,0.483566906,CC
68,0.315652968,628,GO:0120038,plasma membrane bounded cell projection part,0.485843653,CC
-126,0.315751388,168,GO:0005667,transcription factor complex,0.485843653,CC
-257,0.317599752,39,GO:0097525,spliceosomal snRNP complex,0.487237602,CC
425,0.320221315,14,GO:0060187,cell pole,0.489805976,CC
-478,0.321733562,11,GO:0005868,cytoplasmic dynein complex,0.490667409,CC
439,0.322824755,13,GO:0033178,"proton-transporting two-sector ATPase complex, catalytic domain",0.490883524,CC
-288,0.324742192,30,GO:0031233,intrinsic component of external side of plasma membrane,0.492351066,CC
-495,0.327122147,10,GO:0030684;GO:0030686,90S preribosome,0.493562029,CC
-89,0.327624311,328,GO:0099512;GO:0099081,supramolecular fiber,0.493562029,CC
-254,0.328461345,38,GO:0044447,axoneme part,0.493562029,CC
-161,0.329359575,95,GO:0005777;GO:0042579,peroxisome,0.493562029,CC
-164,0.333971861,90,GO:0062023,collagen-containing extracellular matrix,0.499027318,CC
-264,0.336442137,34,GO:0030863,cortical cytoskeleton,0.501183844,CC
212,0.337353922,53,GO:0070160,tight junction,0.501183844,CC
-387,0.349134983,15,GO:0005581,collagen trimer,0.517199961,CC
-209,0.351758718,51,GO:0042383,sarcolemma,0.519597878,CC
317,0.353310824,22,GO:0060205,cytoplasmic vesicle lumen,0.520403692,CC
-67,0.364873249,508,GO:0044429,mitochondrial part,0.534169316,CC
-302,0.36540195,23,GO:0016235,aggresome,0.534169316,CC
126,0.365756166,134,GO:0031300,intrinsic component of organelle membrane,0.534169316,CC
-373,0.383274801,14,GO:0033391,chromatoid body,0.556011223,CC
116,0.383655002,149,GO:0030141,secretory granule,0.556011223,CC
-232,0.38525492,36,GO:0016528,sarcoplasm,0.556011223,CC
419,0.38534506,11,GO:0033268,node of Ranvier,0.556011223,CC
-417,0.386691028,11,GO:0005779,integral component of peroxisomal membrane,0.556011223,CC
-282,0.388228124,24,GO:0031362,anchored component of external side of plasma membrane,0.556011223,CC
-89,0.388239945,254,GO:0005929,cilium,0.556011223,CC
108,0.390328158,168,GO:0005681,spliceosomal complex,0.556964958,CC
-366,0.392481476,14,GO:0005686,U2 snRNP,0.556964958,CC
365,0.392666967,14,GO:0009506;GO:0055044,plasmodesma,0.556964958,CC
-341,0.393215106,16,GO:0005818,aster,0.556964958,CC
224,0.395087999,37,GO:0005871,kinesin complex,0.558088785,CC
313,0.406150934,18,GO:0031091,platelet alpha granule,0.572152678,CC
-255,0.40776065,27,GO:0005918,septate junction,0.572859391,CC
-281,0.410771898,22,GO:0032391,photoreceptor connecting cilium,0.57452018,CC
-137,0.411165313,94,GO:0045211,postsynaptic membrane,0.57452018,CC
116,0.415982429,129,GO:0005770,late endosome,0.579684409,CC
-74,0.419877518,322,GO:0005773,vacuole,0.582384234,CC
288,0.421126448,20,GO:0001725;GO:0097517;GO:0032432,actin filament bundle,0.582384234,CC
248,0.421299233,27,GO:0098573,intrinsic component of mitochondrial membrane,0.582384234,CC
248,0.429167504,26,GO:0032592,integral component of mitochondrial membrane,0.59156947,CC
166,0.430232342,58,GO:0034703,cation channel complex,0.59156947,CC
-179,0.434730773,49,GO:0043197;GO:0044309;GO:0098794,dendritic spine,0.596169256,CC
-344,0.438630048,13,GO:0005859;GO:0016460,myosin II complex,0.59855654,CC
270,0.43945872,21,GO:0055038,recycling endosome membrane,0.59855654,CC
270,0.439944845,21,GO:0030118,clathrin coat,0.59855654,CC
-371,0.441282356,11,GO:0010369,chromocenter,0.598800467,CC
352,0.446000845,12,GO:0030131,clathrin adaptor complex,0.603618945,CC
323,0.450281052,14,GO:0031304;GO:0031305,intrinsic component of mitochondrial inner membrane,0.606744193,CC
-348,0.450657195,12,GO:0005665,"RNA polymerase II, core complex",0.606744193,CC
-380,0.452491702,10,GO:0005753;GO:0045259,mitochondrial proton-transporting ATP synthase complex,0.607631714,CC
-314,0.46233267,14,GO:0005669,transcription factor TFIID complex,0.619238317,CC
148,0.471204612,61,GO:0055037,recycling endosome,0.629490399,CC
-221,0.474286783,27,GO:0044665,MLL1/2 complex,0.631974915,CC
-326,0.479953289,12,GO:0005849,mRNA cleavage factor complex,0.637435222,CC
-133,0.481347152,73,GO:0005930,axoneme,0.637435222,CC
-339,0.482083505,11,GO:0033017,sarcoplasmic reticulum membrane,0.637435222,CC
-192,0.484292207,34,GO:0098803,respiratory chain complex,0.637467717,CC
-54,0.485802465,459,GO:0005730,nucleolus,0.637467717,CC
-154,0.486132129,53,GO:0097014,ciliary plasm,0.637467717,CC
-135,0.487040132,69,GO:0032838,plasma membrane bounded cell projection cytoplasm,0.637467717,CC
-281,0.49575759,15,GO:0030315,T-tubule,0.647239076,CC
-127,0.498400573,74,GO:0044448,cell cortex part,0.64905062,CC
-165,0.504845271,42,GO:0045178,basal part of cell,0.65579147,CC
-257,0.506982493,17,GO:0005732,small nucleolar ribonucleoprotein complex,0.656902944,CC
-319,0.508242123,11,GO:0036379,myofilament,0.656902944,CC
58,0.51155968,353,GO:0005740,mitochondrial envelope,0.659542031,CC
-300,0.515385221,12,GO:0032994,protein-lipid complex,0.662821291,CC
-295,0.523243185,12,GO:0000176,nuclear exosome (RNase complex),0.671257386,CC
-68,0.528123842,227,GO:0031012,extracellular matrix,0.674565859,CC
-280,0.528431669,13,GO:0044435;GO:0044434,plastid part,0.674565859,CC
-284,0.539141526,12,GO:0032806,carboxy-terminal domain protein kinase complex,0.686542288,CC
-114,0.551719969,71,GO:0005905,clathrin-coated pit,0.700833474,CC
-204,0.559435535,21,GO:0060170,ciliary membrane,0.708892577,CC
-65,0.563467792,210,GO:0044437,vacuolar part,0.709505274,CC
-193,0.563813582,23,GO:0071339,MLL1 complex,0.709505274,CC
-181,0.564036108,26,GO:0000315;GO:0005762,organellar large ribosomal subunit,0.709505274,CC
-116,0.575416598,60,GO:0097223,sperm part,0.722064031,CC
-91,0.578637901,96,GO:0005788,endoplasmic reticulum lumen,0.723113957,CC
-256,0.579050635,12,GO:0005891,voltage-gated calcium channel complex,0.723113957,CC
-141,0.5864279,38,GO:0005746;GO:0070469,mitochondrial respirasome,0.729353279,CC
-275,0.586981762,10,GO:0000322;GO:0000324,fungal-type vacuole,0.729353279,CC
-188,0.589844995,21,GO:0005782;GO:0031907,peroxisomal matrix,0.729353279,CC
-73,0.589869352,143,GO:0045121;GO:0098857,membrane raft,0.729353279,CC
67,0.591100627,167,GO:0015629,actin cytoskeleton,0.729353279,CC
195,0.595858679,19,GO:0070852,cell body fiber,0.73347366,CC
174,0.601680255,23,GO:0031519,PcG protein complex,0.738484204,CC
240,0.602785946,12,GO:0030125,clathrin vesicle coat,0.738484204,CC
188,0.607981115,19,GO:0001750,photoreceptor outer segment,0.74238351,CC
77,0.609330481,115,GO:0071013,catalytic step 2 spliceosome,0.74238351,CC
92,0.610276579,79,GO:0030666,endocytic vesicle membrane,0.74238351,CC
255,0.613995375,10,GO:0031306,intrinsic component of mitochondrial outer membrane,0.745154011,CC
145,0.620811502,30,GO:0005758,mitochondrial intermembrane space,0.751661702,CC
99,0.626455479,62,GO:0043195,terminal bouton,0.75672309,CC
105,0.632404819,54,GO:0043230;GO:0065010;GO:1903561,extracellular organelle,0.762128885,CC
-176,0.640105033,18,GO:0005720,nuclear heterochromatin,0.768014017,CC
159,0.640259267,22,GO:0008287,protein serine/threonine phosphatase complex,0.768014017,CC
-214,0.64371852,12,GO:0031231,intrinsic component of peroxisomal membrane,0.770376099,CC
-217,0.652464453,11,GO:0034518,RNA cap binding complex,0.779039543,CC
-135,0.654808474,28,GO:0016592,mediator complex,0.780036822,CC
-31,0.656376573,609,GO:0031967,organelle envelope,0.78010733,CC
131,0.659053078,29,GO:0031983,vesicle lumen,0.781491838,CC
-209,0.665456699,11,GO:0034358;GO:1990777,plasma lipoprotein particle,0.786110377,CC
218,0.665989062,10,GO:0032590,dendrite membrane,0.786110377,CC
146,0.669806584,22,GO:0005776,autophagosome,0.787541474,CC
74,0.670248063,86,GO:0014069;GO:0099572,postsynaptic density,0.787541474,CC
-100,0.678645349,44,GO:0016605,PML body,0.793933481,CC
-71,0.678759379,88,GO:0034702,ion channel complex,0.793933481,CC
137,0.681219408,23,GO:0043190,ATP-binding cassette (ABC) transporter complex,0.795012266,CC
-28,0.684672881,610,GO:0031975,envelope,0.797242971,CC
-54,0.686647344,144,GO:0098589,membrane region,0.797745341,CC
131,0.695278508,23,GO:0045172,germline ring canal,0.805961858,CC
-129,0.705528852,22,GO:0030864,cortical actin cytoskeleton,0.816014354,CC
66,0.709344801,82,GO:0098793;GO:0043679,presynapse,0.818596567,CC
93,0.712639631,40,GO:0001669,acrosomal vesicle,0.820269682,CC
55,0.713967808,116,GO:0005765,lysosomal membrane,0.820269682,CC
-179,0.723943161,10,GO:0070090,metaphase plate,0.829886063,CC
31,0.730410384,338,GO:0031966,mitochondrial membrane,0.835447276,CC
102,0.73726133,28,GO:0009295,nucleoid,0.841421871,CC
66,0.76592364,53,GO:0070062,extracellular exosome,0.872208198,CC
117,0.769273584,16,GO:0005637,nuclear inner membrane,0.874097677,CC
80,0.77200787,34,GO:0016328,lateral plasma membrane,0.874687591,CC
51,0.773176458,84,GO:0044306,neuron projection terminus,0.874687591,CC
44,0.775991252,111,GO:0071011,precatalytic spliceosome,0.87595519,CC
-43,0.788632182,103,GO:0000151,ubiquitin ligase complex,0.886543095,CC
67,0.790323453,41,GO:0017053,transcriptional repressor complex,0.886543095,CC
-40,0.791124724,115,GO:1902495,transmembrane transporter complex,0.886543095,CC
-83,0.79223,26,GO:0042641,actomyosin,0.886543095,CC
115,0.795158332,13,GO:0008328;GO:0098878,neurotransmitter receptor complex,0.88789818,CC
-106,0.803601156,14,GO:0034704,calcium channel complex,0.895391805,CC
-64,0.807741689,37,GO:0031970,organelle envelope lumen,0.898069792,CC
17,0.813772462,525,GO:0044421,extracellular region part,0.901468082,CC
-119,0.814285482,10,GO:0009526;GO:0009941,plastid envelope,0.901468082,CC
23,0.819072757,262,GO:0019866,organelle inner membrane,0.904395937,CC
70,0.820428809,27,GO:0009507;GO:0009536,chloroplast,0.904395937,CC
-95,0.825055203,14,GO:0032839;GO:0120111,dendrite cytoplasm,0.907560723,CC
-69,0.830041649,25,GO:1903293,phosphatase complex,0.90845318,CC
78,0.830769883,19,GO:0030119,AP-type membrane coat adaptor complex,0.90845318,CC
55,0.831460697,38,GO:0000118,histone deacetylase complex,0.90845318,CC
16,0.832895179,517,GO:0098590,plasma membrane region,0.90845318,CC
83,0.836036798,16,GO:0030312,external encapsulating structure,0.908541738,CC
66,0.83787757,25,GO:0034705,potassium channel complex,0.908541738,CC
-37,0.838248373,78,GO:0005604,basement membrane,0.908541738,CC
62,0.840488426,27,GO:0098533,ATPase dependent transmembrane transport complex,0.909063842,CC
71,0.843747054,20,GO:0030173,integral component of Golgi membrane,0.910203708,CC
27,0.845063404,133,GO:0097060,synaptic membrane,0.910203708,CC
-76,0.853289482,15,GO:0035267;GO:0043189,H4/H2A histone acetyltransferase complex,0.916879289,CC
-93,0.854808157,10,GO:0035324,female germline ring canal,0.916879289,CC
-17,0.856634508,322,GO:0005615,extracellular space,0.916935902,CC
-45,0.861863301,38,GO:0032421,stereocilium bundle,0.920286612,CC
-26,0.863760533,118,GO:1990351,transporter complex,0.920286612,CC
-85,0.866795773,10,GO:0031258,lamellipodium membrane,0.920286612,CC
-47,0.866885068,33,GO:0016529,sarcoplasmic reticulum,0.920286612,CC
82,0.871474737,10,GO:0031045,dense core granule,0.921243954,CC
-81,0.873347593,10,GO:0005845,mRNA cap binding complex,0.921243954,CC
17,0.873460449,246,GO:0005743,mitochondrial inner membrane,0.921243954,CC
-26,0.87491447,99,GO:0044455,mitochondrial membrane part,0.921243954,CC
-35,0.879356684,48,GO:0034708;GO:0035097,histone methyltransferase complex,0.922743393,CC
76,0.87990811,10,GO:0005869,dynactin complex,0.922743393,CC
-58,0.89133452,14,GO:0080008,Cul4-RING E3 ubiquitin ligase complex,0.932830663,CC
-47,0.893135741,21,GO:0008076,voltage-gated potassium channel complex,0.932830663,CC
42,0.899913175,23,GO:0031228,intrinsic component of Golgi membrane,0.938014337,CC
23,0.902416279,74,GO:0098858,actin-based cell projection,0.938730817,CC
-34,0.908274608,29,GO:0045169,fusome,0.941720266,CC
16,0.910565245,124,GO:0098852,lytic vacuole membrane,0.941720266,CC
-46,0.910754609,15,GO:0090568,nuclear transcriptional repressor complex,0.941720266,CC
-22,0.920630503,55,GO:0098800,inner mitochondrial membrane protein complex,0.950031876,CC
-37,0.922469477,18,GO:0000786,nucleosome,0.950033306,CC
-13,0.92598381,141,GO:0031253,cell projection membrane,0.951379023,CC
16,0.927456533,85,GO:0005700,polytene chromosome,0.951379023,CC
-20,0.930393905,47,GO:0045111,intermediate filament cytoskeleton,0.952502275,CC
-10,0.93642114,182,GO:0016604,nuclear body,0.956778122,CC
30,0.939090069,17,GO:0036056,filtration diaphragm,0.957612556,CC
-22,0.944910205,26,GO:0045171,intercellular bridge,0.96165074,CC
24,0.949267962,18,GO:0048786,presynaptic active zone,0.964187694,CC
25,0.955293345,13,GO:0005618,cell wall,0.968023146,CC
25,0.956788835,12,GO:0036057,slit diaphragm,0.968023146,CC
19,0.970837602,10,GO:0005719,nuclear euchromatin,0.980318438,CC
8,0.980488401,27,GO:0042645,mitochondrial nucleoid,0.985544384,CC
-9,0.981498564,17,GO:0005689,U12-type spliceosomal complex,0.985544384,CC
-3,0.982370863,168,GO:0030139,endocytic vesicle,0.985544384,CC
-10,0.983638109,10,GO:0051286,cell tip,0.985544384,CC
3,0.991769836,29,GO:0008023,transcription elongation factor complex,0.991769836,CC
504,2.57E-10,466,GO:0004871,obsolete signal transducer activity,1.77E-07,MF
472,1.73E-09,484,GO:0060089,molecular transducer activity,5.98E-07,MF
-876,1.53E-08,116,GO:0005342;GO:0046943,organic acid transmembrane transporter activity,3.52E-06,MF
-741,2.10E-07,137,GO:0140097,"catalytic activity, acting on DNA",3.61E-05,MF
405,3.06E-07,475,GO:0019899,enzyme binding,4.21E-05,MF
-705,5.96E-07,140,GO:0008514,organic anion transmembrane transporter activity,6.84E-05,MF
-851,7.07E-07,94,GO:0004518,nuclease activity,6.96E-05,MF
-913,1.03E-06,79,GO:0008238,exopeptidase activity,8.85E-05,MF
-893,1.77E-06,79,GO:0015171,amino acid transmembrane transporter activity,1.36E-04,MF
380,3.14E-06,445,GO:0032553,ribonucleotide binding,2.14E-04,MF
-408,3.42E-06,378,GO:0016788,"hydrolase activity, acting on ester bonds",2.14E-04,MF
380,3.78E-06,437,GO:0032555,purine ribonucleotide binding,2.17E-04,MF
590,4.46E-06,170,GO:0004842,ubiquitin-protein transferase activity,2.36E-04,MF
-1054,5.61E-06,51,GO:0008028,monocarboxylic acid transmembrane transporter activity,2.76E-04,MF
455,6.90E-06,280,GO:0004888,transmembrane signaling receptor activity,3.17E-04,MF
2040,8.45E-06,13,GO:0005484,SNAP receptor activity,3.64E-04,MF
551,1.02E-05,180,GO:0019787,ubiquitin-like protein transferase activity,4.15E-04,MF
760,1.63E-05,89,GO:0045182,translation regulator activity,6.24E-04,MF
-861,2.15E-05,67,GO:0016798,"hydrolase activity, acting on glycosyl bonds",7.45E-04,MF
539,2.18E-05,174,GO:0032561,guanyl ribonucleotide binding,7.45E-04,MF
-1940,2.29E-05,13,GO:0015183,L-aspartate transmembrane transporter activity,7.45E-04,MF
414,2.45E-05,298,GO:0038023,signaling receptor activity,7.45E-04,MF
343,2.49E-05,447,GO:0017076,purine nucleotide binding,7.45E-04,MF
575,3.27E-05,146,GO:0019900,kinase binding,9.03E-04,MF
363,3.28E-05,382,GO:0035639,purine ribonucleoside triphosphate binding,9.03E-04,MF
487,3.83E-05,202,GO:0019904,protein domain specific binding,9.52E-04,MF
297,3.91E-05,579,GO:0097367,carbohydrate derivative binding,9.52E-04,MF
-2047,3.94E-05,11,GO:0017153,sodium:dicarboxylate symporter activity,9.52E-04,MF
-1003,4.01E-05,46,GO:0016835,carbon-oxygen lyase activity,9.52E-04,MF
-1503,4.78E-05,20,GO:0008513,secondary active organic cation transmembrane transporter activity,0.001098851,MF
512,5.00E-05,176,GO:0019001,guanyl nucleotide binding,0.001112236,MF
-504,6.27E-05,177,GO:0008509,anion transmembrane transporter activity,0.001314147,MF
-753,6.29E-05,78,GO:0016597,amino acid binding,0.001314147,MF
-875,6.81E-05,57,GO:0015370,solute:sodium symporter activity,0.001381029,MF
577,7.62E-05,131,GO:0031267,small GTPase binding,0.001500462,MF
582,9.66E-05,125,GO:0017016,Ras GTPase binding,0.00184791,MF
333,1.01E-04,398,GO:0001883,purine nucleoside binding,0.001878422,MF
331,1.18E-04,396,GO:0032550;GO:0032549,purine ribonucleoside binding,0.002133027,MF
-1156,1.29E-04,30,GO:0003684,damaged DNA binding,0.002282556,MF
-1995,1.33E-04,10,GO:0005314;GO:0015501,glutamate:sodium symporter activity,0.002298629,MF
326,1.40E-04,400,GO:0001882,nucleoside binding,0.002357686,MF
-1607,1.65E-04,15,GO:0015556,C4-dicarboxylate transmembrane transporter activity,0.002701045,MF
493,1.71E-04,163,GO:0051020,GTPase binding,0.00273701,MF
-1093,1.87E-04,32,GO:0005343,organic acid:sodium symporter activity,0.002925566,MF
722,2.02E-04,73,GO:0090079,"translation regulator activity, nucleic acid binding",0.003099968,MF
-1223,2.17E-04,25,GO:0008408,3'-5' exonuclease activity,0.003118941,MF
-1020,2.18E-04,36,GO:0016836,hydro-lyase activity,0.003118941,MF
1133,2.25E-04,29,GO:0030506,ankyrin binding,0.003118941,MF
-989,2.31E-04,38,GO:0004527,exonuclease activity,0.003118941,MF
440,2.33E-04,197,GO:0016881,acid-amino acid ligase activity,0.003118941,MF
-1327,2.34E-04,21,GO:0019825,oxygen binding,0.003118941,MF
-425,2.36E-04,212,GO:0140098,"catalytic activity, acting on RNA",0.003118941,MF
-1325,2.40E-04,21,GO:0015199;GO:0015651;GO:0015226,amino-acid betaine transmembrane transporter activity,0.003118941,MF
-770,2.58E-04,62,GO:0015294;GO:0015293,solute:cation symporter activity,0.003291542,MF
-1282,2.76E-04,22,GO:0005310,dicarboxylic acid transmembrane transporter activity,0.003463025,MF
586,2.95E-04,106,GO:0003735,structural constituent of ribosome,0.003625897,MF
-881,3.10E-04,46,GO:0015179,L-amino acid transmembrane transporter activity,0.003752315,MF
-1483,3.30E-04,16,GO:0015172,acidic amino acid transmembrane transporter activity,0.003924115,MF
1755,4.25E-04,11,GO:0035438,cyclic-di-GMP binding,0.004887024,MF
-1555,4.30E-04,14,GO:0008484,sulfuric ester hydrolase activity,0.004887024,MF
-1141,4.33E-04,26,GO:0005416,amino acid:cation symporter activity,0.004887024,MF
-1550,4.46E-04,14,GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",0.00495775,MF
516,4.70E-04,128,GO:0019901,protein kinase binding,0.005144767,MF
-665,5.23E-04,75,GO:0015238,drug transmembrane transporter activity,0.005625214,MF
-1029,5.32E-04,31,GO:0072341,modified amino acid binding,0.005642994,MF
-732,5.65E-04,61,GO:0004519,endonuclease activity,0.005829814,MF
474,5.67E-04,148,GO:0005525,GTP binding,0.005829814,MF
-1576,5.80E-04,13,GO:0003943,N-acetylgalactosamine-4-sulfatase activity,0.005839464,MF
742,5.85E-04,59,GO:0008135,"translation factor activity, RNA binding",0.005839464,MF
-1019,6.05E-04,31,GO:0004180,carboxypeptidase activity,0.005958224,MF
-525,6.59E-04,117,GO:0016829,lyase activity,0.006391578,MF
-1363,6.72E-04,17,GO:0016595,glutamate binding,0.006433237,MF
652,7.99E-04,73,GO:0005057,"obsolete signal transducer activity, downstream of receptor",0.007544522,MF
-408,8.74E-04,187,GO:0003682,chromatin binding,0.008139508,MF
1095,9.33E-04,25,GO:0030551,cyclic nucleotide binding,0.008540381,MF
-1411,9.45E-04,15,GO:0005313,L-glutamate transmembrane transporter activity,0.008540381,MF
-966,9.54E-04,32,GO:0034061,DNA polymerase activity,0.008540381,MF
455,9.93E-04,146,GO:0003924,GTPase activity,0.008775096,MF
-1087,0.001016374,25,GO:0005283,amino acid:sodium symporter activity,0.008864324,MF
-1712,0.001042999,10,GO:0016725,"oxidoreductase activity, acting on CH or CH2 groups",0.008982826,MF
-951,0.001145758,32,GO:0004536,deoxyribonuclease activity,0.009746013,MF
-851,0.001528322,38,GO:1901618,organic hydroxy compound transmembrane transporter activity,0.01284163,MF
601,0.001722602,75,GO:0060090,molecular adaptor activity,0.014153404,MF
-963,0.001725524,29,GO:0003887,DNA-directed DNA polymerase activity,0.014153404,MF
1126,0.001798055,21,GO:0043022,ribosome binding,0.014248045,MF
383,0.001801269,187,GO:0060589,nucleoside-triphosphatase regulator activity,0.014248045,MF
-579,0.001816933,80,GO:0008168,methyltransferase activity,0.014248045,MF
-1152,0.001831701,20,GO:0016763,"transferase activity, transferring pentosyl groups",0.014248045,MF
-529,0.001843915,96,GO:0016779,nucleotidyltransferase activity,0.014248045,MF
-1549,0.001861138,11,GO:0015929,hexosaminidase activity,0.014248045,MF
-700,0.001908932,54,GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",0.014453341,MF
-540,0.002050495,90,GO:0016741,"transferase activity, transferring one-carbon groups",0.015226553,MF
-807,0.002059145,40,GO:0005326,neurotransmitter transporter activity,0.015226553,MF
-469,0.002077353,120,GO:0031406,carboxylic acid binding,0.015226553,MF
-803,0.002462304,39,GO:0072349,modified amino acid transmembrane transporter activity,0.017788197,MF
394,0.002478472,165,GO:0008047,enzyme activator activity,0.017788197,MF
378,0.002555567,179,GO:0030695,GTPase regulator activity,0.018096483,MF
-457,0.002573955,121,GO:0043177,organic acid binding,0.018096483,MF
1028,0.002855198,23,GO:0017154,semaphorin receptor activity,0.019871028,MF
336,0.002961048,222,GO:0016879,"ligase activity, forming carbon-nitrogen bonds",0.020401624,MF
-1069,0.003029868,21,GO:0016655,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",0.020669102,MF
848,0.003237013,33,GO:0035591,signaling adaptor activity,0.021865709,MF
1296,0.003322175,14,GO:0016715,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen",0.022223092,MF
252,0.00338341,397,GO:0030234,enzyme regulator activity,0.022415094,MF
221,0.003457592,526,GO:1901265,nucleoside phosphate binding,0.022688391,MF
-1522,0.00356836,10,GO:0019104,DNA N-glycosylase activity,0.023083313,MF
-1286,0.003584781,14,GO:0016015,morphogen activity,0.023083313,MF
542,0.003933123,78,GO:0004930,G protein-coupled receptor activity,0.02509187,MF
-761,0.004091122,39,GO:0004177,aminopeptidase activity,0.025860396,MF
1031,0.004245084,21,GO:0005070,SH3/SH2 adaptor activity,0.026589664,MF
216,0.004294059,525,GO:0000166,nucleotide binding,0.026654111,MF
935,0.004713077,25,GO:0005080,protein kinase C binding,0.02874374,MF
-1476,0.00471414,10,GO:0004300,enoyl-CoA hydratase activity,0.02874374,MF
1292,0.004800485,13,GO:0004716,"obsolete signal transducer, downstream of receptor, with protein tyrosine kinase activity",0.029013457,MF
-880,0.004891294,28,GO:0005328,neurotransmitter:sodium symporter activity,0.029305229,MF
605,0.005060365,59,GO:0005088,Ras guanyl-nucleotide exchange factor activity,0.030056822,MF
1278,0.005270777,13,GO:0004500,dopamine beta-monooxygenase activity,0.031039019,MF
-406,0.005513496,130,GO:0015291,secondary active transmembrane transporter activity,0.032193211,MF
565,0.005674013,66,GO:0030674,"protein binding, bridging",0.032852057,MF
-905,0.00621456,25,GO:0016796,"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",0.035681935,MF
-561,0.006852946,64,GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,0.039022148,MF
-1390,0.007769404,10,GO:0000217,DNA secondary structure binding,0.043878026,MF
1320,0.008017856,11,GO:0031369,translation initiation factor binding,0.04491303,MF
-614,0.008133451,51,GO:0004540,ribonuclease activity,0.045193127,MF
494,0.008243931,79,GO:0050839,cell adhesion molecule binding,0.045440546,MF
653,0.008873956,44,GO:0004702,"obsolete signal transducer, downstream of receptor, with serine/threonine kinase activity",0.048525046,MF
-832,0.008973355,27,GO:0016877,"ligase activity, forming carbon-sulfur bonds",0.048682215,MF
236,0.009161789,354,GO:0008092,cytoskeletal protein binding,0.048774788,MF
-1111,0.009182852,15,GO:0070888,E-box binding,0.048774788,MF
617,0.00920279,49,GO:0043021,ribonucleoprotein complex binding,0.048774788,MF
237,0.009299703,349,GO:0004672,protein kinase activity,0.048912179,MF
652,0.009848219,43,GO:0017137,Rab GTPase binding,0.05140472,MF
929,0.009989513,21,GO:0070001,aspartic-type peptidase activity,0.051750186,MF
1259,0.011440619,11,GO:0016675,"oxidoreductase activity, acting on a heme group of donors",0.058825274,MF
-1066,0.012478946,15,GO:0016405,CoA-ligase activity,0.063688841,MF
716,0.012937597,33,GO:0003730,mRNA 3'-UTR binding,0.065544148,MF
-820,0.013105795,25,GO:0004520,endodeoxyribonuclease activity,0.065842209,MF
-1024,0.013187554,16,GO:0016878,acid-thiol ligase activity,0.065842209,MF
939,0.013290954,19,GO:0005546,"phosphatidylinositol-4,5-bisphosphate binding",0.06588106,MF
-318,0.015381472,163,GO:0048037,cofactor binding,0.075698818,MF
-988,0.01678351,16,GO:0008395,steroid hydroxylase activity,0.082013041,MF
-690,0.018394393,32,GO:0008235,metalloexopeptidase activity,0.089251669,MF
966,0.019363354,16,GO:0033613,activating transcription factor binding,0.093296161,MF
195,0.019648189,420,GO:0016301,kinase activity,0.094011126,MF
881,0.020151969,19,GO:0030971;GO:1990782,protein tyrosine kinase binding,0.095756599,MF
-572,0.02047872,45,GO:0008519,ammonium transmembrane transporter activity,0.096642727,MF
-521,0.021041174,54,GO:0052689,carboxylic ester hydrolase activity,0.098557563,MF
777,0.021288454,24,GO:0099106,ion channel regulator activity,0.098557563,MF
-167,0.021313609,572,GO:0003677,DNA binding,0.098557563,MF
233,0.021800343,277,GO:0032559,adenyl ribonucleotide binding,0.099042754,MF
-869,0.021839734,19,GO:0016891,"endoribonuclease activity, producing 5'-phosphomonoesters",0.099042754,MF
327,0.02184978,137,GO:0003779,actin binding,0.099042754,MF
506,0.022306057,56,GO:0015078,proton transmembrane transporter activity,0.100450154,MF
586,0.023393243,41,GO:0003743,translation initiation factor activity,0.104661975,MF
-748,0.023639418,25,GO:0015175,neutral amino acid transmembrane transporter activity,0.104745461,MF
-1126,0.023715953,11,GO:0004693;GO:0097472,cyclin-dependent protein kinase activity,0.104745461,MF
191,0.02432738,409,GO:0003723,RNA binding,0.106761561,MF
-1170,0.025022525,10,GO:0043237,laminin-1 binding,0.10875439,MF
1170,0.025097167,10,GO:0098631,cell adhesion mediator activity,0.10875439,MF
-723,0.025840434,26,GO:0016893,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",0.111275369,MF
-439,0.026041447,71,GO:0030545,receptor regulator activity,0.111444455,MF
175,0.026634974,478,GO:0098772,molecular function regulator,0.113280845,MF
191,0.026991392,392,GO:0016773,"phosphotransferase activity, alcohol group as acceptor",0.113657502,MF
1155,0.027053455,10,GO:0004129;GO:0015002;GO:0016676,"oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor",0.113657502,MF
-883,0.027550934,17,GO:0051287,NAD binding,0.115046023,MF
-515,0.027995263,50,GO:0015101,organic cation transmembrane transporter activity,0.116197206,MF
-482,0.028204934,57,GO:0042393,histone binding,0.116366464,MF
350,0.028377051,109,GO:0004713,protein tyrosine kinase activity,0.116379691,MF
-963,0.02919881,14,GO:0000175,3'-5'-exoribonuclease activity,0.119041302,MF
-1121,0.031865087,10,GO:0019212,phosphatase inhibitor activity,0.129147323,MF
232,0.032551176,242,GO:0005524,ATP binding,0.129451583,MF
943,0.032703459,14,GO:0015020,glucuronosyltransferase activity,0.129451583,MF
-477,0.032792408,55,GO:0048018,receptor ligand activity,0.129451583,MF
615,0.032827641,33,GO:0008381,mechanosensitive ion channel activity,0.129451583,MF
1017,0.032879575,12,GO:0005355;GO:0015149,hexose transmembrane transporter activity,0.129451583,MF
-1110,0.033538821,10,GO:0019894,kinesin binding,0.131296861,MF
-875,0.03416305,16,GO:0003954;GO:0008137;GO:0050136,NADH dehydrogenase (quinone) activity,0.132368965,MF
487,0.034196917,52,GO:0017048,Rho GTPase binding,0.132368965,MF
453,0.034399495,60,GO:0032182,ubiquitin-like protein binding,0.132371251,MF
214,0.034718001,279,GO:0030554,adenyl nucleotide binding,0.132371251,MF
239,0.03477387,220,GO:0004674,protein serine/threonine kinase activity,0.132371251,MF
-407,0.035008745,74,GO:0016616,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",0.132533105,MF
776,0.035688116,20,GO:0004712,protein serine/threonine/tyrosine kinase activity,0.134366734,MF
690,0.03692928,25,GO:0016247,channel regulator activity,0.138284096,MF
-379,0.037865993,83,GO:0016614,"oxidoreductase activity, acting on CH-OH group of donors",0.14034974,MF
-401,0.037888319,74,GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",0.14034974,MF
-1032,0.038281287,11,GO:0016803,ether hydrolase activity,0.141047096,MF
829,0.038581403,17,GO:0043531,ADP binding,0.141396736,MF
613,0.039055982,31,GO:1902936,phosphatidylinositol bisphosphate binding,0.142331238,MF
365,0.039249543,88,GO:0005085,guanyl-nucleotide exchange factor activity,0.142331238,MF
977,0.040432288,12,GO:0000146,microfilament motor activity,0.1458526,MF
-549,0.040947686,38,GO:0005496,steroid binding,0.146942476,MF
870,0.041322752,15,GO:0004708,MAP kinase kinase activity,0.147520083,MF
615,0.041722223,30,GO:0005272,sodium channel activity,0.148038108,MF
840,0.041897578,16,GO:0042169,SH2 domain binding,0.148038108,MF
1056,0.04307892,10,GO:0003746,translation elongation factor activity,0.15143559,MF
809,0.043486017,17,GO:0016500,protein-hormone receptor activity,0.152090687,MF
260,0.043924916,168,GO:0003729,mRNA binding,0.152849832,MF
-547,0.044607437,37,GO:0003697,single-stranded DNA binding,0.154444846,MF
367,0.046676614,81,GO:0004714,transmembrane receptor protein tyrosine kinase activity,0.160800934,MF
-581,0.046933321,32,GO:0004521,endoribonuclease activity,0.160880885,MF
-388,0.047610295,72,GO:0008236,serine-type peptidase activity,0.16239353,MF
518,0.047848752,40,GO:0005178,integrin binding,0.162402907,MF
-1028,0.048904488,10,GO:0030983,mismatched DNA binding,0.165172509,MF
-290,0.050160783,127,GO:0016757,"transferase activity, transferring glycosyl groups",0.166741729,MF
623,0.050246801,27,GO:0061135,endopeptidase regulator activity,0.166741729,MF
-315,0.050335946,107,GO:0015081,sodium ion transmembrane transporter activity,0.166741729,MF
512,0.050565601,40,GO:0019003,GDP binding,0.166741729,MF
863,0.050579131,14,GO:0016722,"oxidoreductase activity, oxidizing metal ions",0.166741729,MF
-891,0.051833869,13,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",0.169820533,MF
587,0.052005998,30,GO:0019955,cytokine binding,0.169820533,MF
-397,0.053683164,65,GO:0003777,microtubule motor activity,0.174470283,MF
-530,0.054496026,36,GO:0003899,DNA-directed 5'-3' RNA polymerase activity,0.176280573,MF
623,0.054777471,26,GO:0015036,disulfide oxidoreductase activity,0.17636298,MF
-702,0.057476553,20,GO:0004181,metallocarboxypeptidase activity,0.184192303,MF
-869,0.057954319,13,GO:0016801,"hydrolase activity, acting on ether bonds",0.184279794,MF
344,0.058038774,84,GO:0019199,transmembrane receptor protein kinase activity,0.184279794,MF
637,0.059192738,24,GO:0019992,diacylglycerol binding,0.187081634,MF
935,0.060490074,11,GO:0004114,"3',5'-cyclic-nucleotide phosphodiesterase activity",0.190308953,MF
353,0.060891566,78,GO:0051082,unfolded protein binding,0.190701315,MF
-672,0.06249108,21,GO:0008173,RNA methyltransferase activity,0.194825132,MF
334,0.063721862,85,GO:0015399;GO:0015405,primary active transmembrane transporter activity,0.197767402,MF
784,0.066134547,15,GO:0015459,potassium channel regulator activity,0.204334989,MF
605,0.067527193,25,GO:0004866,endopeptidase inhibitor activity,0.207706412,MF
628,0.068656851,23,GO:0008188,neuropeptide receptor activity,0.210242534,MF
-461,0.071101292,42,GO:0034062;GO:0097747,5'-3' RNA polymerase activity,0.214770795,MF
-400,0.071268253,56,GO:0008094,DNA-dependent ATPase activity,0.214770795,MF
826,0.071312298,13,GO:0015035,protein disulfide oxidoreductase activity,0.214770795,MF
396,0.071382456,57,GO:0043130,ubiquitin binding,0.214770795,MF
535,0.071793064,31,GO:0070851,growth factor receptor binding,0.21506705,MF
-551,0.072685139,29,GO:0008307,structural constituent of muscle,0.215634673,MF
680,0.072906752,19,GO:0008138,protein tyrosine/serine/threonine phosphatase activity,0.215634673,MF
-765,0.07292145,15,GO:0005254,chloride channel activity,0.215634673,MF
189,0.073669802,254,GO:0004175,endopeptidase activity,0.216916639,MF
887,0.074914219,11,GO:0035250;GO:0008378,UDP-galactosyltransferase activity,0.219642114,MF
-674,0.075365647,19,GO:0005253,anion channel activity,0.220029367,MF
-562,0.07733805,27,GO:0003725,double-stranded RNA binding,0.223860982,MF
481,0.077391909,37,GO:0016667,"oxidoreductase activity, acting on a sulfur group of donors",0.223860982,MF
-441,0.077652794,44,GO:0140101,"catalytic activity, acting on a tRNA",0.223860982,MF
806,0.078711189,13,GO:0015280,ligand-gated sodium channel activity,0.225966706,MF
-250,0.080697361,136,GO:0008237,metallopeptidase activity,0.229374755,MF
-335,0.08080379,75,GO:0017171,serine hydrolase activity,0.229374755,MF
309,0.080897047,88,GO:0042277,peptide binding,0.229374755,MF
544,0.081968618,28,GO:0001653;GO:0008528,peptide receptor activity,0.231460565,MF
826,0.083378008,12,GO:0005021,vascular endothelial growth factor-activated receptor activity,0.234479379,MF
-246,0.083895619,138,GO:0016791,phosphatase activity,0.234975942,MF
465,0.087405831,37,GO:0061134,peptidase regulator activity,0.243816264,MF
-213,0.089895212,178,GO:0042578,phosphoric ester hydrolase activity,0.249749198,MF
803,0.092327032,12,GO:0004322;GO:0016724,"oxidoreductase activity, oxidizing metal ions, oxygen as acceptor",0.255475201,MF
-531,0.095289294,27,GO:0019213,deacetylase activity,0.261695004,MF
421,0.095334464,43,GO:0051087,chaperone binding,0.261695004,MF
663,0.098324884,17,GO:0036442,proton-exporting ATPase activity,0.268832718,MF
-516,0.099051222,28,GO:0016859,cis-trans isomerase activity,0.269360849,MF
525,0.099299936,27,GO:0008013,beta-catenin binding,0.269360849,MF
-467,0.099696497,34,GO:0019842,vitamin binding,0.269376026,MF
-640,0.100573191,18,GO:0004532,exoribonuclease activity,0.270683314,MF
-606,0.101269105,20,GO:0016645,"oxidoreductase activity, acting on the CH-NH group of donors",0.271495771,MF
675,0.102172499,16,GO:0046527,glucosyltransferase activity,0.272856015,MF
-500,0.10339827,29,GO:0015485,cholesterol binding,0.275063353,MF
712,0.106993621,14,GO:0005172,vascular endothelial growth factor receptor binding,0.283183109,MF
306,0.107945206,76,GO:0043492,"ATPase activity, coupled to movement of substances",0.283183109,MF
-542,0.108012979,24,GO:0000049,tRNA binding,0.283183109,MF
-542,0.108094568,24,GO:1901682,sulfur compound transmembrane transporter activity,0.283183109,MF
-134,0.109134258,419,GO:0016491,oxidoreductase activity,0.283799027,MF
707,0.109271814,14,GO:0030296,protein tyrosine kinase activator activity,0.283799027,MF
124,0.110075027,493,GO:0140110,transcription regulator activity,0.283799027,MF
550,0.11056836,23,GO:0051119,sugar transmembrane transporter activity,0.283799027,MF
-527,0.110761752,25,GO:0019888,protein phosphatase regulator activity,0.283799027,MF
-679,0.111251571,15,GO:0005381,iron ion transmembrane transporter activity,0.283799027,MF
385,0.11128282,47,GO:1901981,phosphatidylinositol phosphate binding,0.283799027,MF
791,0.112036164,11,GO:0016668,"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",0.283799027,MF
-261,0.112036771,103,GO:0004386,helicase activity,0.283799027,MF
-457,0.112506165,33,GO:0032934,sterol binding,0.283944131,MF
-243,0.114900775,117,GO:0050662,coenzyme binding,0.28892932,MF
-630,0.115697889,17,GO:0090482,vitamin transmembrane transporter activity,0.289875803,MF
-627,0.117722588,17,GO:0015193,L-proline transmembrane transporter activity,0.293879938,MF
-384,0.119544244,45,GO:0003678,DNA helicase activity,0.295732479,MF
505,0.11960326,26,GO:0030414,peptidase inhibitor activity,0.295732479,MF
-561,0.119790632,21,GO:0015296,anion:cation symporter activity,0.295732479,MF
685,0.120543709,14,GO:0042805,actinin binding,0.295732479,MF
-469,0.120610779,30,GO:0004003,ATP-dependent DNA helicase activity,0.295732479,MF
143,0.122673064,338,GO:0042803,protein homodimerization activity,0.299722486,MF
383,0.124925404,44,GO:0030165,PDZ domain binding,0.304103006,MF
-702,0.125348699,13,GO:0016646,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor",0.304103006,MF
-362,0.126086822,49,GO:0015103,inorganic anion transmembrane transporter activity,0.304820423,MF
726,0.128112393,12,GO:0033691,sialic acid binding,0.308287769,MF
120,0.12860876,480,GO:0017111,nucleoside-triphosphatase activity,0.308287769,MF
670,0.128863393,14,GO:0061980,regulatory RNA binding,0.308287769,MF
370,0.130010449,46,GO:0017022,myosin binding,0.309955708,MF
-489,0.131444625,26,GO:0015108,chloride transmembrane transporter activity,0.312294299,MF
268,0.133162152,87,GO:0005096,GTPase activator activity,0.315287707,MF
743,0.135944999,11,GO:0032500;GO:0050700,muramyl dipeptide binding,0.319801767,MF
742,0.136041065,11,GO:0015450,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,0.319801767,MF
-192,0.136461131,168,GO:0003690,double-stranded DNA binding,0.319801767,MF
678,0.138955205,13,GO:0030291,protein serine/threonine kinase inhibitor activity,0.324542836,MF
-445,0.140691666,30,GO:0030492,hemoglobin binding,0.327112602,MF
140,0.141004997,320,GO:0003700,DNA-binding transcription factor activity,0.327112602,MF
-588,0.142590912,17,GO:0016896,"exoribonuclease activity, producing 5'-phosphomonoesters",0.329681672,MF
-625,0.143166346,15,GO:0008559,xenobiotic transmembrane transporting ATPase activity,0.329905059,MF
-603,0.144104642,16,GO:0015187,glycine transmembrane transporter activity,0.330960327,MF
-263,0.145249384,85,GO:0008026;GO:0070035,ATP-dependent helicase activity,0.332481148,MF
663,0.148120223,13,GO:0005385,zinc ion transmembrane transporter activity,0.337929912,MF
685,0.150720292,12,GO:0005548,phospholipid transporter activity,0.342727001,MF
-747,0.152717803,10,GO:0030515,snoRNA binding,0.345319888,MF
473,0.152947853,25,GO:0004221,obsolete ubiquitin thiolesterase activity,0.345319888,MF
-454,0.15336413,27,GO:0003755,peptidyl-prolyl cis-trans isomerase activity,0.345319888,MF
327,0.155442673,52,GO:0004497,monooxygenase activity,0.34885994,MF
537,0.156947344,19,GO:0008046,axon guidance receptor activity,0.351093247,MF
702,0.158801108,11,GO:0005248,voltage-gated sodium channel activity,0.354090496,MF
272,0.159355555,74,GO:0042626,"ATPase activity, coupled to transmembrane movement of substances",0.354180571,MF
-734,0.159889582,10,GO:0030020,extracellular matrix structural constituent conferring tensile strength,0.35422483,MF
463,0.161101546,25,GO:0031625;GO:0044389,ubiquitin-like protein ligase binding,0.355765914,MF
-513,0.164772302,20,GO:0005125,cytokine activity,0.36093031,MF
636,0.165042274,13,GO:0004707,MAP kinase activity,0.36093031,MF
592,0.165296647,15,GO:0008553,"proton-exporting ATPase activity, phosphorylative mechanism",0.36093031,MF
592,0.165535527,15,GO:0050681,androgen receptor binding,0.36093031,MF
-555,0.166384125,17,GO:0042910,xenobiotic transmembrane transporter activity,0.361636158,MF
-298,0.168127966,59,GO:0016298,lipase activity,0.362436285,MF
657,0.168321524,12,GO:0035198,miRNA binding,0.362436285,MF
-403,0.16833035,32,GO:0050661,NADP binding,0.362436285,MF
605,0.17047208,14,GO:0001191,"obsolete transcriptional repressor activity, RNA polymerase II transcription factor binding",0.365297818,MF
-462,0.170719735,24,GO:0038024,cargo receptor activity,0.365297818,MF
394,0.171412476,33,GO:0015297,antiporter activity,0.365644569,MF
-107,0.17216014,483,GO:0015318,inorganic molecular entity transmembrane transporter activity,0.366105977,MF
-417,0.174636363,29,GO:0030145,manganese ion binding,0.370229089,MF
646,0.17524282,12,GO:0004112,cyclic-nucleotide phosphodiesterase activity,0.370375162,MF
641,0.178782103,12,GO:0051721,protein phosphatase 2A binding,0.376699904,MF
640,0.179462239,12,GO:0015215,nucleotide transmembrane transporter activity,0.376980129,MF
609,0.18360189,13,GO:0032027,myosin light chain binding,0.384503655,MF
-630,0.186544853,12,GO:0005527;GO:0005528,macrolide binding,0.387183177,MF
-304,0.186635889,52,GO:0051213,dioxygenase activity,0.387183177,MF
629,0.186895556,12,GO:0035251,UDP-glucosyltransferase activity,0.387183177,MF
689,0.18712917,10,GO:0030898,actin-dependent ATPase activity,0.387183177,MF
-101,0.191142768,502,GO:0015075,ion transmembrane transporter activity,0.394249569,MF
-312,0.191688833,48,GO:0016811,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",0.394249569,MF
-569,0.197811045,14,GO:0005251,delayed rectifier potassium channel activity,0.405630388,MF
-370,0.198889332,33,GO:0019208,phosphatase regulator activity,0.406631306,MF
401,0.199546322,28,GO:0043621,protein self-association,0.406767503,MF
-513,0.20096643,17,GO:0140103,"catalytic activity, acting on a glycoprotein",0.408453894,MF
602,0.206563615,12,GO:0005545,1-phosphatidylinositol binding,0.41859509,MF
576,0.208615562,13,GO:0070002,glutamic-type peptidase activity,0.421151268,MF
489,0.209047509,18,GO:0005048,signal sequence binding,0.421151268,MF
-624,0.209908488,11,GO:0016846,carbon-sulfur lyase activity,0.421425639,MF
553,0.210757912,14,GO:0030159,receptor signaling complex scaffold activity,0.421425639,MF
141,0.211340196,221,GO:0008134,transcription factor binding,0.421425639,MF
-371,0.211630292,31,GO:0008276,protein methyltransferase activity,0.421425639,MF
287,0.212532427,52,GO:0030594,neurotransmitter receptor activity,0.422002427,MF
-223,0.216203025,85,GO:0003774,motor activity,0.428057139,MF
558,0.22322342,13,GO:0008143,poly(A) binding,0.440690362,MF
-473,0.224373255,18,GO:0005277;GO:1901375,acetylcholine transmembrane transporter activity,0.441694778,MF
633,0.225629289,10,GO:0032452,histone demethylase activity,0.442901938,MF
-601,0.227788459,11,GO:0003896,DNA primase activity,0.445202936,MF
102,0.228093812,412,GO:0046983,protein dimerization activity,0.445202936,MF
422,0.231358275,22,GO:0004745,retinol dehydrogenase activity,0.449551007,MF
-528,0.231626426,14,GO:0008239,dipeptidyl-peptidase activity,0.449551007,MF
463,0.23423801,18,GO:0017147,Wnt-protein binding,0.453342666,MF
221,0.237181498,79,GO:0035091,phosphatidylinositol binding,0.456399635,MF
98,0.237715431,429,GO:0042802,identical protein binding,0.456399635,MF
177,0.238091235,123,GO:0033218,amide binding,0.456399635,MF
-276,0.238921524,50,GO:0005200,structural constituent of cytoskeleton,0.456399635,MF
-615,0.239129562,10,GO:0017056,structural constituent of nuclear pore,0.456399635,MF
-613,0.240817873,10,GO:0004879;GO:0098531,nuclear receptor activity,0.4581957,MF
314,0.241870617,38,GO:0019783,ubiquitin-like protein-specific protease activity,0.4581957,MF
91,0.242065653,498,GO:0016462,pyrophosphatase activity,0.4581957,MF
-322,0.243530322,36,GO:0008170,N-methyltransferase activity,0.459705183,MF
437,0.249534244,19,GO:0001190,"obsolete transcriptional activator activity, RNA polymerase II transcription factor binding",0.469743131,MF
-359,0.250287217,28,GO:0046906,tetrapyrrole binding,0.469743131,MF
-131,0.250893283,217,GO:0022804,active transmembrane transporter activity,0.469743131,MF
205,0.252606203,86,GO:0140297,DNA-binding transcription factor binding,0.471474833,MF
386,0.253186775,24,GO:0005507,copper ion binding,0.471474833,MF
-470,0.25546453,16,GO:0030331,estrogen receptor binding,0.473758546,MF
88,0.255788359,499,GO:0016818;GO:0016817,"hydrolase activity, acting on acid anhydrides",0.473758546,MF
501,0.256903905,14,GO:0016408,C-acyltransferase activity,0.474549036,MF
-563,0.25825304,11,GO:0004806,triglyceride lipase activity,0.475765627,MF
315,0.259850842,35,GO:0005089,Rho guanyl-nucleotide exchange factor activity,0.477432614,MF
327,0.263106358,32,GO:0004843;GO:0036459;GO:0101005,thiol-dependent ubiquitinyl hydrolase activity,0.480450765,MF
-185,0.263569509,101,GO:0008017,microtubule binding,0.480450765,MF
-477,0.263585471,15,GO:0005294;GO:0015375;GO:0005295,glycine:sodium symporter activity,0.480450765,MF
-487,0.269778269,14,GO:0016814,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines",0.489374972,MF
-219,0.269902016,70,GO:0001012,RNA polymerase II regulatory region DNA binding,0.489374972,MF
-548,0.2713398,11,GO:0008641,ubiquitin-like modifier activating enzyme activity,0.49069061,MF
-387,0.272224693,22,GO:0033558,protein deacetylase activity,0.49100213,MF
467,0.273825421,15,GO:0017112,Rab guanyl-nucleotide exchange factor activity,0.492599778,MF
-144,0.274604641,162,GO:0005509,calcium ion binding,0.492715098,MF
-333,0.278039082,29,GO:0030374,nuclear receptor transcription coactivator activity,0.497581629,MF
422,0.278781983,18,GO:0016409,palmitoyltransferase activity,0.497618617,MF
415,0.286926548,18,GO:0005537,mannose binding,0.510833054,MF
-554,0.288466503,10,GO:0030519,snoRNP binding,0.512251083,MF
-391,0.28989889,20,GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",0.513471299,MF
-545,0.296469121,10,GO:0051861,glycolipid binding,0.52298849,MF
310,0.296790275,31,GO:0019829,cation-transporting ATPase activity,0.52298849,MF
102,0.307399663,290,GO:0016874,ligase activity,0.540301959,MF
139,0.309842901,150,GO:0072509,divalent inorganic cation transmembrane transporter activity,0.543210583,MF
284,0.3106747,35,GO:1901505,carbohydrate derivative transmembrane transporter activity,0.543286468,MF
-417,0.313139125,16,GO:0016709,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",0.546209764,MF
391,0.31540985,18,GO:0015145,monosaccharide transmembrane transporter activity,0.547961531,MF
-460,0.315734002,13,GO:0004622,lysophospholipase activity,0.547961531,MF
-160,0.316860792,109,GO:0016758,"transferase activity, transferring hexosyl groups",0.548535392,MF
369,0.318445605,20,GO:0016849,phosphorus-oxygen lyase activity,0.548726945,MF
369,0.318643211,20,GO:0005109,frizzled binding,0.548726945,MF
-278,0.320736049,35,GO:0008375,acetylglucosaminyltransferase activity,0.548726945,MF
349,0.321615956,22,GO:0003756;GO:0016864;GO:0016862,protein disulfide isomerase activity,0.548726945,MF
423,0.321976128,15,GO:0070717,poly-purine tract binding,0.548726945,MF
-422,0.322205861,15,GO:1990939,ATP-dependent microtubule motor activity,0.548726945,MF
-277,0.322743417,35,GO:0016706,2-oxoglutarate-dependent dioxygenase activity,0.548726945,MF
-452,0.323342728,13,GO:0061733,peptide-lysine-N-acetyltransferase activity,0.548726945,MF
-268,0.3245256,37,GO:0005126,cytokine receptor binding,0.549381176,MF
109,0.327117371,228,GO:0044877,protein-containing complex binding,0.552411443,MF
-443,0.333167395,13,GO:0008574,"ATP-dependent microtubule motor activity, plus-end-directed",0.561252653,MF
239,0.338745318,44,GO:0016790,thiolester hydrolase activity,0.568790222,MF
475,0.339706755,11,GO:0016780,"phosphotransferase activity, for other substituted phosphate groups",0.568790222,MF
-228,0.340118391,48,GO:0004620,phospholipase activity,0.568790222,MF
309,0.34136443,26,GO:0015144,carbohydrate transmembrane transporter activity,0.569491749,MF
-213,0.34507388,54,GO:0043178,alcohol binding,0.574289621,MF
-139,0.347179442,128,GO:0015631,tubulin binding,0.574722299,MF
-415,0.347502698,14,GO:0046966,thyroid hormone receptor binding,0.574722299,MF
252,0.347836282,38,GO:0019838,growth factor binding,0.574722299,MF
242,0.349835337,41,GO:0005506,iron ion binding,0.576642458,MF
-300,0.354891053,26,GO:0005544,calcium-dependent phospholipid binding,0.581123086,MF
-312,0.355062753,24,GO:0016765,"transferase activity, transferring alkyl or aryl (other than methyl) groups",0.581123086,MF
-350,0.355900567,19,GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",0.581123086,MF
-185,0.357455764,68,GO:0009055,electron transfer activity,0.581123086,MF
-317,0.357477998,23,GO:0008083,growth factor activity,0.581123086,MF
405,0.358769792,14,GO:0045296,cadherin binding,0.581123086,MF
282,0.359287145,29,GO:0099516,ion antiporter activity,0.581123086,MF
-457,0.359301066,11,GO:0042903;GO:0070840,tubulin deacetylase activity,0.581123086,MF
475,0.362648711,10,GO:0005246,calcium channel regulator activity,0.585163844,MF
344,0.364528523,19,GO:0042834,peptidoglycan binding,0.586822787,MF
-325,0.367471342,21,GO:0004407,histone deacetylase activity,0.590181246,MF
171,0.370675648,76,GO:0030246,carbohydrate binding,0.593681211,MF
-295,0.372200396,25,GO:0004812;GO:0016875,"ligase activity, forming carbon-oxygen bonds",0.593681211,MF
367,0.373954684,16,GO:0015605,organophosphate ester transmembrane transporter activity,0.593681211,MF
407,0.374187325,13,GO:0032036,myosin heavy chain binding,0.593681211,MF
-392,0.375047032,14,GO:0030228,lipoprotein particle receptor activity,0.593681211,MF
463,0.375325169,10,GO:0008200;GO:0016248,ion channel inhibitor activity,0.593681211,MF
-355,0.37568216,17,GO:0016702,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",0.593681211,MF
363,0.380101147,16,GO:0008066,glutamate receptor activity,0.599289909,MF
-276,0.385617216,27,GO:0020037,heme binding,0.606598771,MF
-396,0.3877251,13,GO:0005217,intracellular ligand-gated ion channel activity,0.608525271,MF
448,0.391020492,10,GO:0004559,alpha-mannosidase activity,0.612302543,MF
289,0.392680556,24,GO:0001085,RNA polymerase II transcription factor binding,0.613507716,MF
-315,0.39482657,20,GO:0001047,core promoter binding,0.614475959,MF
261,0.395679866,29,GO:0030295,protein kinase activator activity,0.614475959,MF
252,0.395975799,31,GO:0019209,kinase activator activity,0.614475959,MF
-438,0.401379167,10,GO:0001046,core promoter sequence-specific DNA binding,0.619973345,MF
235,0.401580363,35,GO:0042625;GO:0022853,ATPase coupled ion transmembrane transporter activity,0.619973345,MF
-357,0.403122087,15,GO:0034212,peptide N-acetyltransferase activity,0.619973345,MF
97,0.403401628,210,GO:0043565,sequence-specific DNA binding,0.619973345,MF
382,0.404017463,13,GO:0004709,MAP kinase kinase kinase activity,0.619973345,MF
396,0.405982675,12,GO:0016504,peptidase activator activity,0.621604585,MF
285,0.408536021,23,GO:0008320;GO:0022884,macromolecule transmembrane transporter activity,0.624127092,MF
178,0.410807777,59,GO:0008565,protein transporter activity,0.626209199,MF
72,0.413098878,379,GO:0008144,drug binding,0.628172638,MF
-338,0.413919271,16,GO:0005245,voltage-gated calcium channel activity,0.628172638,MF
-324,0.419343654,17,GO:0019905,syntaxin binding,0.634179971,MF
-298,0.419718529,20,GO:0008536,Ran GTPase binding,0.634179971,MF
-400,0.421491238,11,GO:0043395,heparan sulfate proteoglycan binding,0.635170476,MF
-382,0.42311203,12,GO:0030507,spectrin binding,0.635170476,MF
121,0.423139693,121,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",0.635170476,MF
414,0.428266059,10,GO:0052745,inositol phosphate phosphatase activity,0.63914395,MF
309,0.428342786,18,GO:0015491;GO:0015298,solute:cation antiporter activity,0.63914395,MF
228,0.429005006,33,GO:0046915,transition metal ion transmembrane transporter activity,0.63914395,MF
413,0.429497313,10,GO:0030552,cAMP binding,0.63914395,MF
102,0.432666461,165,GO:0022839;GO:0022836,ion gated channel activity,0.642472396,MF
-312,0.43667362,17,GO:0016831,carboxy-lyase activity,0.64584804,MF
-180,0.437903418,51,GO:0016651,"oxidoreductase activity, acting on NAD(P)H",0.64584804,MF
-261,0.439924388,24,GO:0016782,"transferase activity, transferring sulfur-containing groups",0.64584804,MF
-226,0.440156598,32,GO:0008374,O-acyltransferase activity,0.64584804,MF
137,0.442070835,87,GO:0003714,transcription corepressor activity,0.64584804,MF
-291,0.442375405,19,GO:0042054,histone methyltransferase activity,0.64584804,MF
-270,0.443138626,22,GO:0017124,SH3 domain binding,0.64584804,MF
-218,0.44330054,34,GO:0005201,extracellular matrix structural constituent,0.64584804,MF
380,0.445108838,11,GO:0001099;GO:0001098,basal RNA polymerase II transcription machinery binding,0.64584804,MF
-230,0.445636023,30,GO:0016830,carbon-carbon lyase activity,0.64584804,MF
234,0.446919167,29,GO:0015662,"ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism",0.64584804,MF
-268,0.447229395,22,GO:0005249,voltage-gated potassium channel activity,0.64584804,MF
79,0.447885806,263,GO:0000988,"obsolete transcription factor activity, protein binding",0.64584804,MF
-362,0.448062936,12,GO:0004402,histone acetyltransferase activity,0.64584804,MF
273,0.4498896,21,GO:0016627,"oxidoreductase activity, acting on the CH-CH group of donors",0.647127211,MF
299,0.455742072,17,GO:0016776,"phosphotransferase activity, phosphate group as acceptor",0.654179765,MF
86,0.457445069,212,GO:0005261,cation channel activity,0.655259153,MF
-143,0.461052086,73,GO:0008194,UDP-glycosyltransferase activity,0.659055783,MF
-203,0.467165403,35,GO:0000978,RNA polymerase II proximal promoter sequence-specific DNA binding,0.666411931,MF
201,0.47297641,35,GO:0001228;GO:0001216,DNA-binding transcription activator activity,0.671951881,MF
203,0.473434247,34,GO:0019903,protein phosphatase binding,0.671951881,MF
-316,0.474819898,14,GO:0016411,acylglycerol O-acyltransferase activity,0.671951881,MF
-216,0.474950023,30,GO:0032947,protein-containing complex scaffold activity,0.671951881,MF
354,0.477364258,11,GO:0004715,non-membrane spanning protein tyrosine kinase activity,0.673983553,MF
53,0.479252468,530,GO:0016772,"transferase activity, transferring phosphorus-containing groups",0.675265747,MF
336,0.480450063,12,GO:0070273,phosphatidylinositol-4-phosphate binding,0.675287274,MF
351,0.481227941,11,GO:0052742,phosphatidylinositol kinase activity,0.675287274,MF
-264,0.486140824,19,GO:0043236,laminin binding,0.680794772,MF
72,0.490000008,260,GO:0000989,"obsolete transcription factor activity, transcription factor binding",0.684807314,MF
-154,0.491833863,55,GO:0008186,RNA-dependent ATPase activity,0.685978809,MF
357,0.494357513,10,GO:0015277,kainate selective glutamate receptor activity,0.68810571,MF
182,0.497167864,38,GO:1904680,peptide transmembrane transporter activity,0.690113078,MF
-289,0.497802903,15,GO:0032451,demethylase activity,0.690113078,MF
-57,0.499676304,412,GO:0008324,cation transmembrane transporter activity,0.690812969,MF
-249,0.500313021,20,GO:0033293,monocarboxylic acid binding,0.690812969,MF
305,0.505190183,13,GO:0004970,ionotropic glutamate receptor activity,0.696152072,MF
117,0.506221629,90,GO:0008234,cysteine-type peptidase activity,0.696181042,MF
-148,0.50832717,55,GO:0004252,serine-type endopeptidase activity,0.696599219,MF
-315,0.509340104,12,GO:0019239,deaminase activity,0.696599219,MF
119,0.50955879,85,GO:0000976,transcription regulatory region sequence-specific DNA binding,0.696599219,MF
-311,0.514185568,12,GO:0015205,nucleobase transmembrane transporter activity,0.700135775,MF
-171,0.514729187,40,GO:0016209,antioxidant activity,0.700135775,MF
229,0.515194249,22,GO:0051219,phosphoprotein binding,0.700135775,MF
285,0.518348479,14,GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,0.703035633,MF
-303,0.525317634,12,GO:0070063,RNA polymerase binding,0.709867438,MF
98,0.525446144,116,GO:0005262,calcium channel activity,0.709867438,MF
318,0.542547929,10,GO:0015368,calcium:cation antiporter activity,0.731537227,MF
-54,0.546271166,365,GO:0070011,"peptidase activity, acting on L-amino acid peptides",0.733074196,MF
218,0.546450154,21,GO:0046332,SMAD binding,0.733074196,MF
315,0.546879734,10,GO:0080025,"phosphatidylinositol-3,5-bisphosphate binding",0.733074196,MF
121,0.550293751,67,GO:0001076,"obsolete transcription factor activity, RNA polymerase II transcription factor binding",0.735297946,MF
-264,0.550673062,14,GO:0000030,mannosyltransferase activity,0.735297946,MF
230,0.555575204,18,GO:0030276,clathrin binding,0.739579749,MF
-146,0.557515132,44,GO:0003727,single-stranded RNA binding,0.739579749,MF
-59,0.55753243,286,GO:0046873,metal ion transmembrane transporter activity,0.739579749,MF
235,0.558173396,17,GO:0043394,proteoglycan binding,0.739579749,MF
-104,0.559289738,88,GO:0016853,isomerase activity,0.739636524,MF
-238,0.564368744,16,GO:0002039,p53 binding,0.742876428,MF
-238,0.564471288,16,GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate binding",0.742876428,MF
-264,0.564974236,13,GO:0015373,anion:sodium symporter activity,0.742876428,MF
-99,0.567258578,92,GO:1901681,sulfur compound binding,0.744459353,MF
-220,0.572101332,18,GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,0.749387486,MF
-188,0.577631864,24,GO:0004601;GO:0016684,peroxidase activity,0.753318682,MF
-245,0.57917902,14,GO:0017069,snRNA binding,0.753318682,MF
112,0.579446024,67,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,0.753318682,MF
-244,0.580955623,14,GO:0019798,procollagen-proline dioxygenase activity,0.753318682,MF
60,0.581811391,243,GO:0003712,transcription coregulator activity,0.753318682,MF
79,0.583162708,134,GO:0015085,calcium ion transmembrane transporter activity,0.753318682,MF
203,0.583499369,20,GO:0008301,"DNA binding, bending",0.753318682,MF
-286,0.583849312,10,GO:0005112,Notch binding,0.753318682,MF
75,0.588551992,146,GO:0003713,transcription coactivator activity,0.757966958,MF
280,0.592175944,10,GO:0000339,RNA cap binding,0.761211242,MF
-194,0.598877627,20,GO:0051184,cofactor transmembrane transporter activity,0.768392337,MF
250,0.600068546,12,GO:0050145,nucleoside monophosphate kinase activity,0.768489272,MF
193,0.601615962,20,GO:0043028,cysteine-type endopeptidase regulator activity involved in apoptotic process,0.768858095,MF
180,0.602608464,23,GO:0009975,cyclase activity,0.768858095,MF
187,0.603704252,21,GO:0001158;GO:0035326,enhancer sequence-specific DNA binding,0.768858095,MF
-252,0.612183212,11,GO:0140296,general transcription initiation factor binding,0.775424216,MF
45,0.612804529,374,GO:0022890,inorganic cation transmembrane transporter activity,0.775424216,MF
84,0.613124853,101,GO:0015276;GO:0022834,ligand-gated channel activity,0.775424216,MF
223,0.61336168,14,GO:0008035,high-density lipoprotein particle binding,0.775424216,MF
-107,0.624657081,58,GO:0003724,RNA helicase activity,0.784704402,MF
-158,0.626620973,26,GO:0015932,nucleobase-containing compound transmembrane transporter activity,0.784704402,MF
189,0.627895948,18,GO:0071813;GO:0071814,lipoprotein particle binding,0.784704402,MF
-83,0.628784724,94,GO:0004222,metalloendopeptidase activity,0.784704402,MF
206,0.629527095,15,GO:0070566,adenylyltransferase activity,0.784704402,MF
136,0.630607829,34,GO:0005319,lipid transporter activity,0.784704402,MF
-187,0.630741002,18,GO:0016701,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",0.784704402,MF
239,0.630917185,11,GO:0052744,phosphatidylinositol monophosphate phosphatase activity,0.784704402,MF
76,0.630952451,112,GO:0046982,protein heterodimerization activity,0.784704402,MF
191,0.63457955,17,GO:0000062,fatty-acyl-CoA binding,0.785781899,MF
113,0.635374118,48,GO:0031072,heat shock protein binding,0.785781899,MF
236,0.635866923,11,GO:0015301,anion:anion antiporter activity,0.785781899,MF
-247,0.636380696,10,GO:0071617,lysophospholipid acyltransferase activity,0.785781899,MF
-246,0.637750062,10,GO:0004659,prenyltransferase activity,0.785930089,MF
188,0.638782075,17,GO:0031490,chromatin DNA binding,0.785930089,MF
148,0.642068191,27,GO:0016410,N-acyltransferase activity,0.788565034,MF
-104,0.643276235,54,GO:0004004,ATP-dependent RNA helicase activity,0.788642928,MF
-228,0.646471905,11,GO:0005001;GO:0019198,transmembrane receptor protein phosphatase activity,0.790388288,MF
109,0.647890981,48,GO:0048029,monosaccharide binding,0.790388288,MF
-121,0.648176916,39,GO:0000987,proximal promoter sequence-specific DNA binding,0.790388288,MF
79,0.649288492,92,GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",0.790388288,MF
206,0.652765048,13,GO:0042813,Wnt-activated receptor activity,0.792649734,MF
-155,0.653447096,23,GO:0046875,ephrin receptor binding,0.792649734,MF
213,0.655336054,12,GO:0005536,glucose binding,0.793544009,MF
-35,0.659021155,471,GO:0043169,cation binding,0.796606273,MF
72,0.673114225,96,GO:0016747,"transferase activity, transferring acyl groups other than amino-acyl groups",0.812216639,MF
207,0.677909711,11,GO:0015923,mannosidase activity,0.815572251,MF
-198,0.678262554,12,GO:0005041,low-density lipoprotein particle receptor activity,0.815572251,MF
-109,0.68070644,39,GO:0008081,phosphoric diester hydrolase activity,0.816298293,MF
160,0.682224654,18,GO:0032266,phosphatidylinositol-3-phosphate binding,0.816298293,MF
150,0.684542813,20,GO:0008187,poly-pyrimidine tract binding,0.816298293,MF
-173,0.684567959,15,GO:0004683,calmodulin-dependent protein kinase activity,0.816298293,MF
-70,0.68491497,93,GO:0004721,phosphoprotein phosphatase activity,0.816298293,MF
90,0.685974908,55,GO:0019902,phosphatase binding,0.816298293,MF
-183,0.689819095,13,GO:0022821,potassium ion antiporter activity,0.819457511,MF
174,0.693563854,14,GO:0048156,tau protein binding,0.821158905,MF
-55,0.693634953,145,GO:0005543,phospholipid binding,0.821158905,MF
-83,0.698897362,60,GO:0015079,potassium ion transmembrane transporter activity,0.824366351,MF
39,0.699173025,284,GO:0005198,structural molecule activity,0.824366351,MF
-68,0.701068056,89,GO:0005539,glycosaminoglycan binding,0.824366351,MF
-138,0.701130162,21,GO:0003823,antigen binding,0.824366351,MF
-61,0.70798181,106,GO:1990837,sequence-specific double-stranded DNA binding,0.831004203,MF
-194,0.710280844,10,GO:0031690,adrenergic receptor binding,0.832284866,MF
-30,0.712567253,436,GO:0046872,metal ion binding,0.833546413,MF
-155,0.717198275,15,GO:0052866,phosphatidylinositol phosphate phosphatase activity,0.837541714,MF
91,0.718622042,43,GO:0004722,protein serine/threonine phosphatase activity,0.837784411,MF
-177,0.72221299,11,GO:0034185,apolipoprotein binding,0.840548564,MF
-110,0.724590557,28,GO:0050840,extracellular matrix binding,0.841893581,MF
-94,0.726370372,38,GO:0005230,extracellular ligand-gated ion channel activity,0.842540717,MF
-120,0.728467084,23,GO:0019205,nucleobase-containing compound kinase activity,0.843552641,MF
138,0.729980895,17,GO:0030371,translation repressor activity,0.84388731,MF
-133,0.733399596,18,GO:0016769,"transferase activity, transferring nitrogenous groups",0.845300176,MF
-141,0.733656757,16,GO:0030170;GO:0070279,pyridoxal phosphate binding,0.845300176,MF
-30,0.737551688,374,GO:0008233,peptidase activity,0.845916167,MF
-116,0.737618623,23,GO:0000149,SNARE binding,0.845916167,MF
-84,0.73897576,43,GO:0051015,actin filament binding,0.845916167,MF
-108,0.73910237,26,GO:0005231,excitatory extracellular ligand-gated ion channel activity,0.845916167,MF
-163,0.743139198,11,GO:0016679,"oxidoreductase activity, acting on diphenols and related substances as donors",0.849125883,MF
141,0.748670996,14,GO:0031545,peptidyl-proline 4-dioxygenase activity,0.854030325,MF
-166,0.749934552,10,GO:0001786,phosphatidylserine binding,0.854057696,MF
69,0.752071115,57,GO:0008201,heparin binding,0.855077555,MF
133,0.754992925,15,GO:0008266,poly(U) RNA binding,0.856129958,MF
-155,0.755481879,11,GO:0043325,"phosphatidylinositol-3,4-bisphosphate binding",0.856129958,MF
84,0.758051348,37,GO:0016407,acetyltransferase activity,0.856886241,MF
146,0.758885415,12,GO:0016417,S-acyltransferase activity,0.856886241,MF
-130,0.759880252,15,GO:0008483,transaminase activity,0.856886241,MF
-65,0.766443552,57,GO:0022843,voltage-gated cation channel activity,0.862283111,MF
-65,0.767182818,57,GO:0004197,cysteine-type endopeptidase activity,0.862283111,MF
122,0.768420653,16,GO:0070405,ammonium ion binding,0.862283111,MF
-151,0.772147139,10,GO:0005227,calcium activated cation channel activity,0.864437737,MF
102,0.772849994,22,GO:0008080,N-acetyltransferase activity,0.864437737,MF
-105,0.775513148,20,GO:0004623,phospholipase A2 activity,0.864711446,MF
-136,0.775604752,12,GO:0005504,fatty acid binding,0.864711446,MF
91,0.783799399,25,GO:0042562,hormone binding,0.872400182,MF
-63,0.785033546,52,GO:0035257,nuclear hormone receptor binding,0.872400182,MF
49,0.78761672,85,GO:0019207,kinase regulator activity,0.873861385,MF
-44,0.792683953,97,GO:0004857,enzyme inhibitor activity,0.878069524,MF
-89,0.79580863,23,GO:0042165,neurotransmitter binding,0.878575576,MF
64,0.79695189,45,GO:0001664,G protein-coupled receptor binding,0.878575576,MF
128,0.796966233,11,GO:0043027,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,0.878575576,MF
-53,0.798984557,64,GO:0005244;GO:0022832,voltage-gated channel activity,0.878666294,MF
116,0.79959908,13,GO:0018024,histone-lysine N-methyltransferase activity,0.878666294,MF
-52,0.80218159,65,GO:0000977,RNA polymerase II regulatory region sequence-specific DNA binding,0.880100503,MF
48,0.80395896,75,GO:0019887,protein kinase regulator activity,0.880648209,MF
117,0.805415973,12,GO:0005007,fibroblast growth factor-activated receptor activity,0.880843818,MF
38,0.809551671,111,GO:0016746,"transferase activity, transferring acyl groups",0.88308301,MF
66,0.810714725,36,GO:0005267,potassium channel activity,0.88308301,MF
55,0.811308483,52,GO:0099094,ligand-gated cation channel activity,0.88308301,MF
-79,0.814208512,24,GO:0030546,receptor activator activity,0.884841743,MF
-26,0.816780832,230,GO:0046914,transition metal ion binding,0.88623936,MF
-112,0.822200387,11,GO:0015279,store-operated calcium channel activity,0.890717086,MF
-106,0.824860422,12,GO:0045309,protein phosphorylated amino acid binding,0.892195967,MF
-110,0.833401012,10,GO:0008157,protein phosphatase 1 binding,0.900020842,MF
-29,0.836036126,141,GO:0008270,zinc ion binding,0.901402862,MF
88,0.837297288,15,GO:0042826,histone deacetylase binding,0.901402862,MF
44,0.839091712,58,GO:0005516,calmodulin binding,0.901925413,MF
92,0.84041755,13,GO:0017151,DEAD/H-box RNA helicase binding,0.901943446,MF
-58,0.846160312,31,GO:0019210,kinase inhibitor activity,0.904099188,MF
101,0.846748462,10,GO:0000900,"translation repressor activity, mRNA regulatory element binding",0.904099188,MF
-21,0.847946588,243,GO:0008289,lipid binding,0.904099188,MF
55,0.848656572,33,GO:0051879,Hsp90 protein binding,0.904099188,MF
-43,0.850233182,54,GO:0051427,hormone receptor binding,0.904099188,MF
75,0.850821705,17,GO:0048365,Rac GTPase binding,0.904099188,MF
17,0.851611572,350,GO:0005102,signaling receptor binding,0.904099188,MF
-48,0.860717659,36,GO:0016860,intramolecular oxidoreductase activity,0.912360719,MF
-65,0.864252211,19,GO:0005518,collagen binding,0.914700113,MF
67,0.867587547,17,GO:0016278;GO:0016279,lysine N-methyltransferase activity,0.916752784,MF
-44,0.868852784,39,GO:0016922,nuclear receptor binding,0.916752784,MF
-48,0.872760447,30,GO:0035258,steroid hormone receptor binding,0.91946781,MF
-61,0.882209372,16,GO:0008146,sulfotransferase activity,0.927809332,MF
-60,0.884125637,16,GO:0047485,protein N-terminus binding,0.927809332,MF
48,0.884718043,25,GO:0048487,beta-tubulin binding,0.927809332,MF
60,0.888776673,15,GO:0008376,acetylgalactosaminyltransferase activity,0.93064913,MF
-45,0.890226146,26,GO:0035064;GO:0140034,methylation-dependent protein binding,0.930752375,MF
64,0.892927893,12,GO:0051536;GO:0051540,iron-sulfur cluster binding,0.932162603,MF
-60,0.895497947,13,GO:0004656,procollagen-proline 4-dioxygenase activity,0.933431294,MF
-25,0.897779163,70,GO:0000287,magnesium ion binding,0.934395534,MF
16,0.90469436,156,GO:0001067,regulatory region nucleic acid binding,0.940172571,MF
-13,0.906612966,247,GO:0022838,substrate-specific channel activity,0.94074749,MF
-12,0.911970591,260,GO:0042623,"ATPase activity, coupled",0.944883816,MF
13,0.914430534,179,GO:0015077,monovalent inorganic cation transmembrane transporter activity,0.946009967,MF
22,0.917572088,61,GO:0140030,modification-dependent protein binding,0.947814028,MF
-43,0.919308513,15,GO:0031543,peptidyl-proline dioxygenase activity,0.947814028,MF
34,0.920664163,23,GO:0043014,alpha-tubulin binding,0.947814028,MF
38,0.922434685,18,GO:1901567,fatty acid derivative binding,0.947814028,MF
28,0.923434534,32,GO:0008022,protein C-terminus binding,0.947814028,MF
28,0.926294935,31,GO:0031593,polyubiquitin modification-dependent protein binding,0.947814028,MF
41,0.926409522,14,GO:0050997,quaternary ammonium group binding,0.947814028,MF
10,0.92717947,240,GO:0005216,ion channel activity,0.947814028,MF
36,0.935820673,14,GO:0004383,guanylate cyclase activity,0.955230287,MF
7,0.940154836,297,GO:0016887,ATPase activity,0.958234736,MF
-19,0.946048836,35,GO:0004725,protein tyrosine phosphatase activity,0.962817797,MF
20,0.951693529,26,GO:0004860,protein kinase inhibitor activity,0.967133984,MF
24,0.955576113,15,GO:0035673,oligopeptide transmembrane transporter activity,0.969649399,MF
-22,0.965056606,11,GO:0001530,lipopolysaccharide binding,0.977746421,MF
16,0.966393778,19,GO:0022824;GO:0022835,transmitter-gated ion channel activity,0.977746421,MF
11,0.970499785,33,GO:0050660,flavin adenine dinucleotide binding,0.980460926,MF
16,0.974536379,11,GO:0016307,phosphatidylinositol phosphate kinase activity,0.981905465,MF
-15,0.974779881,12,GO:0034593,phosphatidylinositol bisphosphate phosphatase activity,0.981905465,MF
-14,0.976437939,13,GO:0004869,cysteine-type endopeptidase inhibitor activity,0.982139766,MF
3,0.980876193,250,GO:0015267;GO:0022803,channel activity,0.985165739,MF
-5,0.992270679,10,GO:0016854,racemase and epimerase activity,0.995159386,MF
-1,0.993817925,152,GO:0044212,transcription regulatory region DNA binding,0.995262427,MF
1,0.997430703,45,GO:0042887,amide transmembrane transporter activity,0.997430703,MF